Powered by Deep Web Technologies
Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


1

Comparison of flat cleaved and cylindrical diffusing fibers as treatment sources for interstitial photodynamic therapy  

SciTech Connect (OSTI)

Purpose: For interstitial photodynamic therapy (iPDT) of bulky tumors, careful treatment planning is required in order to ensure that a therapeutic dose is delivered to the tumor, while minimizing damage to surrounding normal tissue. In clinical contexts, iPDT has typically been performed with either flat cleaved or cylindrical diffusing optical fibers as light sources. Here, the authors directly compare these two source geometries in terms of the number of fibers and duration of treatment required to deliver a prescribed light dose to a tumor volume. Methods: Treatment planning software for iPDT was developed based on graphics processing unit enhanced Monte Carlo simulations. This software was used to optimize the number of fibers, total energy delivered by each fiber, and the position of individual fibers in order to deliver a target light dose (D{sub 90}) to 90% of the tumor volume. Treatment plans were developed using both flat cleaved and cylindrical diffusing fibers, based on tissue volumes derived from CT data from a head and neck cancer patient. Plans were created for four cases: fixed energy per fiber, fixed number of fibers, and in cases where both or neither of these factors were fixed. Results: When the number of source fibers was fixed at eight, treatment plans based on flat cleaved fibers required each to deliver 7180–8080 J in order to deposit 90 J/cm{sup 2} in 90% of the tumor volume. For diffusers, each fiber was required to deliver 2270–2350 J (333–1178 J/cm) in order to achieve this same result. For the case of fibers delivering a fixed 900 J, 13 diffusers or 19 flat cleaved fibers at a spacing of 1 cm were required to deliver the desired dose. With energy per fiber fixed at 2400 J and the number of fibers fixed at eight, diffuser fibers delivered the desired dose to 93% of the tumor volume, while flat cleaved fibers delivered this dose to 79%. With both energy and number of fibers allowed to vary, six diffusers delivering 3485–3600 J were required, compared to ten flat cleaved fibers delivering 2780–3600 J. Conclusions: For the same number of fibers, cylindrical diffusers allow for a shorter treatment duration compared to flat cleaved fibers. For the same energy delivered per fiber, diffusers allow for the insertion of fewer fibers in order to deliver the same light dose to a target volume.

Baran, Timothy M., E-mail: timothy.baran@rochester.edu; Foster, Thomas H. [Department of Imaging Sciences, University of Rochester, Rochester, New York 14642 (United States)] [Department of Imaging Sciences, University of Rochester, Rochester, New York 14642 (United States)

2014-02-15T23:59:59.000Z

2

Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease  

SciTech Connect (OSTI)

The authors describe a patient with ulcerative colitis and extracolonic manifestations in whom diffuse interstitial pulmonary disease developed that was responsive to glucocorticoid therapy one year after total proctocolectomy. The patient presented in December 1983 with a subacute course marked by cough and progressive exertional dyspnea, abnormal chest examination results, and a chest roentgenogram that revealed diffuse interstitital and alveolar infiltrates. A transbronchial biopsy specimen revealed a polymorphic interstitial infiltrate, mild interstitial fibrosis without apparent intraluminal fibrosis, and no vasculitis, granulomas, or significant eosinophilic infiltration. Within one week of the initiation of daily high-dose steroid therapy, the patient's symptoms dramatically improved; chest roentgenogram and forced vital capacity (60%) improved at a slower rate. All three measures deteriorated when alternate-day prednisone therapy was started but once again improved until the patient was totally asymptomatic, chest roentgenograms were normal, and forced vital capacity was 80% of the predicted value 2 1/2 years later.

Balestra, D.J.; Balestra, S.T.; Wasson, J.H.

1988-07-01T23:59:59.000Z

3

Carborane derivative development for boron neutron capture therapy. Final report  

SciTech Connect (OSTI)

Boron Neutron Capture Therapy [BNCT] is a binary method of cancer therapy based on the capture of neutrons by a boron-10 atom [{sup 10}B]. Cytotoxic {sup 7}Li nuclei and {alpha}-particles are emitted, with a range in tissue of 9 and 5 {micro}m, respectively, about one cell diameter. The major obstacle to clinically viable BNCT is the selective localization of 5-30 ppm {sup 10}B in tumor cells required for effective therapy. A promising approach to BNCT is based on hydrophilic boron-rich oligomeric phosphate diesters, or ''trailers'' that have been shown to concentrate selectively in tumor tissue. Examples of these compounds were prepared previously at high cost using an automated DNA synthesizer. Direct synthesis methods are needed for the production of gram-scale quantities for further biological evaluation. The work accomplished as a result of the collaboration between Fluorochem, Inc. and UCLA demonstrates that short oligomers containing at least five carborane units with four phosphodiester linkages can be prepared in substantial quantities. This work was accomplished by the application of standard phosphoramidite coupling chemistry.

Barnum, Beverly A.; Yan Hao; Moore, Roger; Hawthorne, M. Frederick; Baum, Kurt

1999-04-01T23:59:59.000Z

4

DFT STUDY REVISES INTERSTITIAL CONFIGURATIONS IN HCP Zr  

SciTech Connect (OSTI)

Analysis of experimental result on microstructure evolution in irradiated Zr and alloys has demonstrated that available knowledge on self-interstitial defects in Zr is in contradiction. We therefore have initiated an extensive theoretical and modeling program to clarify this issue. In this report we present first ab initio calculations results of single SIA configurations in Zr. We demonstrate importance of simulations cell size, applied exchange-correlation functional and simulated c/a ratio. The results obtained demonstrate clearly that the most stable configurations are in basal plane and provide some evidences for enhanced interstitial transport along basal planes. The results obtained will be used in generation a new interatomic potential for Zr to be used in large-scale atomistic modeling of mechanisms relevant for radiation-induced microstructure evolution.

Samolyuk, German D [ORNL; Golubov, Stanislav I [ORNL; Osetskiy, Yury N [ORNL; Stoller, Roger E [ORNL

2012-06-01T23:59:59.000Z

5

Phase I, study of a miniature X-ray source for interstitial radiotherapy of brain metastases  

SciTech Connect (OSTI)

Despite a variety of stereotactic techniques used to increase intracranical local control, dose escalation strategies remain controversial, with respect to therapeutric gain, convenience, and cost effectiveness, in the setting of brain metastases. In this report, we summarize our experience with the safety and efficacy of a new miniature X-ray device for interstitial radiosurgical treatment of intracranial metastatic neoplasms. Although the role of surgical resection of solitary metastases is established, aggressive treatment with proton, gamma knife, and linac radiation therapy for these lesions is under investigation. The new miniature X-ray device offers a very localized, convenient, time and cost efficient means of delivering radiotherapy to these lesions, with lower normal tissue exposure than gamma knife or proton beam techniques. Retreatment of previously irradiated areas are also now under investigation as part of a Phase II trial. The photon radiosurgery system is a miniature battery operated 40 kV x-ray device designed by the Photoelectron Corporation for use in the interstitial treatment of small tumors ({ge}3 cm in diameter) in humans. This 10 cm long, low current, high voltage X-ray generator is easily mounted in a stereotactic frame and produces low energy (10-20 KeV) x-rays to be emitted from the 10 cm long, 3.2 mm diameter probe, after stereotactic insertion into the tumor. Two scintillation detectors positioned on the stereotactic frame near the patient`s scalp monitor radiation. The spherical X-ray beam behaves essentially as a point source, with dose rate nominally 150 cGy/min. at a distance of 10mm, for a beam current of 40 {mu}A and a voltage of 40 kv.

Douglas, R.M.; Beatty, J.; Biggs, P. [Massachusetts General Hospital, Boston, MA (United States)] [and others] [Massachusetts General Hospital, Boston, MA (United States); and others

1995-12-31T23:59:59.000Z

6

Di-interstitial defect in silicon revisited  

SciTech Connect (OSTI)

Infrared spectroscopy was used to study the defect spectrum of Cz-Si samples following fast neutron irradiation. We mainly focus on the band at 533 cm{sup ?1}, which disappears from the spectra at ?170 °C, exhibiting similar thermal stability with the Si-P6 electron paramagnetic resonance (EPR) spectrum previously correlated with the di-interstitial defect. The suggested structural model of this defect comprises of two self-interstitial atoms located symmetrically around a lattice site Si atom. The band anneals out following a first-order kinetics with an activation energy of 0.88 ± 0.3 eV. This value does not deviate considerably from previously quoted experimental and theoretical values for the di-interstitial defect. The present results indicate that the 533 cm{sup ?1} IR band originates from the same structure as that of the Si-P6 EPR spectrum.

Londos, C. A.; Antonaras, G. [Solid State Section, Physics Department, University of Athens, Panepistimiopolis, Zografos, 157 84 Athens (Greece)] [Solid State Section, Physics Department, University of Athens, Panepistimiopolis, Zografos, 157 84 Athens (Greece); Chroneos, A. [Engineering and Innovation, The Open University, Milton Keynes MK7 6AA (United Kingdom) [Engineering and Innovation, The Open University, Milton Keynes MK7 6AA (United Kingdom); Department of Materials, Imperial College London, London SW7 2BP (United Kingdom)

2013-11-21T23:59:59.000Z

7

Integration of microvascular, interstitial, and lymphatic function to determine the effect of their interaction on interstitial fluid volume  

E-Print Network [OSTI]

, three specific aims were achieved. 1) Develop a simple, transparent, and general algebraic approach that predicts interstitial fluid pressure, volume and protein concentration resulting from the interaction of microvascular, interstitial and lymphatic...

Dongaonkar, Ranjeet Manohar

2009-05-15T23:59:59.000Z

8

Structure and high-temperature properties of Ti{sub 5}Si{sub 3} with interstitial additions  

SciTech Connect (OSTI)

This study was motivated by the fact that previous research on the structure and properties of Ti{sub 5}Si{sub 3} showed unacceptably inconsistent results. The primary reason for these inconsistencies was interstitial contamination of Ti{sub 5}Si{sub 3} by carbon, nitrogen and oxygen. Thus, this study measured the effects that these interstitial atoms have on some of the previously reported properties. These properties include crystalline structure, thermal expansion anisotropy, electronic structure and bonding, and high temperature oxidation resistance. In Chapter 2 of this study, the lattice parameters and atomic positions of Ti{sub 5}Si{sub 3} as a function of carbon, nitrogen or oxygen content were measured via x-ray and neutron diffraction. Comparing these lattice parameters to those reported in other studies on supposedly pure Ti{sub 5}Si{sub 3} confirmed that the majority of the previous studies had samples with a considerable amount of interstitial impurities. In fact, the lattice parameter trends given in Chapter 2 can be used to estimate the types and level of impurities in these studies. Furthermore, Chapter 2 discusses how atomic positions change as interstitial atoms are incorporated into the lattice. These changes in atomic separations suggest that strong bonds form between the interstitial atoms and the surrounding titanium atoms. This is in full agreement with the electronic structure calculations given in Chapter 4. These calculations show that bonding does occur between titanium d-states and interstitial atom p-states at the expense of bonding between some of the titanium and silicon atoms. In addition, carbon seems to be the most strongly bonded interstitial atom. Knowledge of the exact interstitial content and its effect on bonding is important because Chapters 3 and 5 have shown that interstitial atoms have a marked effect on the thermal expansion and oxidation resistance. As discussed in Chapter 3, all interstitial atoms lower the thermal expansion anisotropy of Ti{sub 5}Si{sub 3} due to the formation of bonds between the interstitial atom and the surrounding titanium atoms. Although interstitial atoms do have an effect on the thermal expansion of Ti{sub 5}Si{sub 3}, these effects were not strong enough to explain all the scatter of previous studies. These studies most likely suffered from systematic errors as a result of poor experimental design. The experimental procedure used in this study was designed to significantly reduce these systematic errors.

Williams, Jason

1999-12-01T23:59:59.000Z

9

Self-Reported Cognitive Outcomes in Patients With Brain Metastases Before and After Radiation Therapy  

SciTech Connect (OSTI)

Purpose: Patients with brain metastases may experience treatment-related cognitive deficits. In this study, we prospectively assessed the self-reported cognitive abilities of patients with brain metastases from any solid primary cancer before and after irradiation of the brain. Methods and Materials: The treatment group (TG) consisted of adult patients (n=50) with brain metastases who received whole or partial irradiation of the brain without having received prior radiation therapy (RT). The control group (CG) consisted of breast cancer patients (n=27) without cranial involvement who were treated with adjuvant RT. Patients were recruited between May 2008 and December 2010. Self-reported cognitive abilities were acquired before RT and 6 weeks, 3 months, and 6 months after irradiation. The information regarding the neurocognitive status was collected by use of the German questionnaires for self-perceived deficits in attention (FEDA) and subjectively experienced everyday memory performance (FEAG). Results: The baseline data showed a high proportion of self-perceived neurocognitive deficits in both groups. A comparison between the TG and the CG regarding the course of self-reported outcomes after RT showed significant between-group differences for the FEDA scales 2 and 3: fatigue and retardation of daily living activities (P=.002) and decrease in motivation (P=.032) with an increase of attention deficits in the TG, but not in the CG. There was a trend towards significance in FEDA scale 1: distractibility and retardation of mental processes (P=.059) between the TG and the CG. The FEAG assessment presented no significant differences. An additional subgroup analysis within the TG was carried out. FEDA scale 3 showed significant differences in the time-related progress between patients with whole-brain RT and those receiving hypofractionated stereotactic RT (P=.025), with less decrease in motivation in the latter group. Conclusion: Self-reported attention declined in patients with brain metastases after RT to the brain, whereas it remained relatively stable in breast cancer patients.

Cole, Ansa Maer [Department of Radiation Oncology, Medical School Hannover, Hannover (Germany); Scherwath, Angela [Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg (Germany); Ernst, Gundula [Department of Medical Psychology, Medical School Hannover, Hannover (Germany); Lanfermann, Heinrich [Institute for Neuroradiology, Medical School Hannover, Hannover (Germany); Bremer, Michael [Department of Radiation Oncology, Medical School Hannover, Hannover (Germany); Steinmann, Diana, E-mail: steinmann.diana@mh-hannover.de [Department of Radiation Oncology, Medical School Hannover, Hannover (Germany)

2013-11-15T23:59:59.000Z

10

Intraoperative radiation therapy using mobile electron linear accelerators: Report of AAPM Radiation Therapy Committee Task Group No. 72  

SciTech Connect (OSTI)

Intraoperative radiation therapy (IORT) has been customarily performed either in a shielded operating suite located in the operating room (OR) or in a shielded treatment room located within the Department of Radiation Oncology. In both cases, this cancer treatment modality uses stationary linear accelerators. With the development of new technology, mobile linear accelerators have recently become available for IORT. Mobility offers flexibility in treatment location and is leading to a renewed interest in IORT. These mobile accelerator units, which can be transported any day of use to almost any location within a hospital setting, are assembled in a nondedicated environment and used to deliver IORT. Numerous aspects of the design of these new units differ from that of conventional linear accelerators. The scope of this Task Group (TG-72) will focus on items that particularly apply to mobile IORT electron systems. More specifically, the charges to this Task Group are to (i) identify the key differences between stationary and mobile electron linear accelerators used for IORT (ii) describe and recommend the implementation of an IORT program within the OR environment, (iii) present and discuss radiation protection issues and consequences of working within a nondedicated radiotherapy environment, (iv) describe and recommend the acceptance and machine commissioning of items that are specific to mobile electron linear accelerators, and (v) design and recommend an efficient quality assurance program for mobile systems.

Sam Beddar, A.; Biggs, Peter J.; Chang Sha; Ezzell, Gary A.; Faddegon, Bruce A.; Hensley, Frank W.; Mills, Michael D. [Department of Radiation Physics, Division of Radiation Oncology, Unit 94, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030 (United States); Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114 (United States); Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 (United States); Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259 (United States); Department of Radiation Oncology, University of California San Francisco, San Francisco, California 94143 (United States); Department of Radiation Oncology, University of Heidelberg, 69120 Heidelberg (Germany); Department of Radiation Oncology, James Graham Brown Cancer Center, Louisville, Kentucky 40202 (United States)

2006-05-15T23:59:59.000Z

11

Interstitial Fe in MgO  

SciTech Connect (OSTI)

Isolated {sup 57}Fe atoms were studied in MgO single-crystals by emission Mössbauer spectroscopy following implantation of {sup 57}Mn decaying to {sup 57}Fe. Four Mössbauer spectral components were found corresponding to different Fe lattice positions and/or charge states. Two components represent Fe atoms substituting Mg as Fe{sup 2+} and Fe{sup 3+}, respectively; a third component is due to Fe in a strongly implantation-induced disturbed region. The fourth component, which is the focus of this paper, can be assigned to Fe at an interstitial site. Comparison of its measured isomer shift with ab initio calculations suggests that the interstitial Fe is located on, or close to, the face of the rock-salt MgO structure. To harmonize such an assignment with the measured near-zero quadrupole interaction a local motion process (cage motion) of the Fe has to be stipulated. The relation of such a local motion as a starting point for long range diffusion is discussed.

Mřlholt, T. E., E-mail: tem4@hi.is; Gislason, H. P.; Ólafsson, S. [Science Institute, University of Iceland, Dunhaga 3, IS-107 Reykjavík (Iceland); Mantovan, R. [Laboratorio MDM, IMM-CNR, Via Olivetti 2, 20846 Agrate Brianza (MB) (Italy); Gunnlaugsson, H. P.; Svane, A.; Weyer, G. [Department of Physics and Astronomy, Aarhus University, DK-8000 Aarhus C (Denmark); Masenda, H.; Naidoo, D. [School of Physics, University of the Witwatersrand, WITS 2050 (South Africa); Bharuth-Ram, K. [Durban University of Technology, Durban 4001 (South Africa); Fanciulli, M. [Laboratorio MDM, IMM-CNR, Via Olivetti 2, 20846 Agrate Brianza (MB) (Italy); Dipartimento di Scienza dei Materiali, Universitŕ di Milano Bicocca, Milano (Italy); Johnston, K. [PH Department, ISOLDE/CERN, 1211 Geneva 23 (Switzerland); Langouche, G. [Instituut voor Kern-en Stralings fysika, University of Leuven, B-3001 Leuven (Belgium); Sielemann, R. [Helmholtz-Zentrum-Berlin für Materialien und Energie, D-14109 Berlin (Germany)

2014-01-14T23:59:59.000Z

12

E-Print Network 3.0 - acute interstitial nephritis Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

with a possible diagnosis of acute interstitial nephritis in patients treated... of infusion techniques with low-dose bupivacaine and an Interstitial nephritis associated with...

13

Patient-Specific Dosimetry and Radiobiological Modeling of Targeted Radionuclide Therapy Grant - final report  

SciTech Connect (OSTI)

The broad, long-term objectives of this application are to 1. develop easily implementable tools for radionuclide dosimetry that can be used to predict normal organ toxicity and tumor response in targeted radionuclide therapy; and 2. to apply these tools to the analysis of clinical trial data in order to demonstrate dose-response relationships for radionuclide therapy treatment planning. The work is founded on the hypothesis that robust dose-response relationships have not been observed in targeted radionuclide therapy studies because currently available internal dosimetry methodologies are inadequate, failing to adequately account for individual variations in patient anatomy, radionuclide activity distribution/kinetics, absorbed dose-distribution, and absorbed dose-rate. To reduce development time the previously available software package, 3D-ID, one of the first dosimetry software packages to incorporate 3-D radionuclide distribution with individual patient anatomy; and the first to be applied for the comprehensive analysis of patient data, will be used as a platform to build the functionality listed above. The following specific aims are proposed to satisfy the long-term objectives stated above: 1. develop a comprehensive and validated methodology for converting one or more SPECT images of the radionuclide distribution to a 3-D representation of the cumulated activity distribution; 2. account for differences in tissue density and atomic number by incorporating an easily implementable Monte Carlo methodology for the 3-D dosimetry calculations; 3. incorporate the biologically equivalent dose (BED) and equivalent uniform dose (EUD) models to convert the spatial distribution of absorbed dose and dose-rate into equivalent single values that account for differences in dose uniformity and rate and that may be correlated with tumor response and normal organ toxicity; 4. test the hypothesis stated above by applying the resulting package to patient trials of targeted radionuclide therapy to obtain normal organ and tumor dose vs. response correlations. Completion of the aims outlined above will make it possible to perform patient-specific dosimetry that incorporates considerations likely to provide robust dose-response relationships. Such an advance will improve targeted radionuclide therapy by making it possible to adopt treatment planning methodologies.

George Sgouros, Ph.D.

2007-03-20T23:59:59.000Z

14

Effects of interstitial flow on tumor cell migration  

E-Print Network [OSTI]

Interstitial flow is the convective transport of fluid through tissue extracellular matrix. This creeping fluid flow has been shown to affect the morphology and migration of cells such as fibroblasts, cancer cells, endothelial ...

Polacheck, William J. (William Joseph)

2010-01-01T23:59:59.000Z

15

An analytical and experimental investigation for an interstitial insulation technology  

E-Print Network [OSTI]

) as the interstitial insulation material. Both the inner and outer surface temperatures of the coaxial pipes were measured in order to evaluate the effective thermal conductivity and thermal diffusivity of the insulation concept. The predicted results from the model...

Kim, Dong Keun

2009-05-15T23:59:59.000Z

16

Evaluation of anelastic evidence for interstitial solute binding in bcc metals  

SciTech Connect (OSTI)

A Direct Spectrum Analysis (DSA) technique has been applied to key internal friction and elastic after-effect data which are involved in the controversy over the existance of interstitial clustering in the refractory metals. It is found that at relatively high interstitial solute concentrations some of the Snoek peak broadening is due to relaxations that are distinct from the main relaxation. This finding supports the view that interstitial solutes have an interaction that produces clusters of interstitials.

Cost, J.R.; Stanley, J.T.

1985-01-01T23:59:59.000Z

17

Phase-field Model for Interstitial Loop Growth Kinetics and Thermodynamic and Kinetic Models of Irradiated Fe-Cr Alloys  

SciTech Connect (OSTI)

Microstructure evolution kinetics in irradiated materials has strongly spatial correlation. For example, void and second phases prefer to nucleate and grow at pre-existing defects such as dislocations, grain boundaries, and cracks. Inhomogeneous microstructure evolution results in inhomogeneity of microstructure and thermo-mechanical properties. Therefore, the simulation capability for predicting three dimensional (3-D) microstructure evolution kinetics and its subsequent impact on material properties and performance is crucial for scientific design of advanced nuclear materials and optimal operation conditions in order to reduce uncertainty in operational and safety margins. Very recently the meso-scale phase-field (PF) method has been used to predict gas bubble evolution, void swelling, void lattice formation and void migration in irradiated materials,. Although most results of phase-field simulations are qualitative due to the lake of accurate thermodynamic and kinetic properties of defects, possible missing of important kinetic properties and processes, and the capability of current codes and computers for large time and length scale modeling, the simulations demonstrate that PF method is a promising simulation tool for predicting 3-D heterogeneous microstructure and property evolution, and providing microstructure evolution kinetics for higher scale level simulations of microstructure and property evolution such as mean field methods. This report consists of two parts. In part I, we will present a new phase-field model for predicting interstitial loop growth kinetics in irradiated materials. The effect of defect (vacancy/interstitial) generation, diffusion and recombination, sink strength, long-range elastic interaction, inhomogeneous and anisotropic mobility on microstructure evolution kinetics is taken into account in the model. The model is used to study the effect of elastic interaction on interstitial loop growth kinetics, the interstitial flux, and sink strength of interstitial loop for interstitials. In part II, we present a generic phase field model and discuss the thermodynamic and kinetic properties in phase-field models including the reaction kinetics of radiation defects and local free energy of irradiated materials. In particular, a two-sublattice thermodynamic model is suggested to describe the local free energy of alloys with irradiated defects. Fe-Cr alloy is taken as an example to explain the required thermodynamic and kinetic properties for quantitative phase-field modeling. Finally the great challenges in phase-field modeling will be discussed.

Li, Yulan; Hu, Shenyang Y.; Sun, Xin; Khaleel, Mohammad A.

2011-06-15T23:59:59.000Z

18

Atomistic Study of the Migration of Di- and Tri-Interstitials...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

silicon is performed using classical molecular dynamics simulations with a Stillinger-Weber potential. At first the structures and energetics of the di- and the tri-interstitial...

19

On the Origin of Large Interstitial Clusters in Displacement Cascades  

SciTech Connect (OSTI)

Displacement cascades with wide ranges of primary knock-on atom (PKA) energy and mass in iron were simulated using molecular dynamics. New visualisation techniques are introduced to show how the shock-front dynamics and internal structure of a cascade develop over time. These reveal that the nature of the final damage is determined early on in the cascade process. We define a zone (termed 'spaghetti') in which atoms are moved to new lattice sites and show how it is created by a supersonic shock-front expanding from the primary recoil event. A large cluster of self-interstitial atoms can form on the periphery of the spaghetti if a hypersonic recoil creates damage with a supersonic shock ahead of the main supersonic front. When the two fronts meet, the main one injects atoms into the low-density core of the other: these become interstitial atoms during the rapid recovery of the surrounding crystal. The hypersonic recoil occurs in less than 0.1 ps after the primary recoil and the interstitial cluster is formed before the onset of the thermal spike phase of the cascade process. The corresponding number of vacancies is then formed in the spaghetti core as the crystal cools, i.e. at times one to two orders of magnitude longer. By using the spaghetti zone to define cascade volume, the energy density of a cascade is shown to be almost independent of the PKA mass. This throws into doubt the conventional energy-density interpretation of an increased defect yield with increasing PKA mass in ion irradiation.

Andrew, Calder F [University of Liverpool; Barashev, Aleksandr [University of Liverpool; Bacon, David J [University of Liverpool; Osetskiy, Yury N [ORNL

2010-01-01T23:59:59.000Z

20

Stability and Migration of Charged Oxygen Interstitials in ThO2...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

oxygen interstitial mobility in ThO2 than in CeO2. Citation: Xiao HY, Y Zhang, and WJ Weber.2013."Stability and Migration of Charged Oxygen Interstitials in ThO2 and CeO2."Acta...

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


21

Exchange of deeply trapped and interstitial hydrogen in silicon Blair Tuttle  

E-Print Network [OSTI]

Exchange of deeply trapped and interstitial hydrogen in silicon Blair Tuttle Department of Physics Engineering, Arizona State University, Tempe, Arizona 85287-6006 Received 22 May 1998; revised manuscript mechanisms between an interstitial hydrogen atom and a deeply bound H at a silicon-hydrogen bond. We

Adams, James B

22

Relation between thermal expansion and interstitial formation energy in pure Fe and Cr  

E-Print Network [OSTI]

Relation between thermal expansion and interstitial formation energy in pure Fe and Cr Janne potentials give lower interstitial formation energy, but predict too small thermal expansion. We also show University, Uppsala, Sweden Abstract By fitting a potential of modified Finnis­Sinclair type to the thermal

23

Molecular Medicine: Synthesis and In Vivo Detection of Agents for use in Boron Neutron Capture Therapy. Final Report  

SciTech Connect (OSTI)

The primary objective of the project was the development of in vivo methods for the detection and evaluation of tumors in humans. The project was focused on utilizing positron emission tomography (PET) to monitor the distribution and pharamacokinetics of a current boron neutron capture therapy (BNCT) agent, p-boronophenylalanine (BPA) by labeling it with a fluorine-18, a positron emitting isotope. The PET data was then used to develop enhanced treatment planning protocols. The study also involved the synthesis of new tumor selective BNCTagents that could be labeled with radioactive nuclides for the in vivo detection of boron.

Kabalka, G. W.

2005-06-28T23:59:59.000Z

24

Estimation of isodose curves in radiation therapy and related response analysis  

E-Print Network [OSTI]

. The main problem in interstitial radiation therapy is the accurate calculation of dosages from volume needle implants. Some researchers in the U. S. expressed the belief several years ago that new methods of cobalt-60 teletherapy and other external beam... radiation therapy to be effective it is necessary to calculate the intensity distribution created by the several implanted needles. With the advent of high-speed electronic computers the various isodose curves in a given case can be determined and plotted...

Goodlett, James Campbell

1967-01-01T23:59:59.000Z

25

Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report  

E-Print Network [OSTI]

-line JOURNAL OF MEDICAL CASE REPORTS Kasi Loknath Kumar et al. Journal of Medical Case Reports 2014, 8:299 http://www.jmedicalcasereports.com/content/8/1/299Kansas City, KS, USA Full list of author information is available at the end of the articlesetting..., University of Kansas Medical Center,transplant: a case report Anup Kasi Loknath Kumar1*, Christopher Dakhil2, Megha Teeka Satyan1 and Nisreen Haideri3 Abstract Introduction: Extramedullary myeloma that occurs during the clinical course of multiple myeloma...

Kumar, Anup Kasi Loknarth; Dakhil, Christopher; Satyan, Megha Teeka; Haideri, Nisreen

2014-09-08T23:59:59.000Z

26

Effect of interstitials on the mechanical behavior of P/M tantalum  

SciTech Connect (OSTI)

Microstructural characterization by transmission electron microscopy (TEM) has been used in an investigation of the effects of interstitial alloy content on the mechanical properties of P/M tantalum. Compacts were prepared by cold isostatic pressing (CIP) at 50 ksi (345 MPa) followed by hot isostatic pressing (HIP) at 30 ksi (207 MPa) at 1,600 C. Increases in both yield and flow stresses were observed in ambient temperature, quasi-static compression tests due to increases in interstitial alloy content. Variations in yield stress were attributed to solid solution strengthening due to interstitial elements, since no oxides, nitrides or carbides were observed via TEM.

Strutt, A.J.; Vecchio, K.S. [Univ. of California, San Diego, La Jolla, CA (United States). Dept. of Applied Mechanics and Engineering Sciences; Bingert, S.R.; Gray, G.T. III [Los Alamos National Lab., NM (United States). Materials Science and Technology Div.

1996-06-01T23:59:59.000Z

27

Interstitial-phase precipitation in iron-base alloys: a comparative study  

SciTech Connect (OSTI)

Recent developments have elucidated the atomistic mechanisms of precipitation of interstitial elements in simple alloy systems. However, in the more technologically important iron base alloys, interstitial phase precipitation is generally not well understood. The present experimental study was therefore designed to test the applicability of these concepts to more complex ferrous alloys. Hence, a comparative study was made of interstitial phase precipitation in ferritic Fe-Si-C and in austenitic phosphorus-containing Fe-Cr-Ni steels. These systems were subjected to a variety of quench-age thermal treatments, and the microstructural development was subsequently characterized by transmission electron microscopy.

Pelton, A.R.

1982-06-01T23:59:59.000Z

28

Muddy Water? Variation in Reporting Receipt of Breast Cancer Radiation Therapy by Population-Based Tumor Registries  

SciTech Connect (OSTI)

Purpose: To evaluate, in the setting of breast cancer, the accuracy of registry radiation therapy (RT) coding compared with the gold standard of Medicare claims. Methods and Materials: Using Surveillance, Epidemiology, and End Results (SEER)–Medicare data, we identified 73,077 patients aged ?66 years diagnosed with breast cancer in the period 2001-2007. Underascertainment (1 - sensitivity), sensitivity, specificity, ?, and ?{sup 2} were calculated for RT receipt determined by registry data versus claims. Multivariate logistic regression characterized patient, treatment, and geographic factors associated with underascertainment of RT. Findings in the SEER–Medicare registries were compared with three non-SEER registries (Florida, New York, and Texas). Results: In the SEER–Medicare registries, 41.6% (n=30,386) of patients received RT according to registry coding, versus 49.3% (n=36,047) according to Medicare claims (P<.001). Underascertainment of RT was more likely if patients resided in a newer SEER registry (odds ratio [OR] 1.70, 95% confidence interval [CI] 1.60-1.80; P<.001), rural county (OR 1.34, 95% CI 1.21-1.48; P<.001), or if RT was delayed (OR 1.006/day, 95% CI 1.006-1.007; P<.001). Underascertainment of RT receipt in SEER registries was 18.7% (95% CI 18.6-18.8%), compared with 44.3% (95% CI 44.0-44.5%) in non-SEER registries. Conclusions: Population-based tumor registries are highly variable in ascertainment of RT receipt and should be augmented with other data sources when evaluating quality of breast cancer care. Future work should identify opportunities for the radiation oncology community to partner with registries to improve accuracy of treatment data.

Walker, Gary V. [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Giordano, Sharon H. [Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Williams, Melanie [Texas Cancer Registry, Department of State Health Services, Austin, Texas (United States)] [Texas Cancer Registry, Department of State Health Services, Austin, Texas (United States); Jiang, Jing [Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Niu, Jiangong [Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); MacKinnon, Jill; Anderson, Patricia; Wohler, Brad [Florida Cancer Data System, University of Miami School of Medicine, Miami, Florida (United States)] [Florida Cancer Data System, University of Miami School of Medicine, Miami, Florida (United States); Sinclair, Amber H.; Boscoe, Francis P.; Schymura, Maria J. [New York State Cancer Registry, New York State Department of Health, Albany, New York (United States)] [New York State Cancer Registry, New York State Department of Health, Albany, New York (United States); Buchholz, Thomas A. [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Smith, Benjamin D., E-mail: BSmith3@mdanderson.org [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)

2013-07-15T23:59:59.000Z

29

Needle-free interstitial fluid acquisition using a Lorentz-force actuated jet injector  

E-Print Network [OSTI]

Interstitial fluid (ISF) provides information on a patient's health as it contains regulatory molecules that are correlated with disease-related processes. However, current ISF acquisition techniques can be slow, resulting ...

Chang, Jean H

2014-01-01T23:59:59.000Z

30

A theoretical analysis of interstitial hydrogen : pressure-composition-temperature, chemical potential, enthalpy and entropy  

E-Print Network [OSTI]

We provide a first principles analysis of the physics and thermodynamics of interstitial hydrogen in metal. By utilizing recent advances in Density Functional Theory (DFT) to get state energies of the metal-hydrogen system, ...

Orondo, Peter Omondi

2012-01-01T23:59:59.000Z

31

Formation, migration, and clustering of delocalized vacancies and interstitials at a solid-state semicoherent interface  

E-Print Network [OSTI]

Atomistic simulations are used to study the formation, migration, and clustering of delocalized vacancies and interstitials at a model fcc-bcc semicoherent interface formed by adjacent layers of Cu and Nb. These defects ...

Kolluri, Kedarnath

32

Quality assurance for image-guided radiation therapy utilizing CT-based technologies: A report of the AAPM TG-179  

SciTech Connect (OSTI)

Purpose: Commercial CT-based image-guided radiotherapy (IGRT) systems allow widespread management of geometric variations in patient setup and internal organ motion. This document provides consensus recommendations for quality assurance protocols that ensure patient safety and patient treatment fidelity for such systems. Methods: The AAPM TG-179 reviews clinical implementation and quality assurance aspects for commercially available CT-based IGRT, each with their unique capabilities and underlying physics. The systems described are kilovolt and megavolt cone-beam CT, fan-beam MVCT, and CT-on-rails. A summary of the literature describing current clinical usage is also provided. Results: This report proposes a generic quality assurance program for CT-based IGRT systems in an effort to provide a vendor-independent program for clinical users. Published data from long-term, repeated quality control tests form the basis of the proposed test frequencies and tolerances.Conclusion: A program for quality control of CT-based image-guidance systems has been produced, with focus on geometry, image quality, image dose, system operation, and safety. Agreement and clarification with respect to reports from the AAPM TG-101, TG-104, TG-142, and TG-148 has been addressed.

Bissonnette, Jean-Pierre; Balter, Peter A.; Dong Lei; Langen, Katja M.; Lovelock, D. Michael; Miften, Moyed; Moseley, Douglas J.; Pouliot, Jean; Sonke, Jan-Jakob; Yoo, Sua [Task Group 179, Department of Radiation Physics, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, M5G 2M9 (Canada); Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030 (United States); Department of Radiation Oncology, M. D. Anderson Cancer Center Orlando, Orlando, Florida 32806 (United States); Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 (United States); Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States); Department of Radiation Physics, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, M5G 2M9 (Canada); Department of Radiation Oncology, UCSF Comprehensive Cancer Center, 1600 Divisadero St., Suite H 1031, San Francisco, California 94143-1708 (United States); Department of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam (Netherlands); Department of Radiation Oncology, Duke University, Durham, North Carolina 27710 (United States)

2012-04-15T23:59:59.000Z

33

Machine therapy  

E-Print Network [OSTI]

Machine Therapy is a new practice combining art, design, psychoanalysis, and engineering work in ways that access and reveal the vital, though often unnoticed, relevance of people's interactions and relationships with ...

Dobson, Kelly E. (Kelly Elizabeth), 1970-

2007-01-01T23:59:59.000Z

34

Tailoring couple therapy techniques to client needs  

E-Print Network [OSTI]

have limited the accuracy of client reports on therapy. More research on therapeutic change processes in couple therapy is needed (Heatherington, Friedlander, & Greenberg, 2005) to better understand what therapy is rather than just what it does... (Orlinsky, Grawe, & Parks, 1994). In psychotherapy literature, there has been a longstanding debate centered on two components of therapy (Goldfried & Davila, 2005). One perspective focuses on ?common? or, ?nonspecific? factors such as therapeutic...

Hsueh, Annie C.

2010-01-14T23:59:59.000Z

35

Mechanism for the reduction of interstitial supersaturations in MeV-implanted silicon  

SciTech Connect (OSTI)

We demonstrate that the excess vacancies induced by a 1 MeV Si implant reduce the excess interstitials generated by a 40 keV Si implant during thermal annealing when these two implants are superimposed in silicon. It is shown that this previously observed reduction is dominated by vacancy annihilation and not by gettering to deeper interstitial-type extended defects. Interstitial supersaturations were measured using B doping superlattices (DSL) grown on a silicon-on-insulator (SOI) substrate. Implanting MeV and keV Si ions into the B DSL/SOI structure eliminated the B transient enhanced diffusion normally associated with the keV implant. The buried SiO{sub 2} layer in the SOI substrate isolates the deep interstitials-type extended defects of the MeV implant, thereby eliminating the possibility that these defects getter the interstitial excess induced by the keV Si implant. {copyright} {ital 1999 American Institute of Physics.}

Venezia, V.C. [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States)] [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States); Haynes, T.E. [Solid State Division, Oak Ridge National Laboratory, MS-6048, P.O. Box 2008, Oak Ridge, Tennessee 37831 (United States)] [Solid State Division, Oak Ridge National Laboratory, MS-6048, P.O. Box 2008, Oak Ridge, Tennessee 37831 (United States); Agarwal, A. [Semiconductor Equipment Operations, Eaton Corporation, 55 Cherry Hill Drive, Beverly, Massachusetts 01915 (United States)] [Semiconductor Equipment Operations, Eaton Corporation, 55 Cherry Hill Drive, Beverly, Massachusetts 01915 (United States); Pelaz, L.; Gossmann, H.; Jacobson, D.C.; Eaglesham, D.J. [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States)] [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States)

1999-03-01T23:59:59.000Z

36

Reports  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Reports Reports Individual Permit reports are prepared annually to facilitate public review of activities for the previous year. Contact Environmental Communication & Public...

37

Hydrogen and chloride ions effects on the automobile interstitial-free steel corrosion  

E-Print Network [OSTI]

1 Hydrogen and chloride ions effects on the automobile interstitial-free steel corrosion L.Q. Guo 1 abilities of deep formability and fatigue resistance [1,2]. As the main material of the automobile's body. The high susceptibility to atmospheric corrosion limits the automobile steel applications. Although

Volinsky, Alex A.

38

Characterization of the nitrogen split interstitial defect in wurtzite aluminum nitride using density functional theory  

SciTech Connect (OSTI)

We carried out Heyd-Scuseria-Ernzerhof hybrid density functional theory plane wave supercell calculations in wurtzite aluminum nitride in order to characterize the geometry, formation energies, transition levels, and hyperfine tensors of the nitrogen split interstitial defect. The calculated hyperfine tensors may provide useful fingerprint of this defect for electron paramagnetic resonance measurement.

Szállás, A., E-mail: szallas.attila@wigner.mta.hu [Institute for Solid State Physics and Optics, Wigner Research Centre for Physics, Hungarian Academy of Sciences, P.O. Box 49, H-1525 Budapest (Hungary); Szász, K. [Institute for Solid State Physics and Optics, Wigner Research Centre for Physics, Hungarian Academy of Sciences, P.O. Box 49, H-1525 Budapest (Hungary); Institute of Physics, Eötvös University, Pázmány Péter sétány 1/A, H-1117 Budapest (Hungary); Trinh, X. T.; Son, N. T.; Janzén, E. [Department of Physics, Chemistry and Biology, Linköping University, SE-581 83 Linköping (Sweden); Gali, A., E-mail: gali.adam@wigner.mta.hu [Institute for Solid State Physics and Optics, Wigner Research Centre for Physics, Hungarian Academy of Sciences, P.O. Box 49, H-1525 Budapest (Hungary); Department of Atomic Physics, Budapest University of Technology and Economics, Budafoki út 8, H-1111 Budapest (Hungary)

2014-09-21T23:59:59.000Z

39

Yield enhancement of reconfigurable microfluidics-based biochips using interstitial redundancy  

E-Print Network [OSTI]

Microfluidics-based biochips for biochemical analysis are currently receiving much attention. They automate highly repetitive laboratory procedures by replacing cumbersome equipment with miniaturized and integrated systems. As these microfluidics-based microsystems become more complex, manufacturing yield will have significant influence on production volume and product cost. We propose an interstitial redundancy approach to enhance the yield of biochips that are based on droplet-based digital microfluidics. In this design method, spare cells are placed in the interstitial sites within the microfluidic array, and they replace neighboring faulty cells via local reconfiguration. The proposed design method is evaluated using a set of concurrent real-life bioassays. The defect-tolerant design approach based on space redundancy and local reconfiguration is expected to facilitate yield enhancement of microfluidics-based biochips, especially for the emerging marketplace.

Fei Su; Krishnendu Chakrabarty

2006-01-01T23:59:59.000Z

40

Kinetics of oxygen interstitial injection and lattice exchange in rutile TiO{sub 2}  

SciTech Connect (OSTI)

The existence of a facile surface pathway for generation of O interstitials (O{sub i}) in rutile that can facilitate annihilation of O undesirable vacancies has been demonstrated recently. Through isotopic self-diffusion experiments, the present work determines a value of approximately 1.8?eV for the activation energy of O{sub i} injection from TiO{sub 2} (110). The mean path length for O{sub i} diffusion decreases by nearly an order of magnitude upon adsorption of 0.1 monolayer of sulfur. Sulfur apparently inhibits the surface annihilation rate of Ti interstitials, lowering their bulk concentration and the corresponding catalytic effect they seem to exert upon O{sub i} exchange with the lattice.

Gorai, Prashun; Hollister, Alice G.; Pangan-Okimoto, Kristine; Seebauer, Edmund G., E-mail: eseebaue@illinois.edu [Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, Illinois 61801 (United States)

2014-05-12T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


41

Interstitial-impurity interactions in copper-silver and aluminum-magnesium alloys. [Electron beams  

SciTech Connect (OSTI)

The configurations and dynamical properties of complexes formed between interstitials and oversized impurities in electron-irradiated aluminum and copper were determined. Measurements were taken of the ultrasonic attention and resonant frequency in single crystal samples of Cu-Ag and Al-Mg. A variety of peaks appeared in both materials in plots of the logarithmic decrement versus temperature. The simultaneous presence of multiple defects was established by the different annealing behavior shown by each peak. It was found that interstitial trapping in our oversized systems was generally weaker than in previously studied undersized systems. The principal features in Cu-Ag that must be accounted for by a model include the following: (1) Three low-temperature peaks were seen having trigonal symmetry. The main peak annealed away at 110 K uncorrelated with any resistivity recovery and it grew at 60 K, correlated with a resistivity decrease. For Al-MG, the principal features associated with the main peak include: seen at high temperature (>135 K) having trigonal symmetry; annealed away at 127 K and seemed to correlate with a resistivity decrease; remaining peaks grew while the main peak annealed away. The implications of an existing model were developed. No evidence was found for the deeply-trapped <110>-orthorhombic defect predicted by the existing model. Therefore, two alternative models were developed. Model A uses a canted dumb-bell at the next-nearest neighbor position to explain the results. Model B uses a point interstitial at an octahedral position. A distinction between the two which is subject to experimental check is that model A predicts that interstitial migration between different impurity atoms occurs near 127 K in Cu-Ag while model B predicts a migration temperature near 60 K.

Wong, H.P.

1982-01-01T23:59:59.000Z

42

Migration and Directional Change of Interstitial Clusters in ?-Fe: Searching for Transition States by the Dimer Method  

SciTech Connect (OSTI)

The interstitial clusters produced by cascades in metals have very high mobility and exhibit thermally activated, one-dimensional glide along the crowdion direction, as revealed by molecular dynamics (MD) simulations. Only small interstitial clusters (<4) are observed to change their glide direction during the period of MD simulations ({approx} 10 ns), but the directional change for larger clusters is inaccessible to MD due to the limited time-scale. In order to overcome the ''time barrier'' in MD simulations, the dimer method is employed to search for possible transition states of interstitials and small interstitial clusters in alpha-Fe. The method uses only the first derivatives of the potential energy to find saddle points without knowledge of the final state of the transition. The possible transition states are studied as a function of interstitial cluster size, and the lowest energy barriers correspond to defect migration along (111) directions, as seen in MD simulations. Small clusters change their direction by a (110) fragment mechanism involving rotation of each crowdion into and out of the (110) dumbbell configuration, whereas the directional change for larger clusters is a two-step process consisting of translation along a <100> direction and rotation into an equivalent (111) direction. The mechanism of changing direction for a tri-interstitial cluster is also investigated using MD simulations.

Gao, Fei; Heinisch, Howard L.; Kurtz, Richard J.; Osetsky, Yuri N.; Hoagland, Richard G.

2005-02-01T23:59:59.000Z

43

High-Dose-Rate Interstitial Brachytherapy as Monotherapy for Clinically Localized Prostate Cancer: Treatment Evolution and Mature Results  

SciTech Connect (OSTI)

Purpose: To report the clinical outcome of high-dose-rate (HDR) interstitial (IRT) brachytherapy (BRT) as sole treatment (monotherapy) for clinically localized prostate cancer. Methods and Materials: Between January 2002 and December 2009, 718 consecutive patients with clinically localized prostate cancer were treated with transrectal ultrasound (TRUS)-guided HDR monotherapy. Three treatment protocols were applied; 141 patients received 38.0 Gy using one implant in 4 fractions of 9.5 Gy with computed tomography-based treatment planning; 351 patients received 38.0 Gy in 4 fractions of 9.5 Gy, using 2 implants (2 weeks apart) and intraoperative TRUS real-time treatment planning; and 226 patients received 34.5 Gy, using 3 single-fraction implants of 11.5 Gy (3 weeks apart) and intraoperative TRUS real-time treatment planning. Biochemical failure was defined according to the Phoenix consensus, and toxicity was evaluated using Common Toxicity Criteria for Adverse Events version 3. Results: The median follow-up time was 52.8 months. The 36-, 60-, and 96-month biochemical control and metastasis-free survival rates for the entire cohort were 97%, 94%, and 90% and 99%, 98%, and 97%, respectively. Toxicity was scored per event, with 5.4% acute grade 3 genitourinary and 0.2% acute grade 3 gastrointestinal toxicity. Late grade 3 genitourinary and gastrointestinal toxicities were 3.5% and 1.6%, respectively. Two patients developed grade 4 incontinence. No other instance of grade 4 or greater acute or late toxicity was reported. Conclusion: Our results confirm IRT-HDR-BRT is safe and effective as monotherapy for clinically localized prostate cancer.

Zamboglou, Nikolaos [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany)] [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany); Tselis, Nikolaos, E-mail: ntselis@hotmail.com [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany)] [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany); Baltas, Dimos [Department of Medical Physics and Engineering, Klinikum Offenbach, Offenbach (Germany)] [Department of Medical Physics and Engineering, Klinikum Offenbach, Offenbach (Germany); Buhleier, Thomas [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany)] [Department of Radiation Oncology, Klinikum Offenbach, Offenbach (Germany); Martin, Thomas [Department of Radiation Oncology, Klinikum Bremen-Mitte, Bremen (Germany)] [Department of Radiation Oncology, Klinikum Bremen-Mitte, Bremen (Germany); Milickovic, Natasa; Papaioannou, Sokratis [Department of Medical Physics and Engineering, Klinikum Offenbach, Offenbach (Germany)] [Department of Medical Physics and Engineering, Klinikum Offenbach, Offenbach (Germany); Ackermann, Hanns [Institute of Biostatistics, J.W. Goethe University of Frankfurt, Frankfurt (Germany)] [Institute of Biostatistics, J.W. Goethe University of Frankfurt, Frankfurt (Germany); Tunn, Ulf W. [Department of Urology, Klinikum Offenbach, Offenbach (Germany)] [Department of Urology, Klinikum Offenbach, Offenbach (Germany)

2013-03-01T23:59:59.000Z

44

Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214  

SciTech Connect (OSTI)

Purpose: To assess the impact of prophylactic cranial irradiation (PCI) on self-reported cognitive functioning (SRCF), a functional scale on the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30). Methods and Materials: Radiation Therapy Oncology Group (RTOG) protocol 0214 randomized patients with locally advanced non-small cell lung cancer to PCI or observation; RTOG 0212 randomized patients with limited-disease small cell lung cancer to high- or standard-dose PCI. In both trials, Hopkins Verbal Learning Test (HVLT)-Recall and -Delayed Recall and SRCF were assessed at baseline (after locoregional therapy but before PCI or observation) and at 6 and 12 months. Patients developing brain relapse before follow-up evaluation were excluded. Decline was defined using the reliable change index method and correlated with receipt of PCI versus observation using logistic regression modeling. Fisher's exact test correlated decline in SRCF with HVLT decline. Results: Of the eligible patients pooled from RTOG 0212 and RTOG 0214, 410 (93%) receiving PCI and 173 (96%) undergoing observation completed baseline HVLT or EORTC QLQ-C30 testing and were included in this analysis. Prophylactic cranial irradiation was associated with a higher risk of decline in SRCF at 6 months (odds ratio 3.60, 95% confidence interval 2.34-6.37, P<.0001) and 12 months (odds ratio 3.44, 95% confidence interval 1.84-6.44, P<.0001). Decline on HVLT-Recall at 6 and 12 months was also associated with PCI (P=.002 and P=.002, respectively) but was not closely correlated with decline in SRCF at the same time points (P=.05 and P=.86, respectively). Conclusions: In lung cancer patients who do not develop brain relapse, PCI is associated with decline in HVLT-tested and self-reported cognitive functioning. Decline in HVLT and decline in SRCF are not closely correlated, suggesting that they may represent distinct elements of the cognitive spectrum.

Gondi, Vinai, E-mail: vgondi@chicagocancer.org [Central Dupage Hospital Cancer Center, Warrenville, Illinois (United States) [Central Dupage Hospital Cancer Center, Warrenville, Illinois (United States); University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin (United States); Paulus, Rebecca [Radiation Therapy Oncology Group Statistical Center, Philadelphia, Pennsylvania (United States)] [Radiation Therapy Oncology Group Statistical Center, Philadelphia, Pennsylvania (United States); Bruner, Deborah W. [Nell Hodgson Woodfull School of Nursing, Emory University, Atlanta, Georgia (United States)] [Nell Hodgson Woodfull School of Nursing, Emory University, Atlanta, Georgia (United States); Meyers, Christina A. [University of Texas MD Anderson Cancer Center, Houston, Texas (United States)] [University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Gore, Elizabeth M. [Medical College of Wisconsin, Milwaukee, Wisconsin (United States)] [Medical College of Wisconsin, Milwaukee, Wisconsin (United States); Wolfson, Aaron [University of Miami School of Medicine, Miami, Florida (United States)] [University of Miami School of Medicine, Miami, Florida (United States); Werner-Wasik, Maria [Thomas Jefferson University Hospital, Philadelphia, Pennsylvania (United States)] [Thomas Jefferson University Hospital, Philadelphia, Pennsylvania (United States); Sun, Alexander Y. [Princess Margaret Hospital, Toronto, ON (Canada)] [Princess Margaret Hospital, Toronto, ON (Canada); Choy, Hak [University of Texas Southwestern Moncreif Cancer Center, Fort Worth, Texas (United States)] [University of Texas Southwestern Moncreif Cancer Center, Fort Worth, Texas (United States); Movsas, Benjamin [Henry Ford Health System, Detroit, Michigan (United States)] [Henry Ford Health System, Detroit, Michigan (United States)

2013-07-15T23:59:59.000Z

45

Interstitials, Vacancies and Dislocations in Flux-Line Lattices: A Theory of Vortex Crystals, Supersolids and Liquids  

E-Print Network [OSTI]

We study a three dimensional Abrikosov vortex lattice in the presence of an equilibrium concentration of vacancy, interstitial and dislocation loops. Vacancies and interstitials renormalize the long-wavelength bulk and tilt elastic moduli. Dislocation loops lead to the vanishing of the long-wavelength shear modulus. The coupling to vacancies and interstitials - which are always present in the liquid state - allows dislocations to relax stresses by climbing out of their glide plane. Surprisingly, this mechanism does not yield any further independent renormalization of the tilt and compressional moduli at long wavelengths. The long wavelength properties of the resulting state are formally identical to that of the ``flux-line hexatic'' that is a candidate ``normal'' hexatically ordered vortex liquid state.

M. Cristina Marchetti; Leo Radzihovsky

1999-07-01T23:59:59.000Z

46

Interstitial defects in silicon from 1{endash}5 keV Si{sup +} ion implantation  

SciTech Connect (OSTI)

Extended defects from 5-, 2-, and 1-keV Si{sup +} ion implantation are investigated by transmission electron microscopy using implantation doses of 1 and 3{times}10{sup 14}cm{sup {minus}2} and annealing temperatures from 750 to 900{degree}C. Despite the proximity of the surface, {l_brace}311{r_brace}-type defects are observed even for 1 keV. Samples with a peak concentration of excess interstitials exceeding {approximately}1{percent} of the atomic density also contain some {l_brace}311{r_brace} defects which are corrugated across their width. These so-called zig-zag {l_brace}311{r_brace} defects are more stable than the ordinary {l_brace}311{r_brace} defects, having a dissolution rate at 750{degree}C which is ten times smaller. Due to their enhanced stability, the zig-zag {l_brace}311{r_brace} defects grow to lengths that are many times longer than their distance from the surface. It is proposed that zig-zag {l_brace}311{r_brace} defects form during the early stages of annealing by coalescence the high volume density of {l_brace}311{r_brace} defects confined within a very narrow implanted layer. These findings indicate that defect formation and dissolution will continue to control the interstitial supersaturation from ion implantation down to very low energies. {copyright} {ital 1997 American Institute of Physics.}

Agarwal, A.; Haynes, T.E. [Oak Ridge National Laboratory, MS-6048, Oak Ridge, Tennessee 37831 (United States)] [Oak Ridge National Laboratory, MS-6048, Oak Ridge, Tennessee 37831 (United States); Eaglesham, D.J.; Gossmann, H.; Jacobson, D.C.; Poate, J.M. [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States)] [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States); Erokhin, Y.E. [Eaton Corporation, 108 Cherry Hill Drive, Beverly, Massachusetts 01915 (United States)] [Eaton Corporation, 108 Cherry Hill Drive, Beverly, Massachusetts 01915 (United States)

1997-06-01T23:59:59.000Z

47

Effect of interstitials on tensile strength and creep in nanostructured Ni  

SciTech Connect (OSTI)

The tensile, creep and anelastic behavior of nanostructured nickel doped and un-doped with boron was investigated. Specimen material with an average grain size of around 30 nm produced by the pulse electrodeposition method contains impurities such as carbon, sulfur and boron. The interstitials content does not have notable impact on the tensile strength at room temperature and 373 K. But, at 473 K, the minor change in sulfur content from 0.03 to 0.061 at.% raises the ultimate strength by 150 MPa while the boron doping further improves the tensile strength. On the other hand, with increasing sulfur content in nanostructured Ni, the ductility decreases. All the specimens exhibit significant anelastic relaxation from room temperature to 473 K. The creep test results show that both minimum creep rate and creep strain significantly decrease with increasing sulfur or by doping boron in nanostructured nickel. The stress exponent in the expression of Coble-type creep increases to around five at 373 and 473 K from two at room temperature. A model for grain boundary sliding, in which grain boundary dislocations and back stress are introduced, has successfully explained the large stress exponents. The calculated back stress indicates that the interstitials in grain boundaries effectively retard the sliding of grain boundary dislocations.

Yin, W.M. [Department of Mechanical Engineering, Polytechnic University, Six Metrotech Center, Brooklyn, NY 11201 (United States); Whang, S.H. [Department of Mechanical Engineering, Polytechnic University, Six Metrotech Center, Brooklyn, NY 11201 (United States)]. E-mail: swhang@poly.edu; Mirshams, R.A. [Department of Engineering Technology, University of North Texas, Denton, TX 76203-0679 (United States)

2005-01-10T23:59:59.000Z

48

Reports  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStories » Removing nuclearReporting Unethical or

49

REPORT  

Broader source: Energy.gov (indexed) [DOE]

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May Jun Jul(Summary) "ofEarly Careerlumens_placard-green.epsEnergy1.pdfMarket37963American |Purpose This procedurenote: The REPORT

50

Diffusion of Te vacancy and interstitials of Te, Cl, O, S, P and Sb in CdTe: A density functional theory study  

E-Print Network [OSTI]

Diffusion of Te vacancy and interstitials of Te, Cl, O, S, P and Sb in CdTe: A density functional profiles in CdTe of native, Te adatom and vacancy, and anionic non-native interstitial adatoms P, Sb, O, S B.V. All rights reserved. 1. Introduction Cadmium telluride (CdTe) based thin films have emerged

Khare, Sanjay V.

51

Anesthesia for intraoperative radiation therapy in children  

SciTech Connect (OSTI)

Intraoperative radiation therapy (IORT) is a relatively new mode of cancer treatment which is being used with increasing frequency. IORT presents several challenges to the anesthesiologist, including patients who are debilitated from their disease or chemotherapy, operations involving major tumor resections, intraoperative interdepartmental transport of patients, and remote monitoring of patients during electron beam therapy. This report discusses the anesthetic management of ten children undergoing IORT. With adequate preparation and interdepartmental communication, complications can be avoided during these challenging cases.

Friesen, R.H.; Morrison, J.E. Jr.; Verbrugge, J.J.; Daniel, W.E.; Aarestad, N.O.; Burrington, J.D.

1987-06-01T23:59:59.000Z

52

A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity  

SciTech Connect (OSTI)

Purpose: To determine the maximum tolerated dose (MTD) of stereotactic body radiation therapy (SBRT) for lung metastases. Methods and Materials: A Phase I clinical trial was conducted. Eligible patients had one to three pulmonary metastases from a solid tumor, cumulative tumor diameter <7 cm, and adequate pulmonary function (forced expiratory volume in 1 s {>=}1.0 L). The planning target volume (PTV) was typically constructed from the gross tumor volume (GTV) by adding a 5-mm radial and 10-mm craniocaudal margin. The first cohort received 48 Gy to the PTV in three fractions (F). SBRT dose was escalated in subsequent cohorts up to a preselected maximum of 60 Gy/3 F. The percent of normal lung receiving more than 15 Gy (V{sub 15}) was restricted to less than 35%. Respiratory control and a dynamic conformal arc SBRT technique were used. Dose-limiting toxicity (DLT) included acute Grade 3 lung or esophageal toxicity or any acute Grade 4 toxicity within 3 months. After the Phase I dose escalation, the trial continued as a Phase II study, and patients in this cohort are included to increase the number of patients evaluable for early toxicity assessment. Results: Twenty-five eligible patients have been enrolled to date. In the Phase I component of the trial, there were 12 patients (7 male, 5 female): median age, 55 years (range, 31-83 years); the most common primary site was colorectal (4 patients). Seven patients had two lung lesions, and 1 patient had three lesions. The median aggregate volume of all GTVs was 18.7 mL (range, 2-40 mL). No patient experienced a DLT, and dose was escalated to 60 Gy/3 F without reaching the MTD; including the additional Phase II cohort patients, 16 patients have been treated to a dose of 60 Gy/3F without experiencing a DLT in the first 3 months. The equivalent uniform dose to the GTV in the highest dose group ranged from 66 to 77 Gy in 3 F. Conclusions: In patients with limited pulmonary metastases, radiobiologically potent doses of SBRT are well tolerated with minimal early toxicity. A Phase II SBRT study of 60 Gy/3 F for lung metastases is ongoing to evaluate local tumor control rates with this regimen and continue surveillance for any late effects.

Schefter, Tracey E. [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States)]. E-mail: Tracey.Schefter@uchsc.edu; Kavanagh, Brian D. [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Raben, David [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Kane, Madeleine [Division of Medical Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Chen Changhu [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Stuhr, Kelly [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Kelly, Karen [Division of Medical Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Mitchell, John D. [Section of Thoracic Surgery, University of Colorado Health Sciences Center, Aurora, CO (United States); Bunn, Paul A. [Division of Medical Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States); Gaspar, Laurie E. [Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, CO (United States)

2006-11-15T23:59:59.000Z

53

Quality Assurance of Multifractionated Pelvic Interstitial Brachytherapy for Postoperative Recurrences of Cervical Cancers: A Prospective Study  

SciTech Connect (OSTI)

Purpose: To evaluate three-dimensional needle displacements during multifractionated interstitial brachytherapy (BT) for cervical cancers. Methods and Materials: Patients scheduled to undergo pelvic interstitial BT for postoperative and or postradiation vault recurrences were included from November 2009 to December 2010. All procedures were performed under spinal anesthesia. Postprocedure BT planning CT scans were obtained with patients in supine position with arms on the chest (interslice thickness of 3 mm). Thereafter, verification CT was repeated at every alternate fraction. Needle displacements were measured in reference to a relocatable bony point. The mean cranial, caudal, anteroposterior, and mediolateral displacements were recorded. Statistical significance of mean interfraction displacements was evaluated with Wilcoxon Test. Results: Twenty patients were included. Seventeen received boost BT (20 Gy/5 fractions/3 days) after external radiation, three received radical BT alone (36 Gy/9 fractions/5-8 days). An average of three scans (range, 2-3) were available per patient, and 357 needle displacements were analyzed. For the entire study cohort, the average of mean needle displacement was 2.5 mm (range, 0-7.4), 17.4 mm (range, 0-27.9), 1.7 mm (range, 0-6.7), 2.1 mm (range, 0-9.5), 1.7 mm (range, 0-9.3), and 0.6 mm (range, 0-7.8) in cranial, caudal, anterior, posterior, right, and left directions, respectively. The mean displacement in the caudal direction was higher between Days 1 and 2 than that between Days 2 and 3 (13.4 mm vs. 3.8 mm; p = 0.01). The average caudal displacements were no different between reirradiation and boost cohort (15.2 vs. 17.8 mm). Conclusions: Clinically significant caudal displacements occur during multifractionated pelvic brachytherapy. Optimal margins need to be incorporated while preplanning brachytherapy to account for interfraction displacements.

Shukla, Pragya [Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra (India); Chopra, Supriya, E-mail: schopra@actrec.gov.in [Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, Maharashtra (India); Engineer, Reena; Mahantshetty, Umesh [Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra (India); Paul, Siji Nojin; Phurailatpam, Reena [Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, Maharashtra (India); SV, Jamema; Shrivastava, Shyam K. [Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra (India)

2012-03-15T23:59:59.000Z

54

Imaging Tumor Variation in Response to Photodynamic Therapy in Pancreatic Cancer Xenograft Models  

SciTech Connect (OSTI)

Purpose: A treatment monitoring study investigated the differential effects of orthotopic pancreatic cancer models in response to interstitial photodynamic therapy (PDT), and the validity of using magnetic resonance imaging as a surrogate measure of response was assessed. Methods and Materials: Different orthotopic pancreatic cancer xenograft models (AsPC-1 and Panc-1) were used to represent the range of pathophysiology observed in human beings. Identical dose escalation studies (10, 20, and 40J/cm) using interstitial verteporfin PDT were performed, and magnetic resonance imaging with T2-weighted and T1-weighted contrast were used to monitor the total tumor volume and the vascular perfusion volume, respectively. Results: There was a significant amount of necrosis in the slower-growing Panc-1 tumor using high light dose, although complete necrosis was not observed. Lower doses were required for the same level of tumor kill in the faster-growing AsPC-1 cell line. Conclusions: The tumor growth rate and vascular pattern of the tumor affect the optimal PDT treatment regimen, with faster-growing tumors being relatively easier to treat. This highlights the fact that therapy in human beings shows a heterogeneous range of outcomes, and suggests a need for careful individualized treatment outcomes assessment in clinical work.

Samkoe, Kimberley S., E-mail: samkoe@dartmouth.ed [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Chen, Alina [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Rizvi, Imran [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA (United States); O'Hara, Julia A. [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Hoopes, P. Jack [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Department of Surgery, Dartmouth Medical School, Hanover, NH (United States); Pereira, Stephen P. [Institute of Hepatology, University College London Medical School, London (United Kingdom); Hasan, Tayyaba [Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA (United States); Pogue, Brian W. [Thayer School of Engineering, Dartmouth College, Hanover, NH (United States); Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA (United States); Department of Surgery, Dartmouth Medical School, Hanover, NH (United States)

2010-01-15T23:59:59.000Z

55

The effect of strain and path change on the mechanical properties and microstructural evolution of ultrafine grained interstitial free steel during equal channel angular extrusion (ECAE)  

E-Print Network [OSTI]

The objectives of this study were to examine the effect of strain and path change on the microstructural evolution of ultrafine grained interstitial free (IF) steel during equal channel angular extrusion (ECAE); to determine the mechanical...

Sutter, Steven George

2007-04-25T23:59:59.000Z

56

DISCIPLINE OF RADIATION THERAPY SAFETY DOCUMENT  

E-Print Network [OSTI]

DISCIPLINE OF RADIATION THERAPY SAFETY DOCUMENT Contents Page 1. Health & Safety arrangements 1 Inspection 1.4 Hazard Reporting 1.5 Security in College 1.6 Out of Hours Working 1.7 Management of Work.7 Management of Work-related Stress Those experiencing symptoms of work-related stress should raise this matter

O'Mahony, Donal E.

57

Long-Term Outcome for Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy  

SciTech Connect (OSTI)

Purpose: To present the largest series of prostate cancer brachytherapy patients treated with modern brachytherapy techniques and postimplant day 0 dosimetric evaluation. Methods and Materials: Between April 1995 and July 2006, 1,656 consecutive patients were treated with permanent interstitial brachytherapy. Risk group stratification was carried out according to the Mt. Sinai guidelines. Median follow-up was 7.0 years. The median day 0 minimum dose covering at least 90% of the target volume was 118.8% of the prescription dose. Cause of death was determined for each deceased patient. Multiple clinical, treatment, and dosimetric parameters were evaluated for impact on the evaluated survival parameters. Results: At 12 years, biochemical progression-free survival (bPFS), cause-specific survival (CSS), and overall survival (OS) for the entire cohort was 95.6%, 98.2%, and 72.6%, respectively. For low-, intermediate-, and high-risk patients, bPFS was 98.6%, 96.5%, and 90.5%; CSS was 99.8%, 99.3%, and 95.2%; and OS was 77.5%, 71.1%, and 69.2%, respectively. For biochemically controlled patients, the median posttreatment prostate-specific antigen (PSA) concentration was 0.02 ng/ml. bPFS was most closely related to percent positive biopsy specimens and risk group, while Gleason score was the strongest predictor of CSS. OS was best predicted by patient age, hypertension, diabetes, and tobacco use. At 12 years, biochemical failure and cause-specific mortality were 1.8% and 0.2%, 5.1% and 2.1%, and 10.4% and 7.1% for Gleason scores 5 to 6 and 7 and {>=}8, respectively. Conclusions: Excellent long-term outcomes are achievable with high-quality brachytherapy for low-, intermediate-, and high-risk patients. These results compare favorably to alternative treatment modalities including radical prostatectomy.

Taira, Al V. [Department of Radiation Oncology, University of Washington, Seattle, Washington (United States); Merrick, Gregory S., E-mail: gmerrick@urologicresearchinstitute.or [Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia (United States); Butler, Wayne M.; Galbreath, Robert W.; Lief, Jonathan [Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia (United States); Adamovich, Edward [Department of Pathology, Wheeling Hospital, Wheeling, West Virginia (United States); Wallner, Kent E. [Puget Sound Healthcare Corporation, Group Health Cooperative, University of Washington, Seattle, Washington (United States)

2011-04-01T23:59:59.000Z

58

Enzyme replacement therapy for Pompe disease  

E-Print Network [OSTI]

CALIFORNIA, SAN DIEGO Enzyme Replacement Therapy for Pompe3 1.3 Enzyme Replacement Therapy for Pompe Disease…………………… 5Receptor ERT – Enzyme Replacement Therapy LSD – Lysosomal

Burris, Ryan Jonathan William

2010-01-01T23:59:59.000Z

59

Distant Metastases Following Permanent Interstitial Brachytherapy for Patients With Clinically Localized Prostate Cancer  

SciTech Connect (OSTI)

Purpose: Recent publications have suggested high-risk patients undergoing radical prostatectomy have a lower risk of distant metastases and improved cause-specific survival (CSS) than patients receiving definitive external beam radiation therapy (XRT). To date, none of these studies has compared distant metastases and CSS in brachytherapy patients. In this study, we evaluate such parameters in a consecutive cohort of brachytherapy patients. Methods and Materials: From April 1995 to June 2007, 1,840 consecutive patients with clinically localized prostate cancer were treated with brachytherapy. Risk groups were stratified according to National Comprehensive Cancer Network ( (www.nccn.org)) guidelines. Subgroups of 658, 893, and 289 patients were assigned to low, intermediate, and high-risk categories. Median follow-up was 7.2 years. Along with brachytherapy implantation, 901 (49.0%) patients received supplemental XRT, and 670 (36.4%) patients received androgen deprivation therapy (median duration, 4 months). The mode of failure (biochemical, local, or distant) was determined for each patient for whom therapy failed. Cause of death was determined for each deceased patient. Multiple parameters were evaluated for impact on outcome. Results: For the entire cohort, metastases-free survival (MFS) and CSS at 12 years were 98.1% and 98.2%, respectively. When rates were stratified by low, intermediate, and high-risk groups, the 12-year MFS was 99.8%, 98.1%, and 93.8% (p < 0.001), respectively. CSS rates were 99.8%, 98.0%, and 95.3% (p < 0.001) for low, intermediate, and high-risk groups, respectively. Biochemical progression-free survival was 98.7%, 95.9% and 90.4% for low, intermediate, and high-risk patients, respectively (p < 0.001). In multivariate Cox-regression analysis, MFS was mostly closely related to Gleason score and year of treatment, whereas CSS was most closely associated with Gleason score. Conclusions: Excellent CSS and MFS rates are achievable with high-quality brachytherapy for low, intermediate, and high-risk patients. These results compare favorably to alternative treatment modalities. In particular, our MFS and CSS rates for high-risk patients appear superior to those of published radical prostatectomy series.

Taira, Al V. [Western Radiation Oncology, Mountain View, California (United States); Merrick, Gregory S., E-mail: gmerrick@urologicresearchinstitute.org [Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia (United States); Galbreath, Robert W.; Butler, Wayne M.; Lief, Jonathan [Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, West Virginia (United States); Adamovich, Edward [Department of Pathology, Wheeling Hospital, Wheeling, West Virginia (United States); Wallner, Kent E. [Puget Sound Healthcare Corporation, Group Health Cooperative, University of Washington, Seattle, Washington (United States)

2012-02-01T23:59:59.000Z

60

Diffusion of Cd vacancy and interstitials of Cd, Cu, Ag, Au and Mo in CdTe: A first principles investigation  

E-Print Network [OSTI]

Diffusion of Cd vacancy and interstitials of Cd, Cu, Ag, Au and Mo in CdTe: A first principles, Au, and Mo in bulk CdTe. The high symmetry Wyckoff position 4(b) is the global minimum energy enhanced the commercial viability of solar cells to generate electricity. Among them, cadmium telluride (CdTe

Khare, Sanjay V.

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


61

Improving ion irradiated high T{sub c} Josephson junctions by annealing: The role of vacancy-interstitial annihilation  

SciTech Connect (OSTI)

The authors have studied the annealing effect in the transport properties of high T{sub c} Josephson junctions (JJs) made by ion irradiation. Low temperature annealing (80 deg. C) increases the JJ coupling temperature (T{sub J}) and the I{sub c}R{sub n} product, where I{sub c} is the critical current and R{sub n} the normal resistance. They have found that the spread in JJ characteristics can be reduced by sufficient long annealing times, increasing the reproducibility of ion irradiated Josephson junctions. The characteristic annealing time and the evolution of the spread in the JJ characteristics can be explained by a vacancy-interstitial annihilation process rather than by an oxygen diffusion one.

Sirena, M.; Matzen, S.; Bergeal, N.; Lesueur, J.; Faini, G.; Bernard, R.; Briatico, J.; Crete, D. G. [Laboratoire Photons Et Matiere, ESPCI, 10 Rue Vauquelin, 75231 Paris (France); Laboratoire de Photonique et Nanostructures, Route de Nozay, 91460 Marcoussis (France); UMR-CNRS/THALES, Route D128, 91767 Palaiseau (France)

2007-10-01T23:59:59.000Z

62

Binding energetics of substitutional and interstitial helium and di-helium defects with grain boundary structure in ?-Fe  

SciTech Connect (OSTI)

The formation/binding energetics and length scales associated with the interaction between He atoms and grain boundaries in BCC ?-Fe were explored. Ten different low ? grain boundaries from the ?100? and ?110? symmetric tilt grain boundary systems were used. In this work, we then calculated formation/binding energies for 1–2 He atoms in the substitutional and interstitial sites (HeV, He{sub 2}V, HeInt, He{sub 2}Int) at all potential grain boundary sites within 15?Ĺ of the boundary (52?826 simulations total). The present results provide detailed information about the interaction energies and length scales of 1–2 He atoms with grain boundaries for the structures examined. A number of interesting new findings emerge from the present study. For instance, the ?3(112) twin boundary in BCC Fe possesses a much smaller binding energy than other boundaries, which corresponds in long time dynamics simulations to the ability of an interstitial He defect to break away from the boundary in simulations on the order of nanoseconds. Additionally, positive correlations between the calculated formation/binding energies of the He defects (R?>?0.9) asserts that the local environment surrounding each site strongly influences the He defect energies and that highly accurate quantum mechanics calculations of lower order defects may be an adequate predictor of higher order defects. Various metrics to quantify or classify the local environment were compared with the He defect binding energies. The present work shows that the binding and formation energies for He defects are important for understanding the physics of He diffusion and trapping by grain boundaries, which can be important for modeling He interactions in polycrystalline steels.

Tschopp, M. A., E-mail: mark.tschopp@gatech.edu [Dynamic Research Corporation, (on site at) U.S. Army Research Laboratory, Aberdeen Proving Ground, Maryland 21005 (United States); Center for Advanced Vehicular Systems, Mississippi State University, Starkville, Mississippi 39762 (United States); Gao, F.; Yang, L. [Pacific Northwest National Laboratory, Richland, Washington 99352 (United States); Solanki, K. N. [Arizona State University, School for Engineering of Matter, Transport and Energy, Tempe, Arizona 85287 (United States)

2014-01-21T23:59:59.000Z

63

Neutron capture therapies  

DOE Patents [OSTI]

In one embodiment there is provided an application of the .sup.10 B(n,.alpha.).sup.7 Li nuclear reaction or other neutron capture reactions for the treatment of rheumatoid arthritis. This application, called Boron Neutron Capture Synovectomy (BNCS), requires substantially altered demands on neutron beam design than for instance treatment of deep seated tumors. Considerations for neutron beam design for the treatment of arthritic joints via BNCS are provided for, and comparisons with the design requirements for Boron Neutron Capture Therapy (BNCT) of tumors are made. In addition, exemplary moderator/reflector assemblies are provided which produce intense, high-quality neutron beams based on (p,n) accelerator-based reactions. In another embodiment there is provided the use of deuteron-based charged particle reactions to be used as sources for epithermal or thermal neutron beams for neutron capture therapies. Many d,n reactions (e.g. using deuterium, tritium or beryllium targets) are very prolific at relatively low deuteron energies.

Yanch, Jacquelyn C. (Cambridge, MA); Shefer, Ruth E. (Newton, MA); Klinkowstein, Robert E. (Winchester, MA)

1999-01-01T23:59:59.000Z

64

Differential gene expression in the murine gastric fundus lacking interstitial cells of Cajal  

E-Print Network [OSTI]

, Kenton M Sanders3 and Masayuki A Fujino1 Address: 1Department of Medicine, University of Yamanashi Faculty of Medicine, Japan, 2Cancer Genomics Program, Department of Oncology, University of Cambridge School of Medicine, Cambridge, UK and 3Department... [4]. Reduced numbers of ICC have also been reported in sev- eral GI motility disorders, such as chronic intestinal pseudo-obstruction [5,6], infantile hypertrophic pyloric stenosis [7–9], Hirschsprung's disease [10–12], slow-tran- sit constipation...

Daigo, Yataro; Takayama, Ichiro; Ponder, Bruce A J; Caldas, Carlos; Ward, Sean M; Sanders, Kenton M; Fujino, Masayuki A

2003-06-10T23:59:59.000Z

65

Reduction of transient diffusion from 1{endash}5 keV Si{sup +} ion implantation due to surface annihilation of interstitials  

SciTech Connect (OSTI)

The reduction of transient enhanced diffusion (TED) with reduced implantation energy has been investigated and quantified. A fixed dose of 1{times}10{sup 14} cm{sup {minus}2} Si{sup +} was implanted at energies ranging from 0.5 to 20 keV into boron doping superlattices and enhanced diffusion of the buried boron marker layers was measured for anneals at 810, 950, and 1050{degree}C. A linearly decreasing dependence of diffusivity enhancement on decreasing Si{sup +} ion range is observed at all temperatures, extrapolating to {approximately}1 for 0 keV. This is consistent with our expectation that at zero implantation energy there would be no excess interstitials from the implantation and hence no TED. Monte Carlo modeling and continuum simulations are used to fit the experimental data. The results are consistent with a surface recombination length for interstitials of {lt}10 nm. The data presented here demonstrate that in the range of annealing temperatures of interest for p-n junction formation, TED is reduced at smaller ion implantation energies and that this is due to increased interstitial annihilation at the surface. {copyright} {ital 1997 American Institute of Physics.}

Agarwal, A.; Gossmann, H.-.; Eaglesham, D.J.; Pelaz, L.; Jacobson, D.C. [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States)] [Bell Laboratories, Lucent Technologies, 600 Mountain Avenue, Murray Hill, New Jersey 07974 (United States); Haynes, T.E. [Oak Ridge National Laboratory, MS-6048, P.O. Box 2008, Oak Ridge, Tennessee 37831 (United States)] [Oak Ridge National Laboratory, MS-6048, P.O. Box 2008, Oak Ridge, Tennessee 37831 (United States); Erokhin, Y.E. [Eaton Corporation, 108 Cherry Hill Drive, Beverly, Massachusetts 01950 (United States)] [Eaton Corporation, 108 Cherry Hill Drive, Beverly, Massachusetts 01950 (United States)

1997-11-01T23:59:59.000Z

66

Targeted radionuclide therapy  

SciTech Connect (OSTI)

Targeted radionuclide therapy (TRT) seeks molecular and functional targets within patient tumor sites. A number of agents have been constructed and labeled with beta, alpha, and Auger emitters. Radionuclide carriers spanning a broad range of sizes; e.g., antibodies, liposomes, and constructs such as nanoparticles have been used in these studies. Uptake, in percent-injected dose per gram of malignant tissue, is used to evaluate the specificity of the targeting vehicle. Lymphoma (B-cell) has been the primary clinical application. Extension to solid tumors will require raising the macroscopic absorbed dose by several-fold over values found in present technology. Methods that may effect such changes include multistep targeting, simultaneous chemotherapy, and external sequestration of the agent. Toxicity has primarily involved red marrow so that marrow replacement can also be used to enhance future TRT treatments. Correlation of toxicities and treatment efficiency has been limited by relatively poor absorbed dose estimates partly because of using standard (phantom) organ sizes. These associations will be improved in the future by obtaining patient-specific organ size and activity data with hybrid SPECT/CT and PET/CT scanners.

Williams, Lawrence E.; DeNardo, Gerald L.; Meredith, Ruby F. [Radiology Division, City of Hope National Medical Center, Duarte, California 91010 (United States); Internal Medicine, University of California Davis Medical Center, 1508 Alhambra Boulevard, Suite 3100, Sacramento, California 95816 (United States); Department of Radiation Oncology, Wallace Tumor Institute WTI No. 117, University of Alabama at Birmingham, Birmingham, Alabama 35294 (United States)

2008-07-15T23:59:59.000Z

67

In vivo photodynamic therapy using upconversion nanoparticles as remote-  

E-Print Network [OSTI]

destruction. Moreover, invasive interstitial PDT which involves percutaneous implantation of light emitting diode (LED) probes arranged in a cylinder tip to fit into a balloon catheter to illuminate tumors

Chaudhuri, Sanjay

68

STANFORD REDWOOD CITY INFUSION THERAPY CENTER  

E-Print Network [OSTI]

STANFORD REDWOOD CITY INFUSION THERAPY CENTER Stanford Redwood City Infusion Therapy Center 450 that the new Stanford Redwood City Infusion Therapy Center opened on January 6, 2014. This new state previously received infusion treatments in the Infusion Treatment Area (ITA) at the Stanford Cancer Center

Bejerano, Gill

69

BERAC Subcommittee Report on Boron Neutron Capture Therapy (BNCT) Clinical  

Office of Science (SC) Website

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr MayAtmosphericNuclear SecurityTensile Strain Switched5 IndustrialIsadore Perlman,BiosScience(SC) AprilScience

70

First-principles studies on vacancy-modified interstitial diffusion mechanism of oxygen in nickel, associated with large-scale atomic simulation techniques  

SciTech Connect (OSTI)

This paper is concerned with the prediction of oxygen diffusivities in fcc nickel from first-principles calculations and large-scale atomic simulations. Considering only the interstitial octahedral to tetrahedral to octahedral minimum energy pathway for oxygen diffusion in fcc lattice, greatly underestimates the migration barrier and overestimates the diffusivities by several orders of magnitude. The results indicate that vacancies in the Ni-lattice significantly impact the migration barrier of oxygen in nickel. Incorporation of the effect of vacancies results in predicted diffusivities consistent with available experimental data. First-principles calculations show that at high temperatures the vacancy concentration is comparable to the oxygen solubility, and there is a strong binding energy and a redistribution of charge density between the oxygen atom and vacancy. Consequently, there is a strong attraction between the oxygen and vacancy in the Ni lattice, which impacts diffusion.

Fang, H. Z.; Shang, S. L.; Wang, Y.; Liu, Z. K. [National Energy Technology Laboratory Regional University Alliance, U.S. Department of Energy, Pittsburgh, Pennsylvania 15236 (United States); Department of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802 (United States); Alfonso, D.; Alman, D. E. [National Energy Technology Laboratory Regional University Alliance, U.S. Department of Energy, Pittsburgh, Pennsylvania 15236 (United States); National Energy Technology Laboratory, U.S. Department of Energy, Pittsburgh, Pennsylvania 15236 (United States); Shin, Y. K.; Zou, C. Y.; Duin, A. C. T. van [National Energy Technology Laboratory Regional University Alliance, U.S. Department of Energy, Pittsburgh, Pennsylvania 15236 (United States); Department of Mechanical and Nuclear Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802 (United States); Lei, Y. K.; Wang, G. F. [National Energy Technology Laboratory Regional University Alliance, U.S. Department of Energy, Pittsburgh, Pennsylvania 15236 (United States); Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pennsylvania 15261 (United States)

2014-01-28T23:59:59.000Z

71

A Prospective Longitudinal Clinical Trial Evaluating Quality of Life After Breast-Conserving Surgery and High-Dose-Rate Interstitial Brachytherapy for Early-Stage Breast Cancer  

SciTech Connect (OSTI)

Purpose: To prospectively examine quality of life (QOL) of patients with early stage breast cancer treated with accelerated partial breast irradiation (APBI) using high-dose-rate (HDR) interstitial brachytherapy. Methods and Materials: Between March 2004 and December 2008, 151 patients with early stage breast cancer were enrolled in a phase 2 prospective clinical trial. Eligible patients included those with Tis-T2 tumors measuring ?3 cm excised with negative surgical margins and with no nodal involvement. Patients received 3.4 Gy twice daily to a total dose of 34 Gy. QOL was measured using European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, version 3.0, and QLQ-BR23 questionnaires. The QLQ-C30 and QLQ-BR23 questionnaires were evaluated during pretreatment and then at 6 to 8 weeks, 3 to 4 months, 6 to 8 months, and 1 and 2 years after treatment. Results: The median follow-up was 55 months. Breast symptom scores remained stable in the months after treatment, and they significantly improved 6 to 8 months after treatment. Scores for emotional functioning, social functioning, and future perspective showed significant improvement 2 years after treatment. Symptomatic fat necrosis was associated with several changes in QOL, including increased pain, breast symptoms, systemic treatment side effects, dyspnea, and fatigue, as well as decreased role functioning, emotional functioning, and social functioning. Conclusions: HDR multicatheter interstitial brachytherapy was well tolerated, with no significant detrimental effect on measured QOL scales/items through 2 years of follow-up. Compared to pretreatment scores, there was improvement in breast symptoms, emotional functioning, social functioning, and future perspective 2 years after treatment.

Garsa, Adam A.; Ferraro, Daniel J.; DeWees, Todd A. [Department of Radiation Oncology, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Deshields, Teresa L. [Department of Medicine, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Margenthaler, Julie A.; Cyr, Amy E. [Department of Surgery, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Naughton, Michael [Department of Medicine, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Aft, Rebecca [Department of Surgery, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Department of Surgery, John Cochran Veterans Hospital, St. Louis, Missouri (United States); Gillanders, William E.; Eberlein, Timothy [Department of Surgery, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Matesa, Melissa A.; Ochoa, Laura L. [Department of Radiation Oncology, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States); Zoberi, Imran, E-mail: izoberi@radonc.wustl.edu [Department of Radiation Oncology, Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri (United States)

2013-12-01T23:59:59.000Z

72

Proton beam therapy control system  

DOE Patents [OSTI]

A tiered communications architecture for managing network traffic in a distributed system. Communication between client or control computers and a plurality of hardware devices is administered by agent and monitor devices whose activities are coordinated to reduce the number of open channels or sockets. The communications architecture also improves the transparency and scalability of the distributed system by reducing network mapping dependence. The architecture is desirably implemented in a proton beam therapy system to provide flexible security policies which improve patent safety and facilitate system maintenance and development.

Baumann, Michael A; Beloussov, Alexandre V; Bakir, Julide; Armon, Deganit; Olsen, Howard B; Salem, Dana

2013-06-25T23:59:59.000Z

73

Proton beam therapy control system  

DOE Patents [OSTI]

A tiered communications architecture for managing network traffic in a distributed system. Communication between client or control computers and a plurality of hardware devices is administered by agent and monitor devices whose activities are coordinated to reduce the number of open channels or sockets. The communications architecture also improves the transparency and scalability of the distributed system by reducing network mapping dependence. The architecture is desirably implemented in a proton beam therapy system to provide flexible security policies which improve patent safety and facilitate system maintenance and development.

Baumann, Michael A; Beloussov, Alexandre V; Bakir, Julide; Armon, Deganit; Olsen, Howard B; Salem, Dana

2013-12-03T23:59:59.000Z

74

Compact accelerator for medical therapy  

DOE Patents [OSTI]

A compact accelerator system having an integrated particle generator-linear accelerator with a compact, small-scale construction capable of producing an energetic (.about.70-250 MeV) proton beam or other nuclei and transporting the beam direction to a medical therapy patient without the need for bending magnets or other hardware often required for remote beam transport. The integrated particle generator-accelerator is actuable as a unitary body on a support structure to enable scanning of a particle beam by direction actuation of the particle generator-accelerator.

Caporaso, George J.; Chen, Yu-Jiuan; Hawkins, Steven A.; Sampayan, Stephen E.; Paul, Arthur C.

2010-05-04T23:59:59.000Z

75

Proton beam therapy control system  

DOE Patents [OSTI]

A tiered communications architecture for managing network traffic in a distributed system. Communication between client or control computers and a plurality of hardware devices is administered by agent and monitor devices whose activities are coordinated to reduce the number of open channels or sockets. The communications architecture also improves the transparency and scalability of the distributed system by reducing network mapping dependence. The architecture is desirably implemented in a proton beam therapy system to provide flexible security policies which improve patent safety and facilitate system maintenance and development.

Baumann, Michael A. (Riverside, CA); Beloussov, Alexandre V. (Bernardino, CA); Bakir, Julide (Alta Loma, CA); Armon, Deganit (Redlands, CA); Olsen, Howard B. (Colton, CA); Salem, Dana (Riverside, CA)

2008-07-08T23:59:59.000Z

76

Proton beam therapy control system  

DOE Patents [OSTI]

A tiered communications architecture for managing network traffic in a distributed system. Communication between client or control computers and a plurality of hardware devices is administered by agent and monitor devices whose activities are coordinated to reduce the number of open channels or sockets. The communications architecture also improves the transparency and scalability of the distributed system by reducing network mapping dependence. The architecture is desirably implemented in a proton beam therapy system to provide flexible security policies which improve patent safety and facilitate system maintenance and development.

Baumann, Michael A. (Riverside, CA); Beloussov, Alexandre V. (San Bernardino, CA); Bakir, Julide (Alta Loma, CA); Armon, Deganit (Longmeadow, MA); Olsen, Howard B. (Irvine, CA); Salem, Dana (Riverside, CA)

2010-09-21T23:59:59.000Z

77

ORIGINAL CONTRIBUTION Pharmacogenetic Study of Statin Therapy  

E-Print Network [OSTI]

ORIGINAL CONTRIBUTION Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction Daniel I apolipoprotein E (APOE), apolipoprotein B (APOB), cho- lesteryl ester transfer protein (CETP), and the LDL

Posada, David

78

An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston  

SciTech Connect (OSTI)

The number of proton and carbon ion therapy centers is increasing; however, since the publication of the International Commission on Radiation Units and Measurements report, there has been no dedicated report dealing with proton therapy quality assurance. The purpose of this article is to describe the quality assurance procedures performed on the passively scattered proton therapy beams at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center in Houston. The majorities of these procedures are either adopted from procedures outlined in the American Association of Physicists in Medical Task Group (TG) 40 report or are a modified version of the TG 40 procedures. In addition, new procedures, which were designed specifically to be applicable to the synchrotron at the author's center, have been implemented. The authors' procedures were developed and customized to ensure patient safety and accurate operation of synchrotron to within explicit limits. This article describes these procedures and can be used by others as a guideline for developing QA procedures based on particle accelerator specific parameters and local regulations pertinent to any new facility.

Arjomandy, Bijan; Sahoo, Narayan; Zhu, X. Ronald; Zullo, John R.; Wu, Richard Y.; Zhu Mingping; Ding Xiaoning; Martin, Craig; Ciangaru, George; Gillin, Michael T. [Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center, 1840 Old Spanish Trail, Houston, Texas 77025 (United States)

2009-06-15T23:59:59.000Z

79

Interstitial deletion of 8q21{yields}22 associated with minor anomalies, congenital heart defect, and Dandy-Walker variant  

SciTech Connect (OSTI)

We describe an infant with a deletion of 8q21{yields}22 who had distinct clinical manifestations including minor facial anomalies, a congenital heart defect, a Dandy-Walker variant, and mild to moderate developmental delay. Her facial characteristics included small, wide-spaced eyes, asymmetric bilateral epicanthal folds, a broad nasal bridge, a {open_quotes}carp-shaped{close_quotes} mouth, micrognathia, and prominent, apparently low-set ears. Three other reports describe children with larger proximal deletions of 8q that include 8q21 and q22. These four children all have similar facial appearance. Of the others reported, one had a congenital heart defect and one had craniosynostosis. This case, in addition to the previously noted three cases, helps in delineating a recognizable syndrome. 12 refs., 3 figs., 1 tab.

Donahue, M.L. [Medical Univ. of South Carolina, Charleston, SC (United States); Ryan, R.M. [Univ. of Rochester, NY (United States)

1995-03-13T23:59:59.000Z

80

High contrast, CdTe portal scanner for radiation therapy  

SciTech Connect (OSTI)

This paper reports on one of the most promising new technologies for improving the qualify of radiation therapy, the use of real-time systems to produce portal images. In the authors' approach, they are constructing a linear array of 256 CdTe photovoltaic detectors attached to a very compact linear scanner, all of which will be mounted in a cassette shaped package to be located under the patient table. The high stopping power of the CdTe allows a high contrast image to be made using only a single Linac pulse per line, resulting in a high contrast image in under 5 seconds.

Entine, G.; Squillante, M.R.; Hahn, R.; Cirignano, L.J.; McGann, W. (Radiation Monitoring Devices, Inc., Watertown, MA (United States)); Biggs, P.J. (Massachusetts General Hospital, Boston, MA (United States))

1992-10-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


81

Method for microbeam radiation therapy  

DOE Patents [OSTI]

A method is disclosed of performing radiation therapy on a patient, involving exposing a target, usually a tumor, to a therapeutic dose of high energy electromagnetic radiation, preferably X-ray radiation. The dose is in the form of at least two non-overlapping microbeams of radiation, each microbeam having a width of less than about 1 millimeter. Target tissue exposed to the microbeams receives a radiation dose during the exposure that exceeds the maximum dose that such tissue can survive. Non-target tissue between the microbeams receives a dose of radiation below the threshold amount of radiation that can be survived by the tissue, and thereby permits the non-target tissue to regenerate. The microbeams may be directed at the target from one direction, or from more than one direction in which case the microbeams overlap within the target tissue enhancing the lethal effect of the irradiation while sparing the surrounding healthy tissue. No Drawings

Slatkin, D.N.; Dilmanian, F.A.; Spanne, P.O.

1994-08-16T23:59:59.000Z

82

Hadron Therapy in Latin America  

SciTech Connect (OSTI)

The use of proton and heavy ion beams for radiotherapy is a well established cancer treatment modality in the first world, which is becoming increasingly widespread, due to its clear advantages over conventional photon-based treatments. This strategy is suitable when the tumor is spatially well localized. Also the use of neutrons has tradition. Here Boron Neutron Capture Therapy (BNCT) stands out, though on a much smaller scale, being a promising alternative for tumors which are diffuse and infiltrating. On this sector, so far only nuclear reactors have been used as neutron sources. In this paper we briefly describe the situation in Latin America and in particular we discuss the present status of an ongoing project to develop a folded Tandem-ElectroStatic-Quadrupole (TESQ) accelerator for Accelerator-Based (AB)-Boron Neutron Capture Therapy (BNCT) at the Atomic Energy Commission of Argentina. The project goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the {sup 7}Li(p,n){sup 7}Be reaction. These are the specifications needed to produce sufficiently intense and clean epithermal neutron beams to perform BNCT for deep-seated tumors in less than an hour. The machine being currently designed and constructed is a folded TESQ with a terminal at 0.6 MV as a smaller scale prototype. Since the concept is modular the same structure will be used for the 1.2 MV final accelerator.

Kreiner, A. J.; Minsky, D. M. [Gerencia de Investigacion y Aplicaciones, Comision Nacional de Energia Atomica, Av. Gral Paz 1499 (1650), San Martin, Buenos Aires (Argentina); Escuela de Ciencia y Tecnologia. Universidad Nacional de Gral. San Martin, M. De Irigoyen 3100 (1650), San Martin, Buenos Aires (Argentina); CONICET, Avda. Rivadavia 1917 (C1033AAJ), Ciudad Autonoma de Buenos Aires (Argentina); Bergueiro, J.; Castell, W.; Thatar Vento, V.; Cartelli, D.; Kesque, J. M.; Ilardo, J. C.; Baldo, M.; Erhardt, J.; Estrada, L.; Hazarabedian, A.; Johann, F.; Suarez Sandin, J. C.; Igarzabal, M.; Repetto, M.; Obligado, M.; Lell, J.; Padulo, J.; Herrera, M. [Gerencia de Investigacion y Aplicaciones, Comision Nacional de Energia Atomica, Av. Gral Paz 1499 (1650), San Martin, Buenos Aires (Argentina)

2010-08-04T23:59:59.000Z

83

A Dual-Armed Robotic System for Intraoperative Ultrasound Guided Hepatic Ablative Therapy:A  

E-Print Network [OSTI]

A Dual-Armed Robotic System for Intraoperative Ultrasound Guided Hepatic Ablative Therapy, we propose the use of a dual robotic arm system that manages both ultrasound manipulation and needle guidance. We report a prototype of the dual arm system and a comparative performance analysis between

Camesano, Terri

84

Diabetologia . Author manuscript Menopausal hormone therapy and new-onset diabetes in the French Etude  

E-Print Network [OSTI]

@igr.fr > Abstract Aims/hypothesis Two US randomized trials found a lower incidence of type 2 diabetes among women Controlled Trials as Topic Author Keywords adult diabetes ; postmenopause ; menopausal hormone therapy-report or drug reimbursement record linkage, and further validated. Results 1220 new-onset diabetes cases were

Boyer, Edmond

85

Validation of mathematical models for the prediction of organs-at-risk dosimetric metrics in high-dose-rate gynecologic interstitial brachytherapy  

SciTech Connect (OSTI)

Purpose: Given the complicated nature of an interstitial gynecologic brachytherapy treatment plan, the use of a quantitative tool to evaluate the quality of the achieved metrics compared to clinical practice would be advantageous. For this purpose, predictive mathematical models to predict the D{sub 2cc} of rectum and bladder in interstitial gynecologic brachytherapy are discussed and validated.Methods: Previous plans were used to establish the relationship between D2cc and the overlapping volume of the organ at risk with the targeted area (C0) or a 1-cm expansion of the target area (C1). Three mathematical models were evaluated: D{sub 2cc}=?*C{sub 1}+? (LIN); D{sub 2cc}=?– exp(–?*C{sub 0}) (EXP); and a mixed approach (MIX), where both C{sub 0} and C{sub 1} were inputs of the model. The parameters of the models were optimized on a training set of patient data, and the predictive error of each model (predicted D{sub 2cc}? real D{sub 2cc}) was calculated on a validation set of patient data. The data of 20 patients were used to perform a K-fold cross validation analysis, with K = 2, 4, 6, 8, 10, and 20.Results: MIX was associated with the smallest mean prediction error <6.4% for an 18-patient training set; LIN had an error <8.5%; EXP had an error <8.3%. Best case scenario analysis shows that an error ?5% can be achieved for a ten-patient training set with MIX, an error ?7.4% for LIN, and an error ?6.9% for EXP. The error decreases with the increase in training set size, with the most marked decrease observed for MIX.Conclusions: The MIX model can predict the D{sub 2cc} of the organs at risk with an error lower than 5% with a training set of ten patients or greater. The model can be used in the development of quality assurance tools to identify treatment plans with suboptimal sparing of the organs at risk. It can also be used to improve preplanning and in the development of real-time intraoperative planning tools.

Damato, Antonio L.; Viswanathan, Akila N.; Cormack, Robert A. [Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115 (United States)] [Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts 02115 (United States)

2013-10-15T23:59:59.000Z

86

antiandrogen flutamide therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

therapy treatment for cancer Venue: Science Gallery Trinity College Therapist, Zagreb, Croatia 17.00-17.30: Radiation Therapy for Prostate Cancer: Professional and Patient...

87

aroma therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

therapy treatment for cancer Venue: Science Gallery Trinity College Therapist, Zagreb, Croatia 17.00-17.30: Radiation Therapy for Prostate Cancer: Professional and Patient...

88

adjuvant radiation therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

therapy treatment for cancer Venue: Science Gallery Trinity College Therapist, Zagreb, Croatia 17.00-17.30: Radiation Therapy for Prostate Cancer: Professional and Patient...

89

Abstract--This study aimed to compare MR thermal mapping during Laser-induced Interstitial Thermal Therapy (LITT) to thermal lesions observed macroscopically, in order to estimate the 3D size of the coagulative necrosis. Laser irradiation was  

E-Print Network [OSTI]

fiber inside the metastasis. Laser energy is transmitted via this optical fiber resulting in a well for an accurate positioning of the optical fibers in the target area, for real-time monitoring of the thermal of the coagulative necrosis. Laser irradiation was performed ex-vivo with a 980 nm laser in pig liver in a open low

Paris-Sud XI, Université de

90

Decision Regret in Men Undergoing Dose-Escalated Radiation Therapy for Prostate Cancer  

SciTech Connect (OSTI)

Purpose: Decision regret (DR) is a negative emotion associated with medical treatment decisions, and it is an important patient-centered outcome after therapy for localized prostate cancer. DR has been found to occur in up to 53% of patients treated for localized prostate cancer, and it may vary depending on treatment modality. DR after modern dose-escalated radiation therapy (DE-RT) has not been investigated previously, to our knowledge. Our primary aim was to evaluate DR in a cohort of patients treated with DE-RT. Methods and Materials: We surveyed 257 consecutive patients with localized prostate cancer who had previously received DE-RT, by means of a validated questionnaire. Results: There were 220 responses (85.6% response rate). Image-guided intensity modulated radiation therapy was given in 85.0% of patients and 3-dimensional conformal radiation therapy in 15.0%. Doses received included 73.8 Gy (34.5% patients), 74 Gy (53.6%), and 76 Gy (10.9%). Neoadjuvant androgen deprivation (AD) was given in 51.8% of patients and both neoadjuvant and adjuvant AD in 34.5%. The median follow-up time was 23 months (range, 12-67 months). In all, 3.8% of patients expressed DR for their choice of treatment. When asked whether they would choose DE-RT or AD again, only 0.5% probably or definitely would not choose DE-RT again, compared with 8.4% for AD (P<.01). Conclusion: Few patients treated with modern DE-RT express DR, with regret appearing to be lower than in previously published reports of patients treated with radical prostatectomy or older radiation therapy techniques. Patients experienced more regret with the AD component of treatment than with the radiation therapy component, with implications for informed consent. Further research should investigate regret associated with individual components of modern therapy, including AD, radiation therapy and surgery.

Steer, Anna N. [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia)] [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia); Aherne, Noel J., E-mail: noel.aherne@ncahs.health.nsw.gov.au [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia); Rural Clinical School Faculty of Medicine, University of New South Wales, Coffs Harbour (Australia); Gorzynska, Karen; Hoffman, Matthew; Last, Andrew; Hill, Jacques [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia)] [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia); Shakespeare, Thomas P. [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia) [Department of Radiation Oncology, North Coast Cancer Institute, Coffs Harbour (Australia); Rural Clinical School Faculty of Medicine, University of New South Wales, Coffs Harbour (Australia)

2013-07-15T23:59:59.000Z

91

Density functional theory study on the interstitial chemical shifts of main-group-element centered hexazirconium halide clusters; synthetic control of speciation in [(Zr6ZCl12)] (Z = B, C)-based mixed ligand complexes  

E-Print Network [OSTI]

. For carbide-, boride-, and nitride-centered carbonyl- ligated clusters of the later transition metals, such exceptional chemical shifts have also been observed and are quite comparable to data for hexazirconium clusters.79-86 A number of correlative... make the main contributions to paramagnetic shielding. Kaupp calculated 13C chemical shift tensors for interstitial carbides of a series of transition metal carbonyl clusters using sum-over-states density functional perturbation theory (SOS-DFPT)90...

Shen, Jingyi

2005-08-29T23:59:59.000Z

92

CRD Report  

E-Print Network [OSTI]

Research Division Report Deconstructing Microbes Metagenomicon page 2 (Scientific Report SciDAC continued from page 1www.ctwatch.org/quarterly. Report Nano Letters continued

Wang, Ucilia

2007-01-01T23:59:59.000Z

93

Computer simulation of neutron capture therapy.  

E-Print Network [OSTI]

Analytical methods are developed to simulate on a large digital computer the production and use of reactor neutron beams f or boron capture therapy of brain tumors. The simulation accounts for radiation dose distributions ...

Olson, Arne Peter

1967-01-01T23:59:59.000Z

94

Computer simulation of neutron capture therapy  

E-Print Network [OSTI]

Analytical methods are developed to simulate on a large digital computer the production and use of reactor neutron beams f or boron capture therapy of brain tumors. The simulation accounts for radiation dose distributions ...

Olson, Arne Peter

1967-01-01T23:59:59.000Z

95

Cancer Therapies: A Bane and a Boon  

E-Print Network [OSTI]

on the surgical decision-making process for breast cancer.Cancer, 112(3), 489-494. 2. Grealy, Lucy (1994).Mifflin. 3. He, Lin (2011). Cancer Therapy. [PowerPoint

Neogi, Sushrita

2012-01-01T23:59:59.000Z

96

Hypofractionated Whole-Breast Radiation Therapy: Does Breast Size Matter?  

SciTech Connect (OSTI)

Purpose: To evaluate the effects of breast size on dose-volume histogram parameters and clinical toxicity in whole-breast hypofractionated radiation therapy using intensity modulated radiation therapy (IMRT). Materials and Methods: In this retrospective study, all patients undergoing breast-conserving therapy between 2005 and 2009 were screened, and qualifying consecutive patients were included in 1 of 2 cohorts: large-breasted patients (chest wall separation >25 cm or planning target volume [PTV] >1500 cm{sub 3}) (n=97) and small-breasted patients (chest wall separation <25 cm and PTV <1500 cm{sub 3}) (n=32). All patients were treated prone or supine with hypofractionated IMRT to the whole breast (42.4 Gy in 16 fractions) followed by a boost dose (9.6 Gy in 4 fractions). Dosimetric and clinical toxicity data were collected and analyzed using the R statistical package (version 2.12). Results: The mean PTV V95 (percentage of volume receiving >= 95% of prescribed dose) was 90.18% and the mean V105 percentage of volume receiving >= 105% of prescribed dose was 3.55% with no dose greater than 107%. PTV dose was independent of breast size, whereas heart dose and maximum point dose to skin correlated with increasing breast size. Lung dose was markedly decreased in prone compared with supine treatments. Radiation Therapy Oncology Group grade 0, 1, and 2 skin toxicities were noted acutely in 6%, 69%, and 25% of patients, respectively, and at later follow-up (>3 months) in 43%, 57%, and 0% of patients, respectively. Large breast size contributed to increased acute grade 2 toxicity (28% vs 12%, P=.008). Conclusions: Adequate PTV coverage with acceptable hot spots and excellent sparing of organs at risk was achieved by use of IMRT regardless of treatment position and breast size. Although increasing breast size leads to increased heart dose and maximum skin dose, heart dose remained within our institutional constraints and the incidence of overall skin toxicity was comparable to that reported in the literature. Taken together, these data suggest that hypofractionated radiation therapy using IMRT is a viable and appropriate therapeutic modality in large-breasted patients.

Hannan, Raquibul, E-mail: Raquibul.Hannan@gmail.com [Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas (United States)] [Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas (United States); Thompson, Reid F.; Chen Yu; Bernstein, Karen; Kabarriti, Rafi; Skinner, William [Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York (United States)] [Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York (United States); Chen, Chin C. [Department of Radiation Oncology, Columbia University Medical Center, New York, New York (United States)] [Department of Radiation Oncology, Columbia University Medical Center, New York, New York (United States); Landau, Evan; Miller, Ekeni; Spierer, Marnee; Hong, Linda; Kalnicki, Shalom [Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York (United States)] [Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York (United States)

2012-11-15T23:59:59.000Z

97

Alopecia: A review of laser and light therapies  

E-Print Network [OSTI]

with alopecia. ACKNOWLEDGEMENT: Sophia Rangwala gratefullyof laser and light therapies Sophia Rangwala AB, Rashid M

Rangwala, Sophia; Rashid, Rashid M

2012-01-01T23:59:59.000Z

98

PARSII - New Reports and Reports With New Reporting Folder Location...  

Energy Savers [EERE]

- New Reports and Reports With New Reporting Folder Location More Documents & Publications PARSII - New Reports and Reports With New Reporting Folder Location Slide 1 Slide 1...

99

Technical design of hadron therapy facilities  

SciTech Connect (OSTI)

Radiation therapy with hadron beams now has a 40-year track record at many accelerator laboratories around the world, essentially all of these originally physics-research oriented. The great promise shown for treating cancer has led the medical community to seek dedicated accelerator facilities in a hospital setting, where more rapid progress can be made in clinical research. This paper will discuss accelerator and beam characteristics relevant to hadron therapy, particularly as applied to hospital-based facilities. A survey of currently-operating and planned hadron therapy facilities will be given, with particular emphasis on Loma Linda (the first dedicated proton facility in a hospital) and HIMAC (the first dedicated heavy-ion medical facility).

Alonso, J.R.

1993-08-01T23:59:59.000Z

100

Technical Design of Hadron Therapy Facilities  

SciTech Connect (OSTI)

Radiation therapy with hadron beams now has a 40-year track record at many accelerator laboratories around the world, essentially all of these originally physics-research oriented. The great promise shown for treating cancer has led the medical community to seek dedicated accelerator facilities in a hospital setting, where more rapid progress can be made in clinical research. This paper will discuss accelerator and beam characteristics relevant to hadron therapy, particularly as applied to hospital-based facilities. A survey of currently-operating and planned hadron therapy facilities will be given, with particular emphasis on Lorna Linda (the first dedicated proton facility in a hospital) and HIMAC (the first dedicated heavy-ion medical facility).

Alonso, J.R.

1993-08-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


101

Therapy for incorporated radionuclides: scope and need  

SciTech Connect (OSTI)

In the United States the recent termination of funding for research on therapy for incorporated radionuclides has virtually halted progress on improved or new agents and procedures for removing radioactivity from the body. Research was eliminated, but is still needed on new removal agents, improved delivery system, in vitro test systems, and the toxicology of treatments. For many radionuclides, no adequate therapy exists. The relationship between radionuclide removal and reduction in cancer risk is still unanswered. Without proper research support, needed improvements in the treatment for incorporated radionuclides in the US are uncertain.

Smith, V.H.

1981-03-01T23:59:59.000Z

102

Porphyrins for boron neutron capture therapy  

DOE Patents [OSTI]

Novel compounds for treatment of brain tumors in Boron Neutron Capture Therapy are disclosed. A method for preparing the compounds as well as pharmaceutical compositions containing said compounds are also disclosed. The compounds are water soluble, non-toxic and non-labile boronated porphyrins which show significant uptake and retention in tumors.

Miura, Michiko (Center Moriches, NY); Gabel, Detlef (Bremen, DE)

1990-01-01T23:59:59.000Z

103

Radiobiology of normal rat lung in Boron Neutron Capture Therapy  

E-Print Network [OSTI]

Boron Neutron Capture Therapy (BNCT) is a binary cancer radiation therapy that utilizes biochemical tumor cell targeting and provides a mixed field of high and low Linear Energy Transfer (LET) radiation with differing ...

Kiger, Jingli Liu

2006-01-01T23:59:59.000Z

104

Computational aspects of treatment planning for neutron capture therapy  

E-Print Network [OSTI]

Boron Neutron Capture Therapy (BNCT) is a biochemically targeted form of binary radiation therapy that has the potential to deliver radiation to cancers with cellular dose selectivity. Accurate and efficient treatment ...

Albritton, James Raymond, 1977-

2010-01-01T23:59:59.000Z

105

Research report Bilateral near-infrared monitoring of the cerebral concentration and  

E-Print Network [OSTI]

Research report Bilateral near-infrared monitoring of the cerebral concentration and oxygen therapy (ECT). Non-invasive near infrared spectroscopy has previously been shown to reliably measure: Electro-convulsive therapy; Near-infrared spectroscopy; Seizure; Cerebral hemodynamics 1. Introduction

Boas, David

106

From molecular changes to customised therapy A. Hemminki*,1  

E-Print Network [OSTI]

and the Gene Therapy Center, University of Alabama at Birmingham, WTI #602, 1824 6th Ave S., Birmingham, AL

Hemminki, Akseli

107

Radiation therapy of pediatric brain tumors : comparison of long-term health effects and costs between proton therapy and IMRT  

E-Print Network [OSTI]

Radiation therapy is an important component of pediatric brain tumor treatment. However, radiation-induced damage can lead to adverse long-term health effects. Proton therapy has the ability to reduce the dose delivered ...

Vu, An T. (An Thien)

2011-01-01T23:59:59.000Z

108

The University of British Columbia | Department of Physical Therapy Strategic Plan 2010 2014 1 DEPARTMENT OF PHYSICAL THERAPY  

E-Print Network [OSTI]

The University of British Columbia | Department of Physical Therapy Strategic Plan 2010 ­ 2014 1 DEPARTMENT OF PHYSICAL THERAPY UNIVERSITY OF BRITISH COLUMBIA STRATEGIC PLAN 20102014 development. 3. Faculty members teaching assignments. #12;The University of British Columbia | Department

Michelson, David G.

109

2001 annual report 2001 annual report  

E-Print Network [OSTI]

2001 annual report 2001 annual report 2001 annual report 2001 annual report 2001 annual report 2001 annual report 2001 annual report 2001 annual reportelectrical & computer engineering 2001 annual report the university of new mexico department of 2001 annual report 2001 annual report 2001 annual report 2001 annual

New Mexico, University of

110

Bevacizumab as Therapy for Radiation Necrosis in Four Children With Pontine Gliomas  

SciTech Connect (OSTI)

Purpose: Diffuse pontine gliomas are a pediatric brain tumor that is fatal in nearly all patients. Given the poor prognosis for patients with this tumor, their quality of life is very important. Radiation therapy provides some palliation, but can result in radiation necrosis and associated neurologic decline. The typical treatment for this necrosis is steroid therapy. Although the steroids are effective, they have numerous side effects that can often significantly compromise quality of life. Bevacizumab, an antibody against vascular endothelial growth factor, has been suggested as a treatment for radiation necrosis. We report on our initial experience with bevacizumab therapy for radiation necrosis in pediatric pontine gliomas. Materials and Methods: Four children with pontine gliomas treated at the Children's Hospital in Denver and the University of Colorado Denver developed evidence of radiation necrosis both clinically and on imaging. Those 4 children then received bevacizumab as a treatment for the radiation necrosis. We reviewed the clinical outcome and imaging findings. Results: After bevacizumab therapy, 3 children had significant clinical improvement and were able to discontinue steroid use. One child continued to decline, and, in retrospect, had disease progression, not radiation necrosis. In all cases, bevacizumab was well tolerated. Conclusions: In children with pontine gliomas, bevacizumab may provide both therapeutic benefit and diagnostic information. More formal evaluation of bevacizumab in these children is needed.

Liu, Arthur K., E-mail: arthur.liu@ucdenver.ed [University of Colorado Denver, Department of Radiation Oncology, Aurora, CO (United States); Macy, Margaret E.; Foreman, Nicholas K. [Children's Hospital, Denver, Department of Neuro-Oncology, Aurora, CO (United States)

2009-11-15T23:59:59.000Z

111

Failed Retrieval of Potentially Retrievable IVC Filters: A Report of Two Cases  

SciTech Connect (OSTI)

Retrievable inferior vena cava filters are being increasingly used for the prevention of life-threatening pulmonary emboli in patients who have temporary contraindications to anticoagulation therapy. We report two cases of failure to remove these devices.

Kumar, Bangalore C. Anil [Queen's Medical Centre, Department of Radiology (United Kingdom)], E-mail: anil.kumar@doctors.org.uk; Chakraverty, Sam; Zealley, Ian [Ninewells Hospital, Department of Radiology (United Kingdom)

2006-02-15T23:59:59.000Z

112

Optimization of triiodothyronine therapy in beagles  

E-Print Network [OSTI]

OPTIMIZATION OF TRI IODOTHYRONINE Tl-IE RAP Y IN BEAGLES A Thesis by Victoria Carnahan Approved as to style and content by: airman Committee ea o partmen m er Mem er December 1976 ABSTRACT Optimization of Triiodothyronine Therapy... in Beagles. (December, 1976) Victoria Carnahan, B. A. , University of New Mexico; Chai rman: Dan Hightower, D. V. M. , M. S. A three part experiment was done to determine the best dosing sched- ule for hypothyroid beagles being maintained...

Carnahan, Victoria

1976-01-01T23:59:59.000Z

113

Technical Report  

E-Print Network [OSTI]

Dec 12, 2013 ... Technical Report Series: DCC-2013-13. Departamento de Cięncia de Computadores. Faculdade de Cięncias da Universidade do Porto.

Filipe Brandao

2013-12-12T23:59:59.000Z

114

Effect of thermal annealing on charge exchange between oxygen interstitial defects within HfO{sub 2} and oxygen-deficient silicon centers within the SiO{sub 2}/Si interface  

SciTech Connect (OSTI)

We compare the charging response of rapid thermally annealed (800 and 1000 deg. C) 4 nm thick HfO{sub 2} to as-deposited HfO{sub 2} on Si by measuring the surface potential of the HfO{sub 2} layers after vacuum ultraviolet (VUV) irradiation with 11.6 eV photons. From VUV spectroscopy, we determined all HfO{sub 2} layers show the presence of oxygen-interstitial defects (OIDs). The electronic states of OID in HfO{sub 2} line up in energy with oxygen-deficient Si centers within the SiO{sub 2} interfacial layer. This implies charge exchange between OIDs within HfO{sub 2} and the O-deficient silicon centers within the SiO{sub 2} interfacial layer are very important for controlling the radiation-induced trapped charge in HfO{sub 2} dielectric stacks.

Lauer, J. L.; Shohet, J. L. [Department of Electrical and Computer Engineering and Plasma Processing and Technology Laboratory, University of Wisconsin-Madison, Madison, Wisconsin 53706 (United States); Nishi, Y. [Stanford University, Stanford, California 94305 (United States)

2009-04-20T23:59:59.000Z

115

Gantry for medical particle therapy facility  

DOE Patents [OSTI]

A particle therapy gantry for delivering a particle beam to a patient includes a beam tube having a curvature defining a particle beam path and a plurality of fixed field magnets sequentially arranged along the beam tube for guiding the particle beam along the particle path. In a method for delivering a particle beam to a patient through a gantry, a particle beam is guided by a plurality of fixed field magnets sequentially arranged along a beam tube of the gantry and the beam is alternately focused and defocused with alternately arranged focusing and defocusing fixed field magnets.

Trbojevic, Dejan (Wading River, NY)

2012-05-08T23:59:59.000Z

116

Acceleration Of Wound Healing Ny Photodynamic Therapy  

DOE Patents [OSTI]

Disclosed is a method for accelerating wound healing in a mammal. The method includes identifying an unhealed wound site or partially-healed wound site in a mammal; administering a photosensitizer to the mammal; waiting for a time period wherein the photosensitizer reaches an effective tissue concentration at the wound site; and photoactivating the photosensitizer at the wound site. The dose of photodynamic therapy is selected to stimulate the production of one or more growth factor by cells at the wound site, without causing tissue destruction.

Hasan, Tayyaba (Arlington, MA); Hamblin, Michael R. (Revere, MA); Trauner, Kenneth (Sacramento, CA)

2000-08-22T23:59:59.000Z

117

Gantry for medical particle therapy facility  

DOE Patents [OSTI]

A particle therapy gantry for delivering a particle beam to a patient includes a beam tube having a curvature defining a particle beam path and a plurality of superconducting, variable field magnets sequentially arranged along the beam tube for guiding the particle beam along the particle path. In a method for delivering a particle beam to a patient through a gantry, a particle beam is guided by a plurality of variable field magnets sequentially arranged along a beam tube of the gantry and the beam is alternately focused and defocused with alternately arranged focusing and defocusing variable field magnets.

Trbojevic, Dejan

2013-04-23T23:59:59.000Z

118

Metalloporphyrins and their uses as radiosensitizers for radiation therapy  

DOE Patents [OSTI]

The present invention covers radiosensitizers containing as an active ingredient halogenated derivatives of boronated porphyrins containing multiple carborane cages having the structure ##STR1## which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron--capture therapy and photodynamic therapy. The present invention also covers methods for using these radiosensitizers in tumor imaging and cancer treatment.

Miura, Michiko; Slatkin, Daniel N.

2004-07-06T23:59:59.000Z

119

anticoagulation therapy mr-tomographische: Topics by E-print...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

be Indicated in Patients on AnticoagulantAntiplatelet Therapy Following Mild Traumatic Brain Injury University of California eScholarship Repository Summary: head injury and an...

120

antiplatelet therapy i prevention: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

be Indicated in Patients on AnticoagulantAntiplatelet Therapy Following Mild Traumatic Brain Injury University of California eScholarship Repository Summary: head injury and an...

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


121

antibody prodrug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

ION Antibody-based therapies for malaria Richard J. Pleass and tissue fluids, and can protect against malaria by binding and neutralizing malaria parasites of antibodies in the...

122

antithyroid drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

123

antidiabetic drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

124

antiretroviral drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

125

antipsychotic drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

126

antiepileptic drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

127

antiarrhythmic drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

128

adhd drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

129

antihypertensive drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

130

Methods for implementing microbeam radiation therapy  

DOE Patents [OSTI]

A method of performing radiation therapy includes delivering a therapeutic dose such as X-ray only to a target (e.g., tumor) with continuous broad beam (or in-effect continuous) using arrays of parallel planes of radiation (microbeams/microplanar beams). Microbeams spare normal tissues, and when interlaced at a tumor, form a broad-beam for tumor ablation. Bidirectional interlaced microbeam radiation therapy (BIMRT) uses two orthogonal arrays with inter-beam spacing equal to beam thickness. Multidirectional interlaced MRT (MIMRT) includes irradiations of arrays from several angles, which interleave at the target. Contrast agents, such as tungsten and gold, are administered to preferentially increase the target dose relative to the dose in normal tissue. Lighter elements, such as iodine and gadolinium, are used as scattering agents in conjunction with non-interleaving geometries of array(s) (e.g., unidirectional or cross-fired (intersecting) to generate a broad beam effect only within the target by preferentially increasing the valley dose within the tumor.

Dilmanian, F. Avraham; Morris, Gerard M.; Hainfeld, James F.

2007-03-20T23:59:59.000Z

131

Annual Report 2013 Annual Report  

E-Print Network [OSTI]

Responsibility 36 Audit Committee Report 39 Independent Auditors' Report 41 Consolidated Statement of Financial scientists from the Universities of Oxford and Reading and researchers at the Pirbright Institute, which and Technology Facilities Council and the Wellcome Trust. Diamond generates high-energy beams of electrons

Rambaut, Andrew

132

Report2  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStories » Removing nuclear waste,ReportReportReport on a

133

Fan-beam intensity modulated proton therapy  

SciTech Connect (OSTI)

Purpose: This paper presents a concept for a proton therapy system capable of delivering intensity modulated proton therapy using a fan beam of protons. This system would allow present and future gantry-based facilities to deliver state-of-the-art proton therapy with the greater normal tissue sparing made possible by intensity modulation techniques.Methods: A method for producing a divergent fan beam of protons using a pair of electromagnetic quadrupoles is described and particle transport through the quadrupole doublet is simulated using a commercially available software package. To manipulate the fan beam of protons, a modulation device is developed. This modulator inserts or retracts acrylic leaves of varying thickness from subsections of the fan beam. Each subsection, or beam channel, creates what effectively becomes a beam spot within the fan area. Each channel is able to provide 0–255 mm of range shift for its associated beam spot, or stop the beam and act as an intensity modulator. Results of particle transport simulations through the quadrupole system are incorporated into the MCNPX Monte Carlo transport code along with a model of the range and intensity modulation device. Several design parameters were investigated and optimized, culminating in the ability to create topotherapy treatment plans using distal-edge tracking on both phantom and patient datasets.Results: Beam transport calculations show that a pair of electromagnetic quadrupoles can be used to create a divergent fan beam of 200 MeV protons over a distance of 2.1 m. The quadrupole lengths were 30 and 48 cm, respectively, with transverse field gradients less than 20 T/m, which is within the range of water-cooled magnets for the quadrupole radii used. MCNPX simulations of topotherapy treatment plans suggest that, when using the distal edge tracking delivery method, many delivery angles are more important than insisting on narrow beam channel widths in order to obtain conformal target coverage. Overall, the sharp distal falloff of a proton depth-dose distribution was found to provide sufficient control over the dose distribution to meet objectives, even with coarse lateral resolution and channel widths as large as 2 cm. Treatment plans on both phantom and patient data show that dose conformity suffers when treatments are delivered from less than approximately ten angles. Treatment time for a sample prostate delivery is estimated to be on the order of 10 min, and neutron production is estimated to be comparable to that found for existing collimated systems.Conclusions: Fan beam proton therapy is a method of delivering intensity modulated proton therapy which may be employed as an alternative to magnetic scanning systems. A fan beam of protons can be created by a set of quadrupole magnets and modified by a dual-purpose range and intensity modulator. This can be used to deliver inversely planned treatments, with spot intensities optimized to meet user defined dose objectives. Additionally, the ability of a fan beam delivery system to effectively treat multiple beam spots simultaneously may provide advantages as compared to spot scanning deliveries.

Hill, Patrick [Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 (United States)] [Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 (United States); Westerly, David [Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States)] [Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States); Mackie, Thomas [Medical Devices, Morgridge Institute for Research, University of Wisconsin, Madison, Wisconsin 53715 (United States)] [Medical Devices, Morgridge Institute for Research, University of Wisconsin, Madison, Wisconsin 53715 (United States)

2013-11-15T23:59:59.000Z

134

SANDIA REPORT  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

To improve upon and evolve existing solar PV O&M approaches, this report: 1. Provides perspective on the concept of PV "system" reliability and how it can inform plant design,...

135

Final Report  

SciTech Connect (OSTI)

This the final report for the project "Large-Scale Optimization for Bayesian Inference in Complex Systems," for the work in the group of the co-PI George Biros.

Biros, George

2014-08-18T23:59:59.000Z

136

DOE Report  

Broader source: Energy.gov (indexed) [DOE]

C. E., M. F. Baker, R. L. Eng, J. S. Gashwiler, and M. H. Schroeder, 1976, "Conservation Committee Report on Effects of Alteration of Sagebrush Communities on the Associated...

137

Final Report  

SciTech Connect (OSTI)

This document constitutes the Final Report for award DE-FC02-06ER41446 as required by the Office of Science. It summarizes accomplishments and provides copies of scientific publications with significant contribution from this award.

DeTar, Carleton [P.I.

2012-12-10T23:59:59.000Z

138

Informal Report  

Office of Scientific and Technical Information (OSTI)

mm ts LOS ALAMOS SCIENTIFIC LABORATORY Post Office Box 1663 Los Alamos. New Mexico 87545 DISTRDU7irM o r TdiS BGGbT.lENT IS UNLIMITED DISCLAIMER This report was...

139

Quality Assurance of Radiation Therapy Planning Systems: Current Status and Remaining Challenges  

SciTech Connect (OSTI)

Computerized radiation therapy planning systems (RTPSs) are pivotal for treatment planning. The acceptance, commissioning, and quality control of RTPSs are uniquely complex and are described in the American Association of Physicists in Medicine Task Group Report 53 (1998) and International Atomic Energy Agency Technical Report Series No. 430 (2004). The International Atomic Energy Agency also developed a document and data package for use by vendors and purchasers to aid with acceptance testing of RTPSs. This document is based on International Electrotechnical Commission standard 62083 (2000) and describes both 'type' tests to be performed in the factory and 'site' tests to be performed in the clinic. The American Association of Physicists Task Group Report 67 described benchmark tests for the validation of dose calculation algorithms. Test data are being produced with the backing of the U.S. National Cancer Institute. However, significant challenges remain. Technology keeps evolving rapidly, thus requiring new quality assurance (QA) procedures. Intensity-modulated radiation therapy with its use of inverse optimization has added a new dimension to QA, because the results are not intuitively obvious. New technologies such as real-time ultrasound guidance for brachytherapy, TomoTherapy, and Cyberknife, require their own specialized RTPSs with unique QA requirements. On-line imaging allows for the generation of dose reconstructions using image warping techniques to determine the daily dose delivered to the patient. With increasing computer speeds, real-time reoptimization of treatment plans will become a reality. Gating technologies will require four-dimensional dose calculations to determine the actual dose delivered to tissue voxels. With these rapidly changing technologies, it is essential that a strong QA culture is invoked in every institution implementing these procedures and that new protocols are developed as a part of the clinical implementation process.

Van Dyk, Jacob [Department of Physics and Engineering, London Regional Cancer Program/London Health Sciences Centre, London, ON (Canada); Departments of Oncology, Medical Biophysics, Diagnostic Imaging and Nuclear Medicine, and Physics and Astronomy, University of Western Ontario, London, ON (Canada)], E-mail: jake.vandyk@lhsc.on.ca

2008-05-01T23:59:59.000Z

140

Proton Therapy Coverage for Prostate Cancer Treatment  

SciTech Connect (OSTI)

Purpose: To determine the impact of prostate motion on dose coverage in proton therapy. Methods and Materials: A total of 120 prostate positions were analyzed on 10 treatment plans for 10 prostate patients treated using our low-risk proton therapy prostate protocol (University of Florida Proton Therapy Institute 001). Computed tomography and magnetic resonance imaging T{sub 2}-weighted turbo spin-echo scans were registered for all cases. The planning target volume included the prostate with a 5-mm axial and 8-mm superoinferior expansion. The prostate was repositioned using 5- and 10-mm one-dimensional vectors and 10-mm multidimensional vectors (Points A-D). The beam was realigned for the 5- and 10-mm displacements. The prescription dose was 78 Gy equivalent (GE). Results: The mean percentage of rectum receiving 70 Gy (V{sub 70}) was 7.9%, the bladder V{sub 70} was 14.0%, and the femoral head/neck V{sub 50} was 0.1%, and the mean pelvic dose was 4.6 GE. The percentage of prostate receiving 78 Gy (V{sub 78}) with the 5-mm movements changed by -0.2% (range, 0.006-0.5%, p > 0.7). However, the prostate V{sub 78} after a 10-mm displacement changed significantly (p < 0.003) with different movements: 3.4% (superior), -5.6% (inferior), and -10.2% (posterior). The corresponding minimal doses were also reduced: 4.5 GE, -4.7 GE, and -11.7 GE (p {<=} 0.003). For displacement points A-D, the clinical target volume V{sub 78} coverage had a large and significant reduction of 17.4% (range, 13.5-17.4%, p < 0.001) in V{sub 78} coverage of the clinical target volume. The minimal prostate dose was reduced 33% (25.8 GE), on average, for Points A-D. The prostate minimal dose improved from 69.3 GE to 78.2 GE (p < 0.001) with realignment for 10-mm movements. Conclusion: The good dose coverage and low normal doses achieved for the initial plan was maintained with movements of {<=}5 mm. Beam realignment improved coverage for 10-mm displacements.

Vargas, Carlos [University of Florida Proton Therapy Institute, Jacksonville, FL (United States); Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL (United States)], E-mail: c2002@ufl.edu; Wagner, Marcus; Mahajan, Chaitali [University of Florida Proton Therapy Institute, Jacksonville, FL (United States); Indelicato, Daniel [Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL (United States); Fryer, Amber; Falchook, Aaron; Horne, David C.; Chellini, Angela; McKenzie, Craig C.; Lawlor, Paula C.; Li Zuofeng; Lin Liyong; Keole, Sameer [University of Florida Proton Therapy Institute, Jacksonville, FL (United States)

2008-04-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


141

Combined Ethanol Injection Therapy and Radiofrequency Ablation Therapy in Percutaneous Treatment of Hepatocellular Carcinoma Larger than 4 cm  

SciTech Connect (OSTI)

Background. Optimal treatment of large-sized hepatocellular carcinoma (HCC) is still debated, because percutaneous ablation therapies alone do not always achieve complete necrosis. Objective. To report our experience in the treatment of patients with HCC larger than 4 cm in diameter by combined percutaneous ethanol injection and radiofrequency thermal ablation. Methods. In a 5-year period there were 40 consecutive patients meeting the inclusion criteria (24 men and 16 women; age range 41-72 years, mean 58 years). These subjects had a single HCC larger than 4 cm. Twelve subjects also had one or two additional nodules smaller than 4 cm (mean 1.2 nodules per patient). Patients were submitted to one to three sessions consisting of ethanol injection at two opposite tumor poles (mean 12 ml) and then of radiofrequency application through one or two electrodes placed at the tumor center (mean treatment duration 30 min). Results. Complete necrosis was obtained in all cases with one to three sessions (mean 1.3 sessions per patient). All patients experienced pain and fever but one only subject had a major complication requiring treatment (abscess development and fistulization). Overall follow-up was 7-69 months. Two patients showed local recurrence and 9 developed new etherotopic HCC nodules. Seven subjects died during follow-up while 33 were free from recurrence 8-69 months after treatment. Conclusion. A combination of ethanol injection and radiofrequency ablation is effective in the treatment of large HCC.

Vallone, Paolo; Catalano, Orlando [National Cancer Institute, Department of Radiology (Italy)], E-mail: orlandcat@tin.it; Izzo, Francesco [National Cancer Institute, Department of Surgical Oncology 'D' (Italy); Siani, Alfredo [National Cancer Institute, Department of Radiology (Italy)

2006-08-15T23:59:59.000Z

142

Dosimetry for radiocolloid therapy of cystic craniopharyngiomas  

E-Print Network [OSTI]

The dosimetry for radiocolloid therapy of cystic craniopharyngiomas is investigated. Analytical calculations based on the Loevinger and the Berger formulae for electrons and photons, respectively, are compared with Monte Carlo simulations. The role of the material of which the colloid introduced inside the craniopharyngioma is made of as well as that forming the cyst wall is analyzed. It is found that the analytical approaches provide a very good description of the simulated data in the conditions where they can be applied (i.e., in the case of a uniform and infinite homogeneous medium). However, the consideration of the different materials and interfaces produces a strong reduction of the dose delivered to the cyst wall in relation to that predicted by the Loevinger and the Berger formulae.

Rojas, E L; Lallena, A M; Bodineau, C; Galan, P; Al-Dweri, Feras M.O.; Lallena, Antonio M.; Bodineau, Coral; Galan, Pedro

2003-01-01T23:59:59.000Z

143

Radiation Therapy With Full-Dose Gemcitabine and Oxaliplatin for Unresectable Pancreatic Cancer  

SciTech Connect (OSTI)

Purpose: We completed a Phase I trial of gemcitabine and oxaliplatin with concurrent radiotherapy in patients with previously untreated pancreatic cancer. The results of a subset of patients with unresectable disease who went on to receive planned additional therapy are reported here. Methods and Materials: All patients received two 28-day cycles of gemcitabine (1,000 mg/m{sup 2} on Days 1, 8, and 15) and oxaliplatin (40-85 mg/m{sup 2} on Days 1 and 15, per a dose-escalation schema). Radiation therapy was delivered concurrently with Cycle 1 (27 Gy in 1.8-Gy fractions). At 9 weeks, patients were reassessed for resectability. Those deemed to have unresectable disease were offered a second round of treatment consisting of 2 cycles of gemcitabine and oxaliplatin and 27 Gy of radiation therapy (total, 54 Gy). Radiation was delivered to the gross tumor volume plus 1 cm by use of a three-dimensional conformal technique. We used the Common Terminology Criteria for Adverse Events to assess acute toxicity. Late toxicity was scored per the Radiation Therapy Oncology Group scale. Computed tomography scans were reviewed to determine pattern of failure, local response, and disease progression. Kaplan-Meier methodology and Cox regression models were used to evaluate survival and freedom from failure. Results: Thirty-two patients from the Phase I dose-escalation study had unresectable disease, three of whom had low-volume metastatic disease. Of this group, 16 patients went on to receive additional therapy to complete a total of 4 cycles of chemotherapy and 54 Gy of concurrent radiation. For this subset, 38% had at least a partial tumor response at a median of 3.2 months. Median survival was 11.8 months (range, 4.4-26.3 months). The 1-year freedom from local progression rate was 93.8% (95% confidence interval, 63.2-99.1). Conclusions: Radiation therapy to 54 Gy with concurrent full-dose gemcitabine and oxaliplatin is well tolerated and results in favorable rates of local tumor response and 1-year freedom from local progression.

Hunter, Klaudia U.; Feng, Felix Y. [Department of Radiation Oncology, University of Michigan, Ann Arbor, MI (United States); Griffith, Kent A. [Comprehensive Cancer Center Biostatistics Unit, University of Michigan, Ann Arbor, MI (United States); Francis, Isaac R. [Department of Radiology, University of Michigan, Ann Arbor, MI (United States); Lawrence, Theodore S. [Department of Radiation Oncology, University of Michigan, Ann Arbor, MI (United States); Desai, Sameer [Department of Internal Medicine, University of Michigan, Ann Arbor, MI (United States); Murphy, James D. [School of Medicine, University of Michigan, Ann Arbor, MI (United States); Zalupski, Mark M. [Department of Internal Medicine, University of Michigan, Ann Arbor, MI (United States); Ben-Josef, Edgar, E-mail: edgarb@med.umich.edu [Department of Radiation Oncology, University of Michigan, Ann Arbor, MI (United States)

2012-07-01T23:59:59.000Z

144

Lidar Report  

SciTech Connect (OSTI)

This report provides an overview of the LiDAR acquisition methodology employed by Woolpert on the 2009 USDA - Savannah River LiDAR Site Project. LiDAR system parameters and flight and equipment information is also included. The LiDAR data acquisition was executed in ten sessions from February 21 through final reflights on March 2, 2009; using two Leica ALS50-II 150kHz Multi-pulse enabled LiDAR Systems. Specific details about the ALS50-II systems are included in Section 4 of this report.

Wollpert.

2009-04-01T23:59:59.000Z

145

Occurrence Reporting  

Broader source: Directives, Delegations, and Requirements [Office of Management (MA)]

To establish and maintain a system for reporting operations information related to DOE-owned or -operated facilities and processing that information to identify the root causes of Unusual, Off-Normal, and Emergency Occurrences and provide for appropriate corrective action. Cancels DOE 5000.3B.

1995-09-25T23:59:59.000Z

146

Activity report  

SciTech Connect (OSTI)

This report is aimed to show the author's activities to support the LDRD. The title is 'Investigation of the Double-C Behavior in the Pu-Ga Time-Temperature-Transformation Diagram' The sections are: (1) Sample Holder Test; (2) Calculation of x-ray diffraction patterns; (3) Literature search and preparing publications; (4) Tasks Required for APS Experiments; and (5) Communications.

Yu, S W

2008-08-11T23:59:59.000Z

147

E-Print Network 3.0 - art therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Law, Natural Sciences, Summary: of Creative Art Therapies Where Inspiration Meets Innovation Faculty of Social Welfare and Health Sciences... of Creative Art Therapies The...

148

Boron containing compounds and their preparation and use in neutron capture therapy  

DOE Patents [OSTI]

The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy.

Gabel, Detlef (Bremen, DE)

1992-01-01T23:59:59.000Z

149

Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma  

DOE Patents [OSTI]

The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy.

Gabel, Detlef (Bremen, DE)

1991-01-01T23:59:59.000Z

150

Cognitive Behavior Therapy for Anxiety: Adapting Interventions for Children with Autism and Intellectual Disability  

E-Print Network [OSTI]

1996). Family enhancement of cognitive style in anxious andC. R. (2006). Understanding cognitive behaviour therapy: AJ. , et al. (2010). Cognitive behavioral therapy for 4- to7-

Danial, John

2013-01-01T23:59:59.000Z

151

Cognitive behavioral therapy for insomnia in breast cancer survivors : randomized controlled crossover study  

E-Print Network [OSTI]

C. , & Bouchard, S. (2004). Cognitive-behavioral therapy forQuillian, R. E. (2001). Cognitive behavioral therapy forT. , & Posner, D. (2005). Cognitive behavioral treatment of

Fiorentino, Lavinia

2008-01-01T23:59:59.000Z

152

E-Print Network 3.0 - aligning physical therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

in Physical Therapy Presented by the School of Physical Therapy, University of Saskatchewan, Summary: 1 Practice and Policy Issues Surrounding Advanced Practice in Physical...

153

E-Print Network 3.0 - adult gene therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Summary: matched bone marrow donor. A clinical trial using stem cell gene therapy for sickle cell patients... team includes experts in stem cell gene therapy, clinical bone c...

154

Osteoporosis Therapies: Evidence from Health-Care Databases and Observational Population Studies  

E-Print Network [OSTI]

for the S. L. Silverman: Osteoporosis Therapies Fig. 2010-9400-1 REVIEW Osteoporosis Therapies: Evidence fromSpringerlink.com Abstract Osteoporosis is a well-recognized

Silverman, Stuart L.

2010-01-01T23:59:59.000Z

155

E-Print Network 3.0 - arc therapy development Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Development and Family Studies Gifford Building Fort Collins, Colorado 80523-1570 Ph: 970-491-5991 Fax: 970... or couple therapy Family Therapy Premarital and couple...

156

E-Print Network 3.0 - antiretroviral therapy haart Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

in Abidjan, Cte d'Ivoire Summary: active antiretroviral therapy (HAART) in rural Uganda (abstract TUPE0354). In: XVI International AIDS... 1 Antiretroviral therapy in...

157

E-Print Network 3.0 - atorvastatin combination therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

of Bexxar Combined with External Beam Radiation Therapy for Patients with Relapsed... of Low-dose (12 Gy) Total Skin Electron Beam Therapy (TSEBT) Combined with Vorinostat Versus...

158

Cold atmospheric plasma in cancer therapy  

SciTech Connect (OSTI)

Recent progress in atmospheric plasmas has led to the creation of cold plasmas with ion temperature close to room temperature. This paper outlines recent progress in understanding of cold plasma physics as well as application of cold atmospheric plasma (CAP) in cancer therapy. Varieties of novel plasma diagnostic techniques were developed recently in a quest to understand physics of CAP. It was established that the streamer head charge is about 10{sup 8} electrons, the electrical field in the head vicinity is about 10{sup 7} V/m, and the electron density of the streamer column is about 10{sup 19} m{sup ?3}. Both in-vitro and in-vivo studies of CAP action on cancer were performed. It was shown that the cold plasma application selectively eradicates cancer cells in-vitro without damaging normal cells and significantly reduces tumor size in-vivo. Studies indicate that the mechanism of action of cold plasma on cancer cells is related to generation of reactive oxygen species with possible induction of the apoptosis pathway. It is also shown that the cancer cells are more susceptible to the effects of CAP because a greater percentage of cells are in the S phase of the cell cycle.

Keidar, Michael; Shashurin, Alex; Volotskova, Olga [Mechanical and Aerospace Engineering, George Washington University, Washington DC 20052 (United States)] [Mechanical and Aerospace Engineering, George Washington University, Washington DC 20052 (United States); Ann Stepp, Mary [Medical School, George Washington University, Washington DC 20052 (United States)] [Medical School, George Washington University, Washington DC 20052 (United States); Srinivasan, Priya; Sandler, Anthony [Childrens National Medical Center, Washington DC 20010 (United States)] [Childrens National Medical Center, Washington DC 20010 (United States); Trink, Barry [Head and Neck Cancer Research Division, Department of Otolaryngology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205 (United States)] [Head and Neck Cancer Research Division, Department of Otolaryngology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205 (United States)

2013-05-15T23:59:59.000Z

159

The effects of interstitial atoms H and B on magnetic properties and magnetocaloric effect in LaFe{sub 11.5}Al{sub 1.5} compound  

SciTech Connect (OSTI)

The changes in magnetic properties of LaFe{sub 11.5}Al{sub 1.5}H{sub x} and LaFe{sub 11.5}Al{sub 1.5}B{sub y} have been investigated. By introducing interstitial atoms H or B, the magnetic ground state is changed from the antiferromagnetic to the ferromagnetic state, accompanied by significant increases in the saturated magnetization (Ms) and the Curie temperature (T{sub C}). An attractive feature is that the magnetic transition from the second-order to the weakly first-order with increasing hydrogen content compared to the magnetic transition from the weakly first-order to the second-order with increasing boron content. The maximum magnetic entropy change (??S{sub M}) under a field change of 0–5?T increases from 10.1?J/kg?·?K for hydrogen content x?=?0.12 to 12.3?J/kg?·?K for x?=?1.3, while decreases from 9.6?J/kg?·?K for boron content y?=?0.1 to 9.2?J/kg?·?K for y?=?0.3.

Zhang, D. K. [College of Applied Sciences, Beijing University of Technology, Beijing 100124 (China); College of Materials Science and Engineering, Beijing University of Technology, Beijing 100124 (China); Zhao, J. L., E-mail: zhaojinliang@bjut.edu.cn [College of Applied Sciences, Beijing University of Technology, Beijing 100124 (China); Shen, J. [Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190 (China); Zhang, H. G.; Yue, M. [College of Materials Science and Engineering, Beijing University of Technology, Beijing 100124 (China)

2014-05-14T23:59:59.000Z

160

Biomarkers and predictors of restorative therapy effects after stroke  

E-Print Network [OSTI]

hours after acute ischemic stroke. N Engl J Med. 2008; 359(the human brain after stroke. II. Restorative therapies.recovery from ischemic stroke. J Magn Reson Imaging. 2010;

Burke, Erin; Cramer, Steven C.

2013-01-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


161

Effects of Low Level Laser Therapy on Orthodontic Pain  

E-Print Network [OSTI]

Purpose: To determine the effectiveness of low level laser therapy applied extra orally on the reduction of orthodontic pain. Materials and Methods: Sixty dental students were voluntarily recruited for this randomized, double-blinded, placebo...

Buchwald, Bradley

2014-04-28T23:59:59.000Z

162

Mindfulness and Attachment Security as Predictors of Sucess in Therapy  

E-Print Network [OSTI]

its effectiveness (Stricker & Gold, 2001). While there is considerable research concerning common aspects of effective therapy, few studies have explicitly examined which client variables best explain differences in therapeutic outcomes (Castonquay...

Martin, David Matthew

2012-08-31T23:59:59.000Z

163

A novel nanodelivery system for combination tumor therapy  

E-Print Network [OSTI]

Anti-angiogenic therapy offers many benefits over traditional cytotoxic chemotherapy including fewer toxic side effects and the reduced development of drug resistance. Anti-angiogenics alone have not proven effective in ...

Eavarone, David A. (David Alan)

2004-01-01T23:59:59.000Z

164

Dynamic optimization of fractionation schedules in radiation therapy  

E-Print Network [OSTI]

In this thesis, we investigate the improvement in treatment effectiveness when dynamically optimizing the fractionation scheme in radiation therapy. In the first part of the thesis, we consider delivering a different dose ...

Ramakrishnan, Jagdish

2013-01-01T23:59:59.000Z

165

PARSII - New Reports and Reports With New Reporting Folder Location  

Office of Environmental Management (EM)

active projects listing PrePost CD-2 and 's including RYG status. Multi-Project 3A Red-Yellow Project Status Report PARS Reports Monthly Reports For every project that has...

166

An Examination of Music Therapy with Adolescent Populations  

E-Print Network [OSTI]

who shared their knowledge and supported me throughout my studies. Special thanks to Dr. Colwell who patiently worked with me on this thesis and worked hard to help me finish it up this semester. Thank you to my Mom, Dad, and sister for all..., and traumatic brain injury. Juvenile delinquents, pregnant teens, abused adolescents and grieving adolescents have also received music therapy services. See Appendix A for article citations. This same review of music therapy journal articles revealed...

Seagren, Stephanie

2009-05-01T23:59:59.000Z

167

Final Report  

SciTech Connect (OSTI)

OAK-B135 This is the final report from the project Hydrodynamics by High-Energy-Density Plasma Flow and Hydrodynamics and Radiation Hydrodynamics with Astrophysical Applications. This project supported a group at the University of Michigan in the invention, design, performance, and analysis of experiments using high-energy-density research facilities. The experiments explored compressible nonlinear hydrodynamics, in particular at decelerating interfaces, and the radiation hydrodynamics of strong shock waves. It has application to supernovae, astrophysical jets, shock-cloud interactions, and radiative shock waves.

R Paul Drake

2004-01-12T23:59:59.000Z

168

Annual Report  

Office of Environmental Management (EM)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May Jun Jul(Summary) "of EnergyEnergy Cooperation |South42.2 (April 2012) 1Annual Fuel Economy Guide with 20141 2011 Annual Report

169

SANDIA REPORT  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStoriesSANDIA REPORT SAND 2011-3958 Unlimited Release

170

SANDIA REPORT  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStoriesSANDIA REPORT SAND 2011-3958 Unlimited Release4-4161

171

SANDIA REPORT  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStoriesSANDIA REPORT SAND 2011-3958 Unlimited

172

FINAL REPORT  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr MayAtmospheric Optical Depth7-1D: Vegetation ProposedUsing ZirconiaPolicy andExsolutionFES Committees of9, 2011 FINALOffice of FINAL REPORT

173

Workshop Reports  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLasDelivered energy consumption byAbout SRNL Home SRNL main campus Working withWorkshop Reports

174

Reporting Requirements  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr MayAtmosphericNuclear Security Administration the1 -the Mid-Infrared at 278, 298,NIST31 ORV 15051SoilWindFraud toDepartmentReporting

175

Scatter factors assessment in microbeam radiation therapy  

SciTech Connect (OSTI)

Purpose: The success of the preclinical studies in Microbeam Radiation Therapy (MRT) paved the way to the clinical trials under preparation at the Biomedical Beamline of the European Synchrotron Radiation Facility. Within this framework, an accurate determination of the deposited dose is crucial. With that aim, the scatter factors, which translate the absolute dose measured in reference conditions (2 x 2 cm{sup 2} field size at 2 cm-depth in water) to peak doses, were assessed. Methods: Monte Carlo (MC) simulations were performed with two different widely used codes, PENELOPE and GEANT4, for the sake of safety. The scatter factors were obtained as the ratio of the doses that are deposited by a microbeam and by a field of reference size, at the reference depth. The calculated values were compared with the experimental data obtained by radiochromic (ISP HD-810) films and a PTW 34070 large area chamber. Results: The scatter factors for different microbeam field sizes assessed by the two MC codes were in agreement and reproduced the experimental data within uncertainty bars. Those correction factors were shown to be non-negligible for the future MRT clinical settings: an average 30% lower dose was deposited by a 50 {mu}m microbeam with respect to the reference conditions. Conclusions: For the first time, the scatter factors in MRT were systematically studied. They constitute an essential key to deposit accurate doses in the forthcoming clinical trials in MRT. The good agreement between the different calculations and the experimental data confirms the reliability of this challenging micrometric dose estimation.

Prezado, Y.; Martinez-Rovira, I.; Sanchez, M. [Laboratoire Imagerie et Modelisation en Neurobiologie et Cancerologie IMNC-UMR 8165, Centre National de la Recherche Scientifique (CNRS), Campus Universitaire, Bat. 440, 15 rue Georges Clemenceau, 91406 Orsay Cedex (France); Institut de Tecniques Energetiques, Universitat Politecnica de Catalunya, Diagonal 647, E-08028 Barcelona (Spain) and ID17 Biomedical Beamline, European Synchrotron Radiation Facility (ESRF), 6 Rue Jules Horowitz, B.P. 220, 38043 Grenoble Cedex (France); Servicio de Radiofisica, Complejo Hospitalario de Santiago de Compostela, Rua Choupana S/N, 15706 Santiago de Compostela (Spain)

2012-03-15T23:59:59.000Z

176

E-Print Network 3.0 - antiretroviral therapy studies Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

active antiretroviral therapy ... Source: Bonhoeffer, Sebastian - Institut fr Integrative Biologie, Eidgenssische Technische Hochschule Zrich (ETHZ) Collection:...

177

COMMUNITY REPORT September 2014  

E-Print Network [OSTI]

COMMUNITY REPORT September 2014 BIAS REPORT AND SUPPORT SYSTEM #12;8 Bias Report and Support System Charge: The Bias Report at Washington University. Through the BRSS, students will be able to report incidents of bias. The working group

Larson-Prior, Linda

178

2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT RESEARCH REPORT2010ANNUAL RESEARCH REPORT2010ANNUAL RESEARCH REPORT  

E-Print Network [OSTI]

2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT RESEARCH REPORT2010ANNUAL RESEARCH REPORT2010ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT 2010 ANNUAL RESEARCH REPORT RESEARCH REPORT2010ANNUAL RESEARCH REPORT2010ANNUAL RESEARCH REPORT

Jawitz, James W.

179

Prospective Study of Local Control and Late Radiation Toxicity After Intraoperative Radiation Therapy Boost for Early Breast Cancer  

SciTech Connect (OSTI)

Purpose: To report the local recurrence rate and late toxicity of intraoperative radiation therapy (IORT) boost to the tumor bed using the Intrabeam System followed by external-beam whole-breast irradiation (WBI) in women with early-stage breast cancer in a prospective single-institution study. Methods and Materials: Women with breast cancer ?3 cm were recruited between February 2003 and May 2005. After breast-conserving surgery, a single dose of 5 Gy IORT boost was delivered using 50-kV x-rays to a depth of 10 mm from the applicator surface. This was followed by WBI to a total dose of 50 Gy in 25 fractions. Patients were reviewed at regular, predefined intervals. Late toxicities were recorded using the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer Late Radiation Morbidity Scoring systems. Results: Fifty-five patients completed both IORT boost and external-beam WBI. Median follow-up was 3.3 years (range, 1.4-4.1 years). There was no reported locoregional recurrence or death. One patient developed distant metastases. Grade 2 and 3 subcutaneous fibrosis was detected in 29 (53%) and 8 patients (15%), respectively. Conclusions: The use of IORT as a tumor bed boost using kV x-rays in breast-conserving therapy was associated with good local control but a clinically significant rate of grade 2 and 3 subcutaneous fibrosis.

Chang, David W., E-mail: David.Chang@petermac.org [Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria (Australia); Marvelde, Luc te [Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria (Australia); Chua, Boon H. [Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria (Australia); Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria (Australia)

2014-01-01T23:59:59.000Z

180

Final Report  

SciTech Connect (OSTI)

Overview The High Energy Physics Group at Texas A&M University is submitting this final report for our grant number DE-FG02-95ER40917. This grant has supported our wide range of research activities for over a decade. The reports contained here summarize the latest work done by our research team. Task A (Collider Physics Program): CMS & CDF Profs. T. Kamon, A. Safonov, and D. Toback co-lead the Texas A&M (TAMU) collider program focusing on CDF and CMS experiments. Task D: Particle Physics Theory Our particle physics theory task is the combined effort of Profs. B. Dutta, D. Nanopoulos, and C. Pope. Task E (Underground Physics): LUX & NEXT Profs. R. Webb and J. White(deceased) lead the Xenon-based underground research program consisting of two main thrusts: the first, participation in the LUX two-phase xenon dark matter search experiment and the second, detector R&D primarily aimed at developing future detectors for underground physics (e.g. NEXT and LZ).

Webb, Robert C. [Texas A& M University] [Texas A& M University; Kamon, Teruki [Texas A& M University] [Texas A& M University; Toback, David [Texas A& M University] [Texas A& M University; Safonov, Alexei [Texas A& M University] [Texas A& M University; Dutta, Bhaskar [Texas A& M University] [Texas A& M University; Dimitri, Nanopoulos [Texas A& M University] [Texas A& M University; Pope, Christopher [Texas A& M University] [Texas A& M University; White, James [Texas A& M University] [Texas A& M University

2013-11-18T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


181

Final Report  

SciTech Connect (OSTI)

Transition metal carbides have recently attracted a great deal of interest due to their potential to replace noble metal catalysts in a variety of reactions. To date, attempts to develop commercial applications with bulk metal carbides have been unsuccessful, however, the catalytic behavior of nanometer-sized carbide particles are reported to be sufficiently different from the bulk materials that new research in this area is warranted. In this report, Mo/W carbides were synthesized using carbon nanotubes both as carbon source and as a catalyst support. These carbon nanotubes (FIBRIL[TM] Nanotubes) are composed of parallel layers of trigonal carbon, but in the form of a series of concentric tubes disposed about the longitudinal axis of the fibrils with diameter of 8{approx}10 nm. The special dimensions of nanotubes stabilize fine dispersion of catalytic entities as only particles with limited sizes, ca <8nm, could be supported on this nanoscale substrate. Two types of catalysts have been prepared in this manner. First, highly dispersed Mo carbide particles were generated on the carbon nanotube surface with average particle size of 3{approx}10 nm. Furthermore, stoichiometric Mo carbide was also obtained in the form of highly porous assemblages of nanorods by careful control of the reaction conditions. The prepared Mo and W carbide catalysts were tested in several industrial reactions with significant energy savings. Results from these studies demonstrated the ''poor man's platinum'' hypothesis as well as many great potentials associated with these novel catalysts in chemical and refinery industries.

Ma, Jun; Hoch, Robert

2002-08-01T23:59:59.000Z

182

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

FINAL COPY Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4069-3 2. Government-Service Structures with Premature 5. Report Date October 2004, Rev. September 2005 Concrete Deterioration: Synthesis Report 6. Performing Organization Code 7. Author(s) 8. Performing Organization Report No. Amy E. Eskridge

Texas at Austin, University of

183

Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer  

SciTech Connect (OSTI)

Purpose: To report quality of life (QOL)/toxicity in men treated with proton beam therapy for localized prostate cancer and to compare outcomes between passively scattered proton therapy (PSPT) and spot-scanning proton therapy (SSPT). Methods and Materials: Men with localized prostate cancer enrolled on a prospective QOL protocol with a minimum of 2 years' follow-up were reviewed. Comparative groups were defined by technique (PSPT vs SSPT). Patients completed Expanded Prostate Cancer Index Composite questionnaires at baseline and every 3-6 months after proton beam therapy. Clinically meaningful differences in QOL were defined as ?0.5 × baseline standard deviation. The cumulative incidence of modified Radiation Therapy Oncology Group grade ?2 gastrointestinal (GI) or genitourinary (GU) toxicity and argon plasma coagulation were determined by the Kaplan-Meier method. Results: A total of 226 men received PSPT, and 65 received SSPT. Both PSPT and SSPT resulted in statistically significant changes in sexual, urinary, and bowel Expanded Prostate Cancer Index Composite summary scores. Only bowel summary, function, and bother resulted in clinically meaningful decrements beyond treatment completion. The decrement in bowel QOL persisted through 24-month follow-up. Cumulative grade ?2 GU and GI toxicity at 24 months were 13.4% and 9.6%, respectively. There was 1 grade 3 GI toxicity (PSPT group) and no other grade ?3 GI or GU toxicity. Argon plasma coagulation application was infrequent (PSPT 4.4% vs SSPT 1.5%; P=.21). No statistically significant differences were appreciated between PSPT and SSPT regarding toxicity or QOL. Conclusion: Both PSPT and SSPT confer low rates of grade ?2 GI or GU toxicity, with preservation of meaningful sexual and urinary QOL at 24 months. A modest, yet clinically meaningful, decrement in bowel QOL was seen throughout follow-up. No toxicity or QOL differences between PSPT and SSPT were identified. Long-term comparative results in a larger patient cohort are warranted.

Pugh, Thomas J. [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Munsell, Mark F. [Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Choi, Seungtaek; Nguyen, Quyhn Nhu; Mathai, Benson [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Zhu, X. Ron; Sahoo, Narayan; Gillin, Michael; Johnson, Jennifer L.; Amos, Richard A. [Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Dong, Lei [Scripps Proton Therapy Center, San Diego, California (United States); Mahmood, Usama; Kuban, Deborah A.; Frank, Steven J.; Hoffman, Karen E.; McGuire, Sean E. [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States); Lee, Andrew K., E-mail: aklee@mdanderson.org [Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (United States)

2013-12-01T23:59:59.000Z

184

Interim report  

SciTech Connect (OSTI)

This Interim Report summarizes the research and development activities of the Superconducting Super Collider project carried out from the completion of the Reference Designs Study (May 1984) to June 1985. It was prepared by the SSC Central Design Group in draft form on the occasion of the DOE Annual Review, June 19--21, 1985. Now largely organized by CDG Divisions, the bulk of each chapter documents the progress and accomplishments to date, while the final section(s) describe plans for future work. Chapter 1, Introduction, provides a basic brief description of the SSC, its physics justification, its origins, and the R&D organization set up to carry out the work. Chapter 2 gives a summary of the main results of the R&D program, the tasks assigned to the four magnet R&D centers, and an overview of the future plans. The reader wishing a quick look at the SSC Phase I effort can skim Chapter 1 and read Chapter 2. Subsequent chapters discuss in more detail the activities on accelerator physics, accelerator systems, magnets and cryostats, injector, detector R&D, conventional facilities, and project planning and management. The magnet chapter (5) documents in text and photographs the impressive progress in successful construction of many model magnets, the development of cryostats with low heat leaks, and the improvement in current-carrying capacity of superconducting strand. Chapter 9 contains the budgets and schedules of the COG Divisions, the overall R&D program, including the laboratories, and also preliminary projections for construction. Appendices provide information on the various panels, task forces and workshops held by the CDG in FY 1985, a bibliography of COG and Laboratory reports on SSC and SSC-related work, and on private industrial involvement in the project.

NONE

1985-06-01T23:59:59.000Z

185

Robust optimization of intensity modulated proton therapy  

SciTech Connect (OSTI)

Purpose: Intensity modulated proton therapy (IMPT) is highly sensitive to range uncertainties and uncertainties caused by setup variation. The conventional inverse treatment planning of IMPT optimized based on the planning target volume (PTV) is not often sufficient to ensure robustness of treatment plans. In this paper, a method that takes the uncertainties into account during plan optimization is used to mitigate the influence of uncertainties in IMPT. Methods: The authors use the so-called ''worst-case robust optimization'' to render IMPT plans robust in the face of uncertainties. For each iteration, nine different dose distributions are computed--one each for {+-} setup uncertainties along anteroposterior (A-P), lateral (R-L) and superior-inferior (S-I) directions, for {+-} range uncertainty, and the nominal dose distribution. The worst-case dose distribution is obtained by assigning the lowest dose among the nine doses to each voxel in the clinical target volume (CTV) and the highest dose to each voxel outside the CTV. Conceptually, the use of worst-case dose distribution is similar to the dose distribution achieved based on the use of PTV in traditional planning. The objective function value for a given iteration is computed using this worst-case dose distribution. The objective function used has been extended to further constrain the target dose inhomogeneity. Results: The worst-case robust optimization method is applied to a lung case, a skull base case, and a prostate case. Compared with IMPT plans optimized using conventional methods based on the PTV, our method yields plans that are considerably less sensitive to range and setup uncertainties. An interesting finding of the work presented here is that, in addition to reducing sensitivity to uncertainties, robust optimization also leads to improved optimality of treatment plans compared to the PTV-based optimization. This is reflected in reduction in plan scores and in the lower normal tissue doses for the same coverage of the target volume when subjected to uncertainties. Conclusions: The authors find that the worst-case robust optimization provides robust target coverage without sacrificing, and possibly even improving, the sparing of normal tissues. Our results demonstrate the importance of robust optimization. The authors assert that all IMPT plans should be robustly optimized.

Liu Wei; Zhang Xiaodong; Li Yupeng; Mohan, Radhe [Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030 (United States)

2012-02-15T23:59:59.000Z

186

The Efficacy of Radiation Therapy in the Treatment of Graves' Orbitopathy  

SciTech Connect (OSTI)

Purpose: To review our institutional outcomes of patients treated with radiation therapy (RT) for Graves' orbitopathy (GO), assess the role of orbital reirradiation, and identify prognostic factors of complete response (CR). Methods and Materials: This is a retrospective review of 211 patients who presented with a diagnosis of GO and received RT between January 2000-2010. RT dose was 20 Gy in 10 fractions. Patient median age was 51 years (range, 15-84 years), median follow-up was 11 months (range, 1-88 months). Patient symptoms included any combination of proptosis (90.9%), extraocular muscle dysfunction (78.9%), soft tissue signs (68.4%), and diplopia (58.4%). Corticosteroids were used as first-line therapy in 20.6% of patients. Among those who achieved either CR or partial response (PR), prognostic factors were evaluated. Results: Stabilization of disease without recurrence was clinically achieved overall in 202 patients (96.7%). At the completion of RT, 176 patients (84.2%) reported a symptomatic improvement of pretreatment symptoms. CR of GO symptoms was achieved using multiple treatment modalities, including RT by 93 patients (44.5%), of which 32 patients received RT only. Corticosteroids were discontinued in 97.8% of patients who received them as initial therapy. Surgical intervention following radiotherapy was required for 144 (68.9%) of all patients. Fourteen patients received orbital reirradiation for persistent or recurrent symptoms. Five of these achieved a CR, and the other nine achieved disease stabilization but retained persistent ocular symptoms. Long-term side effects of RT included dry eyes (12%). Of the prognostic factors we investigated, only gender predicted CR, which was less common in men (33.9%) than in women (49.7%) p = 0.0471. Conclusions: Orbital radiation for GO is an established treatment modality for patients. Orbital reirradiation is beneficial for patients who do not respond to initial RT or experience symptom recurrence without an apparent risk of increased morbidity.

Matthiesen, Chance, E-mail: chance-matthiesen@ouhsc.edu [Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK (United States); Thompson, J. Spencer [Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK (United States); Thompson, David [Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK (United States); Farris, Bradley; Wilkes, Byron [Dean A. McGee Eye Institute, Oklahoma City, OK (United States); Ahmad, Salahuddin; Herman, Terence; Bogardus, Carl [Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK (United States)

2012-01-01T23:59:59.000Z

187

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. 1732-S 2. Government Accession No. 3. Recipients, geometric design, entrance ramps, exit ramps 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

188

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report  

E-Print Network [OSTI]

Firouzi M, Moshayedi P, Saberi H, Mobasheri H, Abolhassaniwith material of fetal origin. Saberi et al [7] reportedtrial. Brain 2008, 7. Saberi H, Moshayedi P, Aghayan HR,

2010-01-01T23:59:59.000Z

189

Medical accelerator safety considerations: Report of AAPM Radiation Therapy Committee Task Group No. 35  

SciTech Connect (OSTI)

Ensuring safe operation for a medical accelerator is a difficult task. Users must assume more responsibility in using contemporary equipment. Additionally, users must work closely with manufacturers in promoting the safe and effective use of such complex equipment. Complex treatment techniques and treatment modality changeover procedures merit detailed, unambiguous written procedural instruction at the control console. A thorough hands on training period after receiving instructions, and before assuming treatment responsibilities, is essential for all technologists. Unambiguous written instructions must also be provided to guide technologists in safe response when equipment malfunctions or exhibits unexpected behavior or after any component has been changed or readjusted. Technologists should be given a written list of the appropriate individuals to consult when unexpected machine behavior occurs. They should be assisted in identifying aberrant behavior of equipment. Many centers already provide this instruction, but others may not. Practiced response and discussion with technologists should be a part of an ongoing quality assurance program. An important aspect of a safety program is the need for continuous vigilance. Table III gives a summary of a comprehensive safety program for medical accelerators. Table IV gives a list of summary recommendations as an example of how one might mitigate the consequences of an equipment failure and improve procedures and operator response in the context of the environment described. Most of these recommendations can be implemented almost immediately at any individual treatment center.

Purdy, J.A.; Biggs, P.J.; Bowers, C.; Dally, E.; Downs, W.; Fraass, B.A.; Karzmark, C.J.; Khan, F.; Morgan, P.; Morton, R.

1993-07-01T23:59:59.000Z

190

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report  

E-Print Network [OSTI]

cord in adult mice in an SDF-1- and HGF-dependent manner.effectors such as BDNF, VEGF, SDF-1, TrkB, Nrp-1, CXCR4 andlocal homing through a SDF-1 and HGF-1-dependent mechanism [

2010-01-01T23:59:59.000Z

191

Transcranial LED therapy for cognitive dysfunction in chronic, mild traumatic brain injury: Two case reports  

E-Print Network [OSTI]

Two chronic, traumatic brain injury (TBI) cases are presented, where cognitive function improved following treatment with transcranial light emitting diodes (LEDs). At age 59, P1 had closed-head injury from a motor vehicle ...

Hamblin, Michael R.

192

Refinery Capacity Report  

Gasoline and Diesel Fuel Update (EIA)

Refinery Capacity Report Released: June 15, 2006 Refinery Capacity Report --- Full report in PDF (1 MB) XLS --- Refinery Capacity Data by individual refinery as of January 1, 2006...

193

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy  

SciTech Connect (OSTI)

The radiochemical properties of radium-223 (223Ra, T1/2 = 11.4 d) render this alpha-emitting radionuclide promising for targeted cancer therapy. Together with its short-lived daughters, each 223Ra decay produces four alpha-particle emissions—which enhance therapy effectiveness at the cellular level. In this paper, we review the recently published data reported for pre-clinical and clinical use of 223Ra in cancer treatment. We have evaluated two distinct chemical forms of 223Ra in vivo: 1) cationic 223Ra as dissolved RaCl2, and 2) liposome-encapsulated 223Ra. Cationic 223Ra seeks metabolically active osteoblastic bone and tumor lesions with high uptake and strong binding affinity based on its similarities to calcium. Based on these properties, we have advanced the clinical use of 223Ra for treating bone metastases from late-stage breast and prostate cancer. The results show impressive anti-tumor activity and improved overall survival in hormone-refractory prostate cancer patients with bone metastases. In other studies, we have evaluated the biodistribution and tumor uptake of liposomally encapsulated 223Ra in mice with human osteosarcoma xenografts, and in dogs with spontaneous osteosarcoma and associated soft tissue metastases. Results indicate excellent biodistributions in both species. In dogs, we found considerable uptake of liposomal 223Ra in cancer metastases in multiple organs, resulting in favorable tumor-to-normal soft tissue ratios. Collectively, these findings show an outstanding potential for 223Ra as a therapeutic agent.

Bruland, Oyvind S.; Jonasdottir, Thora J.; Fisher, Darrell R.; Larsen, Roy H.

2008-09-15T23:59:59.000Z

194

Successful High Power Acceleration of the HSC Type Injector for Cancer Therapy in IMP  

E-Print Network [OSTI]

A Hybrid single cavity (HSC) linac, which is formed by combining a radio frequency quadrupole (RFQ) structure and a drift tube (DT) structure into one interdigital-H (IH) cavity, is fabricated and assembled as a proof of principle (PoP) type injector for cancer therapy synchrotron according to the series researches. The injection method of the HSC linac adopt a direct plasma injection scheme (DPIS), which is considered to be the only method for accelerating an intense current heavy ion beam produced by a laser ion source (LIS). The input beam current of the HSC was designed to be 20 milliampere (mA) C6+ ions. According to numerical simulations, the HSC linac could accelerate a 6-mA C6+ beam which meets requirement of the needed particle number for cancer therapy use (108~9 ions per pulse). The injection system adopted HSC injector with the method of DPIS can make the existing multi-turn injection system and the stripping system unnecessary, and also can make the beam pipe of the existing synchrotron magnets downsize which could reduce the whole cost of synchrotron (estimated millions dollars). Details of the measurements and evaluations of the assembled HSC linac, and the results of the high power test using a LIS with DPIS are reported in this paper.

Liang Lu

2015-03-25T23:59:59.000Z

195

Developing Quality Assurance Processes for Image-Guided Adaptive Radiation Therapy  

SciTech Connect (OSTI)

Quality assurance has long been implemented in radiation treatment as systematic actions necessary to provide adequate confidence that the radiation oncology service will satisfy the given requirements for quality care. The existing reports from the American Association of Physicists in Medicine Task Groups 40 and 53 have provided highly detailed QA guidelines for conventional radiotherapy and treatment planning. However, advanced treatment processes recently developed with emerging high technology have introduced new QA requirements that have not been addressed previously in the conventional QA program. Therefore, it is necessary to expand the existing QA guidelines to also include new considerations. Image-guided adaptive radiation therapy (IGART) is a closed-loop treatment process that is designed to include the individual treatment information, such as patient-specific anatomic variation and delivered dose assessed during the therapy course in treatment evaluation and planning optimization. Clinical implementation of IGART requires high levels of automation in image acquisition, registration, segmentation, treatment dose construction, and adaptive planning optimization, which brings new challenges to the conventional QA program. In this article, clinical QA procedures for IGART are outlined. The discussion focuses on the dynamic or four-dimensional aspects of the IGART process, avoiding overlap with conventional QA guidelines.

Yan Di [Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI (United States)], E-mail: dyan@beaumont.edu

2008-05-01T23:59:59.000Z

196

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-5020-1 2. Government Accession No. 3 3208 Red River, Suite 200 Austin, TX 78705-2650 11. Contract or Grant No. 0-5020 13. Type of Report Documentation Page 1. Report No. FHWA/TX-07/0-5020-1 2. Government Accession No. 3. Recipient's Catalog No. 5

Texas at Austin, University of

197

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4079-1 2. Government Accession No. 3 Austin, TX 78705-2650 11. Contract or Grant No. Technical Report 0-4079 13. Type of Report and Period in order to expedite the acquisition process, minimize cost, and build property owners' trust in government

Texas at Austin, University of

198

Report 1: JISC Good APIs Management Report  

E-Print Network [OSTI]

Report 1: JISC Good APIs Management Report A review of good practice in the provision of machine) Document Name: good_api_JISC_report_v0.8.doc Notes: Acknowledgements UKOLN is funded by the MLA to all those who gave up time to help with the report. Vital to this work were the people who filled

Rzepa, Henry S.

199

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. Preliminary Review Copy FHWA/TX-03/1833-01-imp-1 2. Government Accession No. 3. Recipient's Catalog No. 5. Report Date October 2002 4. Title Harrison Michael Bomba 8. Performing Organization Report No. 1833-01-imp-1 10. Work Unit No. (TRAIS)9

Texas at Austin, University of

200

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-0-4197-1 2. Government Accession No. 3 of Intelligent Transportation Systems 5. Report Date May 2001 6. Performing Organization Code7. Authors Tejas Mehta, Hani S. Mahmassani, and Chandra Bhat 8. Performing Organization Report No. 10. Work Unit No

Texas at Austin, University of

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


201

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-08/0-5708-1 2. Government Accession No. 3. Recipient's Catalog No. 4. Title and Subtitle Design of CrackScope (VCrack) [Reprint] 5. Report Date October Organization Report No. 0-5708-1 9. Performing Organization Name and Address Center for Transportation Research

Texas at Austin, University of

202

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5546-1 2. Government Accession No. 3 of Incompatible Uses 5. Report Date September 2007; Rev. January 2008 6. Performing Organization Code 7. Author(s) Lisa Loftus-Otway, C. Michael Walton, Lynn Blais, Nathan Hutson 8. Performing Organization Report No. 0

Texas at Austin, University of

203

Development of a fast neutron therapy beam placement film technique  

E-Print Network [OSTI]

used are surgery and radiotherapy. High energy X rays and gamma rays are most often used when radio- therapy is required, but new interest in the use of other types of radiation has recently been generated. One of the first characteristics... of neutron radiation to be noted by Chadwick in 1932 was its ability to penetrate matter in manner similar to X rays (2). Although the results of Stone and his colleagues (3-5) caused Stone to recommend that neutrons not be used in cancer therapy, more...

Baron, Robert Layton

1971-01-01T23:59:59.000Z

204

CREATIVE ARTS ANNUAL REPORT  

E-Print Network [OSTI]

2012 COLLEGE OF CREATIVE ARTS ANNUAL REPORT #12;contents COLLEGE OF CREATIVE ARTS 2012 ANNUAL REPORT 2 COLLEGE OF CREATIVE ARTS NEWS 4 COLLEGE OF CREATIVE ARTS ENROLLMENT & FUNDRAISING 8 ART MUSEUM OF WVU REPORT SCHOOL OF ART & DESIGN REPORT 22SCHOOL OF MUSIC REPORT 30SCHOOL OF THEATRE & DANCE REPORT

Mohaghegh, Shahab

205

Final Report  

SciTech Connect (OSTI)

The purpose of this project was to investigate metal-induced crystallization of amorphous silicon at low temperatures using excitation sources such as laser and rapid thermal annealing, as well as, electric field. Deposition of high quality crystalline silicon at low temperatures allows the use of low cost soda-lime glass and polymeric films for economically viable photovoltaic solar cells and low cost large area flat panel displays. In light of current and expected demands on Si supply due to expanding use of consumer electronic products throughout the world and the incessant demand for electric power the need for developing high grade Si thin films on low cost substrate becomes even more important. We used hydrogenated and un-hydrogenated amorphous silicon deposited by plasma enhanced chemical vapor deposition and sputtering techniques (both of which are extensively used in electronic and solar cell industries) to fabricate nano-crystalline, poly-crystalline (small as well as large grain), and single-crystalline (epitaxial) films at low temperatures. We demonstrated Si nanowires on flat surfaces that can be used for fabricating nanometer scale transistors. We also demonstrated lateral crystallization using Al with and without an applied electric field. These results are critical for high mobility thin film transistors (TFT) for large area display applications. Large grain silicon (~30-50 µm grain size for < 0.5 µm thick films) was demonstrated on glass substrates at low temperatures. We also demonstrated epitaxial growth of silicon on (100) Si substrates at temperatures as low as 450?C. Thin film Si solar cells are being projected as the material of choice for low cost high efficiency solar cells when properly coupled with excellent light-trapping schemes. Ar ion laser (CW) was shown to produce dendritic nanowire structures at low power whereas at higher powers yielded continuous polycrystalline films. The power density required for films in contact with Al was demonstrated to be at least two orders of magnitude lower that that reported in the literature before. Polysilicon was successfully achieved on polyimide (Kapton©) films. Thin film Si solar cells on lightweight stoable polymer offer great advantage for terrestrial and space power applications. In summary we have demonstrated through this research the viability of producing low cost nano-, poly-, and epitaxial Si material on substrates of choice for applications in economically viable environmentally friendly sustainable solar power systems. This truly enabling technology has widespread applications in multibillion dollar electronic industry and consumer products.

Hameed A. Naseem, Husam H. Abu-Safe

2007-02-09T23:59:59.000Z

206

Development of a Novel Robot for Transperineal Needle Based Interventions: Focal Therapy, Brachytherapy and Prostate Biopsies  

E-Print Network [OSTI]

Purpose: We report what is to our knowledge the initial experience with a new 3-dimensional ultrasound robotic system for prostate brachytherapy assistance, focal therapy and prostate biopsies. Its ability to track prostate motion intraoperatively allows it to manage motions and guide needles to predefined targets. Materials and Methods: A robotic system was created for transrectal ultrasound guided needle implantation combined with intraoperative prostate tracking. Experiments were done on 90 targets embedded in a total of 9 mobile, deformable, synthetic prostate phantoms. Experiments involved trying to insert glass beads as close as possible to targets in multimodal anthropomorphic imaging phantoms. Results were measured by segmenting the inserted beads in computerized tomography volumes of the phantoms. Results: The robot reached the chosen targets in phantoms with a median accuracy of 2.73 mm and a median prostate motion of 5.46 mm. Accuracy was better at the apex than at the base (2.28 vs 3.83 mm, p <...

Long, Jean-Alexandre; Baumann, Michael; Descotes, Jean-Luc; Bolla, Michel; Giraud, Jean-Yves; Rambeaud, Jean-Jacques; Troccaz, Jocelyne; 10.1016/j.juro.2012.06.003

2012-01-01T23:59:59.000Z

207

Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy  

SciTech Connect (OSTI)

Purpose: To describe biological-based optimization and Monte Carlo (MC) dose calculation-based treatment planning for volumetric modulated arc therapy (VMAT) delivery of stereotactic body radiation therapy (SBRT) in lung, liver, and prostate patients. Methods: Optimization strategies and VMAT planning parameters using a biological-based optimization MC planning system were analyzed for 24 SBRT patients. Patients received a median dose of 45 Gy [range, 34-54 Gy] for lung tumors in 1-5 fxs and a median dose of 52 Gy [range, 48-60 Gy] for liver tumors in 3-6 fxs. Prostate patients received a fractional dose of 10 Gy in 5 fxs. Biological-cost functions were used for plan optimization, and its dosimetric quality was evaluated using the conformity index (CI), the conformation number (CN), the ratio of the volume receiving 50% of the prescription dose over the planning target volume (Rx/PTV50). The quality and efficiency of the delivery were assessed according to measured quality assurance (QA) passing rates and delivery times. For each disease site, one patient was replanned using physical cost function and compared to the corresponding biological plan. Results: Median CI, CN, and Rx/PTV50 for all 24 patients were 1.13 (1.02-1.28), 0.79 (0.70-0.88), and 5.3 (3.1-10.8), respectively. The median delivery rate for all patients was 410 MU/min with a maximum possible rate of 480 MU/min (85%). Median QA passing rate was 96.7%, and it did not significantly vary with the tumor site. Conclusions: VMAT delivery of SBRT plans optimized using biological-motivated cost-functions result in highly conformal dose distributions. Plans offer shorter treatment-time benefits and provide efficient dose delivery without compromising the plan conformity for tumors in the prostate, lung, and liver, thereby improving patient comfort and clinical throughput. The short delivery times minimize the risk of patient setup and intrafraction motion errors often associated with long SBRT treatment delivery times.

Diot, Quentin; Kavanagh, Brian; Timmerman, Robert; Miften, Moyed [Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States); Department of Radiation Oncology, University of Texas Southwestern Medical School, Dallas, Texas 75390 (United States); Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States)

2012-01-15T23:59:59.000Z

208

Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study  

E-Print Network [OSTI]

making about renal replacement therapies. Qual Health ResOpen Access Selecting renal replacement therapies: what doneed to inform renal replacement therapy (RRT) decisions.

2013-01-01T23:59:59.000Z

209

Verifying Therapy Safety Interlock System with SPIN Motlatsi Seotsanyana1  

E-Print Network [OSTI]

, air traffic and space vehicle control systems, nuclear power plant safety control systems, medical as banking systems) to embedded environments (such as nuclear power plant safety control systemsVerifying Therapy Safety Interlock System with SPIN Motlatsi Seotsanyana1 , Jaco Geldenhuys2 1

Geldenhuys, Jaco

210

Proceedings of the first international symposium on neutron capture therapy  

SciTech Connect (OSTI)

This meeting was arranged jointly by MIT and BNL in order to illuminate progress in the synthesis and targeting of boron compounds and to evaluate and document progress in radiobiological and dosimetric aspects of neutron capture therapy. It is hoped that this meeting will facilitate transfer of information between groups working in these fields, and encourage synergistic collaboration.

Fairchild, R.G.; Brownell, G.L. (eds.)

1982-01-01T23:59:59.000Z

211

A Systems Approach to Breast Cancer Carcinogenesis to Therapy  

E-Print Network [OSTI]

A Systems Approach to Breast Cancer ­ Carcinogenesis to Therapy Speaker: Dr. Joe Gray Director, Center for Spatial Systems Biomedicine Oregon Health & Science University Date: Monday, April 18, 2011 that influence cancer behavior, (b) systems biology approaches to elucidate mechanisms by which cancer

212

E-Print Network 3.0 - arterial infusion therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Powered by Explorit Topic List Advanced Search Sample search results for: arterial infusion therapy Page: << < 1 2 3 4 5 > >> 1 HUMAN GENE THERAPY 16:299306 (March 2005) Mary...

213

E-Print Network 3.0 - anti-motion sickness therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Therapy Dalhousie University If I am sick with flu-like symptoms (i.e., fever andor cough... School of Occupational Therapy Room 215, 5869 University Avenue Halifax, NS...

214

Quantitative analysis of non-viral gene therapy in primary liver culture systems  

E-Print Network [OSTI]

Gene therapy has the potential to cure thousands of diseases caused by genetic abnormalities, provide novel combination therapies for cancers and viral infections, and offer a new and effective platform for next generation ...

Tedford, Nathan C

2007-01-01T23:59:59.000Z

215

Treatment of Canine Osseous Tumors with Photodynamic Therapy: A Pilot Study  

E-Print Network [OSTI]

Momma T, Hamblin MR, Wu HC, Hasan T. Photodynamic therapy ofSzeto D, Lampros E, Hasan T, Cincotta AH. BenzophenothiazineGoodwin IA, Chen B, Swartz HM, Hasan T. Photodynamic therapy

Burch, S.; London, C.; Seguin, B.; Rodriguez, C.; Wilson, B. C.; Bisland, S. K.

2009-01-01T23:59:59.000Z

216

E-Print Network 3.0 - anticoagulant therapy inr Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

1371 OR Charge Nurse 1616 Respiratory Therapy-Adult 1716 1684 1742... Respiratory Therapy-Pediatric 1989 Radiology-Portables 1384 Social Worker-ED 284-2845 3462 Trauma Center......

217

Cancer gene therapy with oncolytic adenoviruses K. Guse,A. Hemminki  

E-Print Network [OSTI]

Cancer gene therapy with oncolytic adenoviruses K. Guse,A. Hemminki Cancer Gene Therapy Group, Molecular Cancer Biology Program & Transplantation Laboratory & Haartman Institute & Finnish Institute, Helsinki, Finland Summary Metastatic cancer remains difficult to treat effectively and treatments

Hemminki, Akseli

218

Home-Based Therapy: Effectiveness and Processes--A Brief Review of the National Literature  

E-Print Network [OSTI]

Since the late 1980s, home-based family therapy has become an increasingly popular service. The delivery of family therapy in families’ homes presents various advantages and challenges. This review focuses on empirical ...

Walter, Uta M.; Petr, Chris

2006-06-01T23:59:59.000Z

219

Annual Site Environmental Report Calendar Year 2010  

SciTech Connect (OSTI)

This report summarizes the environmental status of Ames Laboratory for calendar year 2010. It includes descriptions of the Laboratory site, its mission, the status of its compliance with applicable environmental regulations, its planning and activities to maintain compliance, and a comprehensive review of its environmental protection, surveillance and monitoring activities. In 2010, the Laboratory accumulated and disposed of waste under U.S. Environmental Protection Agency (EPA) issued generator numbers. All waste is handled according to all applicable EPA, State, Local regulations and DOE Orders. In 2006 the Laboratory reduced its generator status from a Large Quantity Generator (LQG) to a Small Quantity Generator (SQG). EPA Region VII was notified of this change. The Laboratory's RCRA hazardous waste management program was inspected by EPA Region VII in April 2006. There were no notices of violations. The inspector was impressed with the improvements of the Laboratory's waste management program over the past ten years. The Laboratory was in compliance with all applicable federal, state, local and DOE regulations and orders in 2010. There were no radiological air emissions or exposures to the general public due to Laboratory activities in 2010. See U.S. Department of Energy Air Emissions Annual Report in Appendix B. As indicated in prior SERs, pollution awareness, waste minimization and recycling programs have been in practice since 1990, with improvements implemented most recently in 2010. Included in these efforts were battery and CRT recycling, miscellaneous electronic office equipment, waste white paper and green computer paper-recycling and corrugated cardboard recycling. Ames Laboratory also recycles/reuses salvageable metal, used oil, foamed polystyrene peanuts, batteries, fluorescent lamps and telephone books. Ames Laboratory reported to DOE-Ames Site Office (AMSO), through the Laboratory's Performance Evaluation Measurement Plan, on its Affirmative Procurement Performance Measure. A performance level of 'A-' was achieved in 2010 for Integrated Safety, Health and Environmental Protection. As reported in Site Environmental Reports for prior years, the Laboratory's Environmental Management System (EMS) has been integrated into the Laboratory's Integrated Safety Management System since 2005. The integration of EMS into the way the Laboratory does business allows the Laboratory to systematically review, address and respond to the Laboratory's environmental impacts. The Laboratory's EMS was audited in April 2009 by DOE-CH. There were four 'Sufficiently in Conformity' findings as a result of the audit. All four findings were tracked in the Laboratory's corrective action database for completion. Beryllium was used routinely at Ames Laboratory in the 1940's and 1950's in processes developed for the production of highly pure uranium and thorium in support of the historic Manhattan Project. Laboratory metallurgists also worked on a process to produce pure beryllium metal from beryllium fluoride. In the early 1950's, beryllium oxide powder was used to produce shaped beryllium and crucibles. As a result of that work, beryllium contamination now exists in many interstitial spaces (e.g., utility chases) and ventilation systems in Wilhelm, Spedding and Metals Development buildings. Extensive characterization and remediation efforts have occurred in 2009 and 2010 in order to better understand the extent of the contamination. Analysis of extensive sampling data suggests that a fairly wide dispersion of beryllium occurred (most likely in the 1950's and 60's) in Wilhelm Hall and in certain areas of Spedding Hall and Metals Development. Area air-sampling results and work-area surface characterizations indicate the exposure potential to current workers, building visitors and the public remains extremely low. This information is now used to guide cleaning efforts and to provide worker protection during remodeling and maintenance activities. Results were shared with the DOE's Former Worker Program to support former worker medical test

Kayser, Dan

2011-01-31T23:59:59.000Z

220

Separating Cloud Forming Nuclei from Interstitial Aerosol  

SciTech Connect (OSTI)

It has become important to characterize the physicochemical properties of aerosol that have initiated the warm and ice clouds. The data is urgently needed to better represent the aerosol-cloud interaction mechanisms in the climate models. The laboratory and in-situ techniques to separate precisely the aerosol particles that act as cloud condensation nuclei (CCN) and ice nuclei (IN), termed as cloud nuclei (CN) henceforth, have become imperative in studying aerosol effects on clouds and the environment. This review summarizes these techniques, design considerations, associated artifacts and challenges, and briefly discusses the need for improved designs to expand the CN measurement database.

Kulkarni, Gourihar R.

2012-09-12T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


221

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Glover, and Nicolas Norboge 8. Performing Organization Report No. Report 5-6395-01-1 9. Performing Brianne Glover, J.D. Associate Transportation Researcher Texas Transportation Institute and Nicolas

222

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

. Report Date April 2009 6. Performing Organization Code 7. Author(s) Jennifer Bennett and Tracy McMillan 8 Sector's Role in Public School Facility Planning by Jennifer Bennett Tracy McMillan Research Report SWUTC

223

2011 ECSE Annual Report Annual Report 2011  

E-Print Network [OSTI]

on is the only sustainable driver of economic growth. For these economies engineers are the "professional2011 ECSE Annual Report Annual Report 2011 Electrical, Computer & Systems Engineering & Systems Engineering Department Kim Boyer, Professor and Head Jonsson Engineering Center Rensselaer

Bystroff, Chris

224

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-02/1884-2 2. Government Accession No. 3, paratransit systems 18. Distribution Statement No restrictions. This document is available to the public

Texas at Austin, University of

225

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5367-1 2. Government Accession No. 3, deck, slab, shear, fatigue 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

226

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-00-1795-S 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

227

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03/4382-1 2. Government Accession No. 3, concrete pavement, sensitivity, fatigue, distress 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

228

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/5-4829-01-1 2. Government Accession No, stiffness 18. Distribution Statement No restrictions. This document is available to the public through

Zornberg, Jorge G.

229

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4485-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

230

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-00/0-1843-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

231

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. 1747-3 2. Government Accession No. 3. Recipient, Information Technology 18. Distribution Statement No restrictions. This document is available to the public

Texas at Austin, University of

232

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03/4083-2 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

233

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-12/5-4829-01-3 2. Government Accession No No restrictions. This document is available to the public through the National Technical Information Service

Zornberg, Jorge G.

234

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/5-5517-01-1 2. Government Accession No, field monitoring 18. Distribution Statement No restrictions. This document is available to the public

Zornberg, Jorge G.

235

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-0-1814-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

236

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-0-2122-1 2. Government Accession No. 3, regulations, vehicle characteristics 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

237

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FWHA/TX-05/0-1774-3 2. Government Accession No. 3, rehabilitation, encapsulation 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

238

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5197-4 2. Government Accession No. 3 consolidating concrete, microcracking 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

239

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03/1892-1 2. Government Accession No. 3, nondestructive testing 18. Distribution Statement No restrictions. This document is available to the public

Texas at Austin, University of

240

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/9-580/589-1 2. Government Accession No resistance, creep, shrinkage 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


241

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-5812-1 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Zornberg, Jorge G.

242

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-08/0-4562-2 2. Government Accession No. 3 concrete 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

243

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-1405-9 2. Government Accession No. 3 joints, reinforcement coatings 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

244

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03-1838-8 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

245

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03/1898-1 2. Government Accession No. 3 after the deck had hardened. 17. Key Words 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

246

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-00/1754-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

247

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/9-580/589-2 2. Government Accession No. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

248

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/1778-4 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

249

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-1734-S 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

250

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-00/1795-1 2. Government Accession No. 3 strategies 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

251

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-11/0-6348-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

252

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-00/1785-2 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

253

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03/4386-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

254

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4085-5 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

255

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-1401-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

256

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-5974-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

257

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-02/1395-2F 2. Government Accession No. 3 Bracing, Brace Forces, Torsional Stiffness 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

258

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-1471-4 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

259

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-0-1748-2 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

260

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-4808-1 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


261

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-6048-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Zornberg, Jorge G.

262

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/5-3933-01-P1-4 2. Government Accession No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

263

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4437-1 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

264

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-02-1810-2 2. Government Accession No. 3 in Texas 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

265

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/5-4975-01-1 2. Government Accession No. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

266

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4185-4 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

267

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/5-1291-01-1 2. Government Accession No),PASSER II, GEOPAK, Vehicle Turn Templates 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

268

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

i Technical Report Documentation Page 1. Report No. FHWA/TX-07 / 0-1774-4 2. Government Accession, encapsulation 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

269

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-5185-3 2. Government Accession No. 3 Pavement. 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

270

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4958-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

271

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-11/0-6095-2 2. Government Accession No. 3 Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

272

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-02/1852-1 2. Government Accession No. 3 concrete mix design 18. Distribution Statement No restrictions. This document is available to the public

Texas at Austin, University of

273

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-1700-7 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

274

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-5410-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

275

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4661-1 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

276

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-1700-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

277

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-08/5-4958-01-1 2. Government Accession No lens 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

278

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-03-1810-3 2. Government Accession No. 3, Highway user taxes, Highway finance 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

279

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/4576-3 2. Government Accession No. 3 Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

280

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5799-1 2. Government Accession No. 3 Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


281

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-7-4957-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

282

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

FINAL COPY Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1700-2 2. Government-based specifications. 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

283

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4416-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

284

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-1895-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

285

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-0-2129-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

286

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4410-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

287

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-5202-3 2. Government Accession No. 3 Shale, Paris Clay, Beaumont Clay. 18. Distribution Statement No restrictions. This document is available

Zornberg, Jorge G.

288

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5830-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

289

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4069-1 2. Government Accession No. 3. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

290

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-4080-8 2. Government Accession No. 3 frameworks, econometric models, empirical results 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

291

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. 0-4080-1 2. Government Accession No. 3. Recipient modeling 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

292

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. 9-572-1 2. Government Accession No. 3. Recipient Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

293

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4661-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

294

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1713-1 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

295

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-5202-2 2. Government Accession No. 3 No restrictions. This document is available to the public through the National Technical Information Service

Zornberg, Jorge G.

296

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-4185-3 2. Government Accession No. 3 Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

297

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-5973-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

298

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-13/5-4829-01-2 2. Government Accession No. This document is available to the public through the National Technical Information Service, Springfield

Zornberg, Jorge G.

299

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-7-2957-2 2. Government Accession No. 3/pavement interaction, pavement noise, noise level. 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

300

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1713-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


301

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-07/0-5176-2 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

302

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/5-1924-01-1 2. Government Accession No No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

303

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-09/0-5668-1 2. Government Accession No. 3. Distribution Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

304

E-Print Network 3.0 - anti-platelet therapy including Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

management including exercise, cognitive behavioral therapy 3. ... Source: Messersmith, Phillip B.- Department of Materials Science and Engineering, Northwestern University...

305

E-Print Network 3.0 - aetiologie therapie und Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

und tiefenpsychologisch fundierte Therapie. Bd. 3: Verhaltenstherapie. Mnchen: CIP... Institut fr Psychotherapeutische Aus- und Weiterbildung (IPAW) ... Source:...

306

E-Print Network 3.0 - activated cell therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

by therapy. The risk of inducing ... Source: Bonhoeffer, Sebastian - Institut fr Integrative Biologie, Eidgenssische Technische Hochschule Zrich (ETHZ) Collection:...

307

Cruise Report 2010 RMP Sediment Report  

E-Print Network [OSTI]

Cruise Report 2010 RMP Sediment Report February 1 ­ 12, 2010 #12;2010 RMP Sediment Cruise Report sediment cruise. The cruise was redesigned in 2002 to adopt a randomized sampling strategy in place). The objectives of the sampling effort were to: 1. Collect sediment samples from 27 sites for analysis of trace

308

Cruise Report 2005 RMP Sediment Report  

E-Print Network [OSTI]

Cruise Report 2005 RMP Sediment Report August 23-30, 2005 A P P L I E D S C I E N C E S #12;2005 RMP Sediment Cruise Report August 23 - 30, 2005 Applied Marine Sciences, Inc. Page 2 1.0 INTRODUCTION Francisco Estuary (RMP) annual sediment cruise. The cruise was redesigned in 2002 to adopt a randomized

309

Cruise Report 2008 RMP Sediment Report  

E-Print Network [OSTI]

Cruise Report 2008 RMP Sediment Report July 23 ­ August 1, 2008 #12;2008 RMP Sediment Cruise Report sediment cruise. The cruise was redesigned in 2002 to adopt a randomized sampling strategy in place sediment samples from 47 sites for analysis of trace organics by East Bay Municipal Utility District (EBMUD

310

Cruise Report 2007 RMP Sediment Report  

E-Print Network [OSTI]

Cruise Report 2007 RMP Sediment Report August 21-29, 2007 #12;2007 RMP Sediment Cruise Report sediment cruise. The cruise was redesigned in 2002 to adopt a randomized sampling strategy in place was conducted from the R/V Endeavor. The objectives of the sampling effort were to: 1. Collect sediment samples

311

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

IN HOT-MIX ASPHALT CONSTRUCTION 5. Report Date February 2005 Resubmitted: January 2006 Published: April, and Wenting Liu 8. Performing Organization Report No. Report 0-4577-2 10. Work Unit No. (TRAIS)9. Performing IN HOT-MIX ASPHALT CONSTRUCTION by Stephen Sebesta Associate Transportation Researcher Texas

312

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1778-3 2. Government Accession No. 3, and others. A number of reports, tables, and queries have been prepared and documented herein showing example. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

313

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1778-6 2. Government Accession No. 3 summarizes the tasks conducted under TxDOT Project 0-1778 "TxDOT Rigid Pavement Database." This document report is the final technical document prepared for the project. Additional information is provided

Texas at Austin, University of

314

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FWHA/TX-04/0-1741-4 2. Government Accession No. 3 Administration, and the Texas Department of Transportation. 16. Abstract This report documents the results, rehabilitation, evaluation 18. Distribution Statement No restrictions. This document is available to the public

Texas at Austin, University of

315

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-1405-7 2. Government Accession No. 3 researchers, after an extensive literature review. This report documents the final evaluation of the long No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

316

Economic Impact Reporting Framework  

E-Print Network [OSTI]

Economic Impact Reporting Framework 2007/08 November 2008 #12;#12;Economic Impact Reporting Framework 2007/08 #12;STFC Economic Impact Reporting Framework 2007/08 Contents: Introduction..............................................................................................................................................2 1: Overall Economic Impacts

317

Economic Impact Reporting Framework  

E-Print Network [OSTI]

Economic Impact Reporting Framework 2008/09 #12;#12;Economic Impact Reporting Framework 2008/09 #12;STFC Economic Impact Reporting Framework 2008/09 Contents: Introduction..............................................................................................................................................2 1: Overall Economic Impacts

318

Study on neutron radiation field of carbon ions therapy  

E-Print Network [OSTI]

Carbon ions offer significant advantages for deep-seated local tumors therapy due to their physical and biological properties. Secondary particles, especially neutrons caused by heavy ion reactions should be carefully considered in treatment process and radiation protection. For radiation protection purposes, the FLUKA Code was used in order to evaluate the radiation field at deep tumor therapy room of HIRFL in this paper. The neutron energy spectra, neutron dose and energy deposition of carbon ion and neutron in tissue-like media was studied for bombardment of solid water target by 430MeV/u C ions. It is found that the calculated neutron dose have a good agreement with the experimental date, and the secondary neutron dose may not exceed one in a thousand of the carbon ions dose at Bragg peak area in tissue-like media.

Xu, Jun-Kui; Li, Wu-Yuan; Yan, Wei-Wei; Chen, Xi-Meng; Mao, Wang; Pang, Cheng-Guo

2015-01-01T23:59:59.000Z

319

Nanoscience and Nanotechnology: From Energy Applications to Advanced Medical Therapies  

ScienceCinema (OSTI)

Dr. Rajh will present a general talk on nanotechnology ? an overview of why nanotechnology is important and how it is useful in various fields. The specific focus will be on Solar energy conversion, environmental applications and advanced medical therapies. She has broad expertise in synthesis and characterization of nanomaterials that are used in nanotechnology including novel hybrid systems connecting semiconductors to biological molecules like DNA and antibodies. This technology could lead to new gene therapy procedures, cancer treatments and other medical applications. She will also discuss technologies made possible by organizing small semiconductor particles called quantum dots, materials that exhibit a rich variety of phenomena that are size and shape dependent. Development of these new materials that harnesses the unique properties of materials at the 1-100 nanometer scale resulted in the new field of nanotechnology that currently affects many applications in technological and medical fields.

Tijana Rajh

2010-01-08T23:59:59.000Z

320

Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy  

DOE Patents [OSTI]

A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

Miura, Michiko (Hampton Bays, NY); Slatkin, Daniel N. (Southold, NY)

1997-03-18T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


321

Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy  

DOE Patents [OSTI]

A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na{sub 4}B{sub 12}I{sub 11}SSB{sub 12}I{sub 11}, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy. 1 fig.

Miura, M.; Slatkin, D.N.

1997-03-18T23:59:59.000Z

322

Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy  

DOE Patents [OSTI]

A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

Miura, Michiko (Hampton Bays, NY); Slatkin, Daniel N. (Southold, NY)

1995-10-03T23:59:59.000Z

323

Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy  

DOE Patents [OSTI]

A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na{sub 4}B{sub 12}I{sub 11}SSB{sub 12}I{sub 11}, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy. 1 fig.

Miura, M.; Slatkin, D.N.

1997-08-05T23:59:59.000Z

324

Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy  

DOE Patents [OSTI]

A method for performing boron neutron capture therapy for the treatment of tumors is disclosed. The method includes administering to a patient an iodinated sulfidohydroborane, a boron-10-containing compound. The site of the tumor is localized. by visualizing the increased concentration of the iodine labelled compound at the tumor. The targeted tumor is then irradiated with a beam of neutrons having an energy distribution effective for neutron capture. Destruction of the tumor occurs due to high LET particle irradiation of the tissue secondary to the incident neutrons being captured by the boron-10 nuclei. Iodinated sulfidohydroboranes are disclosed which are especially suitable for the method of the invention. In a preferred embodiment, a compound having the formula Na.sub.4 B.sub.12 I.sub.11 SSB.sub.12 I.sub.11, or another pharmaceutically acceptable salt of the compound, may be administered to a cancer patient for boron neutron capture therapy.

Miura, Michiko (Hampton Bays, NY); Slatkin, Daniel N. (Southold, NY)

1997-08-05T23:59:59.000Z

325

TESLA Report 1997-22 TESLA Report 1997-22  

E-Print Network [OSTI]

TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12;TESLA Report 1997-22 #12

326

TESLA Report 1998-28 TESLA Report 1998-28  

E-Print Network [OSTI]

TESLA Report 1998-28 #12;TESLA Report 1998-28 #12;TESLA Report 1998-28TESLA Report 1998-28TESLA Report 1998-28 Page 3 TESLA Report 1998-28 Page 1 #12;TESLA Report 1998-28TESLA Report 1998-28TESLA Report 1998-28 Page 4 TESLA Report 1998-28 Page 2 #12;TESLA Report 1998-28TESLA Report 1998-28TESLA

327

Evaluation of intakes of transuranics influenced by chelation therapy  

SciTech Connect (OSTI)

Once an intake of transuranics occurs, there are only three therapeutic procedures available to the physician for reducing the intake and mitigating the dose: excision of material from wounds, removal of material from the lungs with lavage, and chelation therapy. The only chelation agents approved in the United States for the treatment of occupational intakes of transuranics are the zinc and calcium salts of diethylene-triamine-pentaacetic acid, better known as Zn-DTPA and Ca-DTPA. In the past 35 years, approximately 3000 doses of DTPA have been administrated to over 500 individuals who had intakes of transuranics. The drug is considered to be quiet safe and has few side effects. For the internal dosimetrist, perhaps the most important aspects of chelation therapy is that if enhances the excretion rate of a transuranic and perturbs the shape of the urinary excretion curve. These perturbations last for months and are so great that standard urinary excretion models cannot be used to evaluate the intake. We review here a method for evaluating intakes of transuranics influenced by chelation therapy that has been used with some degree of success at the Savannah River Site for over 20 years.

LaBone, T.R.

1994-02-01T23:59:59.000Z

328

Replanning During Intensity Modulated Radiation Therapy Improved Quality of Life in Patients With Nasopharyngeal Carcinoma  

SciTech Connect (OSTI)

Purpose: Anatomic and dosimetric changes have been reported during intensity modulated radiation therapy (IMRT) in patients with nasopharyngeal carcinoma (NPC). The purpose of this study was to evaluate the effects of replanning on quality of life (QoL) and clinical outcomes during the course of IMRT for NPC patients. Methods and Materials: Between June 2007 and August 2011, 129 patients with NPC were enrolled. Forty-three patients received IMRT without replanning, while 86 patients received IMRT replanning after computed tomography (CT) images were retaken part way through therapy. Chinese versions of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 and Head and Neck Quality of Life Questionnaire 35 were completed before treatment began and at the end of treatment and at 1, 3, 6, and 12 months after the completion of treatment. Overall survival (OS) data were compared using the Kaplan-Meier method. Results: IMRT replanning had a profound impact on the QoL of NPC patients, as determined by statistically significant changes in global QoL and other QoL scales. Additionally, the clinical outcome comparison indicates that replanning during IMRT for NPC significantly improved 2-year local regional control (97.2% vs 92.4%, respectively, P=.040) but did not improve 2-year OS (89.8% vs 82.2%, respectively, P=.475). Conclusions: IMRT replanning improves QoL as well as local regional control in patients with NPC. Future research is needed to determine the criteria for replanning for NPC patients undergoing IMRT.

Yang Haihua [Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang Province (China)] [Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang Province (China); Hu Wei, E-mail: huw@enzemed.com [Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang Province (China); Wang Wei; Chen Peifang; Ding Weijun [Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang Province (China)] [Department of Radiation Oncology, Laboratory of Cellular and Molecular Radiation Oncology, Taizhou Hospital, Wenzhou Medical College, Taizhou, Zhejiang Province (China); Luo Wei [Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky (United States)] [Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky (United States)

2013-01-01T23:59:59.000Z

329

Annual Reports | Department of Energy  

Energy Savers [EERE]

2000 (pdf) Annual Report for 1999 (pdf) Annual Report for 1998 (pdf) Annual Report for 1997 (pdf) Annual Report for 1996 (pdf) Annual Report for 1995 (pdf) Annual Report for 1994...

330

Cruise Report 2003 RMP Sediment Report  

E-Print Network [OSTI]

Cruise Report 2003 RMP Sediment Report August 18 - 26, 2003 A P P L I E D S C I E N C E S #12;2003 RMP Sediment Cruise Report August 18-26, 2003 Applied Marine Sciences, Inc. Page 1 1.0 INTRODUCTION in the San Francisco Estuary (RMP) sediment cruise. The cruise was redesigned in 2002 to adopt a randomized

331

STEP Program Benchmark Report  

Broader source: Energy.gov [DOE]

STEP Program Benchmark Report, from the Tool Kit Framework: Small Town University Energy Program (STEP).

332

2008 Annual Report  

SciTech Connect (OSTI)

This annual report includes: a brief overview of Western; FY 2008 operational highlights; and financial data.

none,

2008-01-01T23:59:59.000Z

333

Annual Fire Safety Report  

E-Print Network [OSTI]

2010 Annual Fire Safety Report University of California, Irvine HIGHER EDUCATION OPPORTUNITY to the Fire Safety in Student Housing Buildings of current or perspective students and employees be reported publish an annual fire safety report, keep a fire log, and report fire statistics to the Secretary

Loudon, Catherine

334

Quarterly Progress Report  

Broader source: Energy.gov [DOE]

Quarterly Progress Report, from the Tool Kit Framework: Small Town University Energy Program (STEP).

335

STEP Participant Survey Report  

Broader source: Energy.gov [DOE]

STEP Participant Survey Report, from the Tool Kit Framework: Small Town University Energy Program (STEP).

336

TomoTherapy MLC verification using exit detector data  

SciTech Connect (OSTI)

Purpose: Treatment delivery verification (DV) is important in the field of intensity modulated radiation therapy (IMRT). While IMRT and image guided radiation therapy (IGRT), allow us to create more conformal plans and enables the use of tighter margins, an erroneously executed plan can have detrimental effects on the treatment outcome. The purpose of this study is to develop a DV technique to verify TomoTherapy's multileaf collimator (MLC) using the onboard mega-voltage CT detectors. Methods: The proposed DV method uses temporal changes in the MVCT detector signal to predict actual leaf open times delivered on the treatment machine. Penumbra and scattered radiation effects may produce confounding results when determining leaf open times from the raw detector data. To reduce the impact of the effects, an iterative, Richardson-Lucy (R-L) deconvolution algorithm is applied. Optical sensors installed on each MLC leaf are used to verify the accuracy of the DV technique. The robustness of the DV technique is examined by introducing different attenuation materials in the beam. Additionally, the DV technique has been used to investigate several clinical plans which failed to pass delivery quality assurance (DQA) and was successful in identifying MLC timing discrepancies as the root cause. Results: The leaf open time extracted from the exit detector showed good agreement with the optical sensors under a variety of conditions. Detector-measured leaf open times agreed with optical sensor data to within 0.2 ms, and 99% of the results agreed within 8.5 ms. These results changed little when attenuation was added in the beam. For the clinical plans failing DQA, the dose calculated from reconstructed leaf open times played an instrumental role in discovering the root-cause of the problem. Throughout the retrospective study, it is found that the reconstructed dose always agrees with measured doses to within 1%. Conclusions: The exit detectors in the TomoTherapy treatment systems can provide valuable information about MLC behavior during delivery. A technique to estimate the TomoTherapy binary MLC leaf open time from exit detector signals is described. This technique is shown to be both robust and accurate for delivery verification.

Chen Quan; Westerly, David; Fang Zhenyu; Sheng, Ke; Chen Yu [TomoTherapy Inc., 1240 Deming Way, Madison, Wisconsin 53717 (United States); Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045 (United States); Xinghua Cancer Hospital, Xinghua, Jiangsu 225700 (China); Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, California 90095 (United States); TomoTherapy Inc., 1240 Deming Way, Madison, Wisconsin 53717 (United States)

2012-01-15T23:59:59.000Z

337

State Report forState Report forState Report forState Report for From the Research Project  

E-Print Network [OSTI]

State Report forState Report forState Report forState Report for From the Research Project State Report forState Report forState Report forState Report for Washington University In cooperation with the Washington Department of Fish and Wildlife FINAL REPORT April 2011

338

Pitfalls of tungsten multileaf collimator in proton beam therapy  

SciTech Connect (OSTI)

Purpose: Particle beam therapy is associated with significant startup and operational cost. Multileaf collimator (MLC) provides an attractive option to improve the efficiency and reduce the treatment cost. A direct transfer of the MLC technology from external beam radiation therapy is intuitively straightforward to proton therapy. However, activation, neutron production, and the associated secondary cancer risk in proton beam should be an important consideration which is evaluated. Methods: Monte Carlo simulation with FLUKA particle transport code was applied in this study for a number of treatment models. The authors have performed a detailed study of the neutron generation, ambient dose equivalent [H*(10)], and activation of a typical tungsten MLC and compared with those obtained from a brass aperture used in a typical proton therapy system. Brass aperture and tungsten MLC were modeled by absorber blocks in this study, representing worst-case scenario of a fully closed collimator. Results: With a tungsten MLC, the secondary neutron dose to the patient is at least 1.5 times higher than that from a brass aperture. The H*(10) from a tungsten MLC at 10 cm downstream is about 22.3 mSv/Gy delivered to water phantom by noncollimated 200 MeV beam of 20 cm diameter compared to 14 mSv/Gy for the brass aperture. For a 30-fraction treatment course, the activity per unit volume in brass aperture reaches 5.3 x 10{sup 4} Bq cm{sup -3} at the end of the last treatment. The activity in brass decreases by a factor of 380 after 24 h, additional 6.2 times after 40 days of cooling, and is reduced to background level after 1 yr. Initial activity in tungsten after 30 days of treating 30 patients per day is about 3.4 times higher than in brass that decreases only by a factor of 2 after 40 days and accumulates to 1.2 x 10{sup 6} Bq cm{sup -3} after a full year of operation. The daily utilization of the MLC leads to buildup of activity with time. The overall activity continues to increase due to {sup 179}Ta with a half-life of 1.82 yr and thus require prolonged storage for activity cooling. The H*(10) near the patient side of the tungsten block is about 100 {mu}Sv/h and is 27 times higher at the upstream side of the block. This would lead to an accumulated dose for therapists in a year that may exceed occupational maximum permissible dose (50 mSv/yr). The value of H*(10) at the upstream surface of the tungsten block is about 220 times higher than that of the brass. Conclusions: MLC is an efficient way for beam shaping and overall cost reduction device in proton therapy. However, based on this study, tungsten seems to be not an optimal material for MLC in proton beam therapy. Usage of tungsten MLC in clinic may create unnecessary risks associated with the secondary neutrons and induced radioactivity for patients and staff depending on the patient load. A careful selection of material for manufacturing of an optimal MLC for proton therapy is thus desired.

Moskvin, Vadim; Cheng, Chee-Wai; Das, Indra J. [Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202 (United States) and Indiana University Health Proton Therapy Center (Formerly Midwest Proton Radiotherapy Institute), Bloomington, Indiana 47408 (United States)

2011-12-15T23:59:59.000Z

339

Final Report: 8th International Symposium on NCT for Cancer, May 15, 1998 - May 15, 1999  

SciTech Connect (OSTI)

The 8th International Symposium on Neutron Capture Therapy for Cancer (8th ISNCTC) was held in La Jolla, CA on Sept. 13-18, 1998. This biennial meeting of the International Society for Neutron Capture Therapy (ISNCT) was hosted by Society President M.F. Hawthorne (UCLA Dept. of Chemistry and Biochemistry). The Symposium brought together scientists (300 registrants from 21 countries) from diverse fields to report the latest developments in NCT. Topics of the 275 papers presented (30 plenary lectures, 81 oral presentations, and 164 posters) included the physics of neutron sources, chemistry of tumor-targeting agents, dosimetry, radiobiological studies, and clinical applications.

Hawthorne, M.F.

1999-09-01T23:59:59.000Z

340

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

. Williams, Eun Sug Park 8. Performing Organization Report No. Report 167142-1 10. Work Unit No. (TRAIS)9. Chrysler, Ph.D. Research Scientist Texas Transportation Institute Alicia A. Williams Research Associate variables. Texas A&M students Sara Meischen and Jeff

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


341

PROJECT REPORT COOLERADO H80 FIELD REPORT  

E-Print Network [OSTI]

the UC Davis Energy Efficiency Center in 2007 through a grant from the California Clean Energy FundPROJECT REPORT COOLERADO H80 FIELD REPORT University House at UC Davis & Embry-Riddle Aeronautical.0 About the Technology 5 3.0 Demonstration at University House, UC Davis 6 3.1 Results 6 4.0 Demonstration

California at Davis, University of

342

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

. A survey of the Houston dray industry and its driver workforce is then reported. Since other deep-water Project performed in cooperation with the Texas Department of Transportation and the Federal Highway: 0-5068-2 Report Date: November 2006; Revised February 2007 Project: 0-5068 Project Title: Planning

Texas at Austin, University of

343

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

and solar panel installation. The Phase II installation utilized a more powerful datalogger at the Mustang. Type of Report and Period Covered Project Summary Report (9/99-12/99) 12. Sponsoring Agency Name ultrasonic sensors mounted on four different bridge piers. Researchers had access to the scour and stage data

Texas at Austin, University of

344

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

. Recipient's Catalog No. 4. Title and Subtitle Phase 1 Report on the Development of Predictive Model for Bridge Deck Cracking and Strength Development 5. Report Date January 2009 6. Performing Organization Code coupled with autogenous and thermal shrinkage), can have several detrimental effects on long-term behavior

Texas at Austin, University of

345

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. SWUTC/13/600451-00073-1 2. Government Accession in both traditional internal combustion engine vehicles (ICEs) and electric vehicles (EVs) have a strong influence on transportation revenue by reducing fuel consumption per vehicle and ultimately drawing down

346

2010annual report 2010annual report  

E-Print Network [OSTI]

of Energy. It was a good year for Illinois Institute of Technology on ma academic and research highlights 4 financial report 5 institutional giving report Illinois Institute-track faculty members and promoted or 1 Illinois Institute of Technology Office of the President IIT Tower 10 W

Heller, Barbara

347

Library Annual Report Library Annual Report  

E-Print Network [OSTI]

Library Annual Report 2007 Library Annual Report 2007 #12;www.library.uwa.edu.au Our mission: By delivering excellent information resources and services the Library is integral to the University's mission of advancing, transmitting and sustaining knowledge. Our vision: The Library will continue to be at the heart

Tobar, Michael

348

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

satellite coverage was poor. Both monitoring systems are evaluated in this report. 17. Key Words bridge No restrictions. This document is available to the public through the National Technical Information Service, Springfield, Virginia 22161. 19. Security Classif. (of report) Unclassified 20. Security Classif. (of

Texas at Austin, University of

349

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/0-4266-2 2. Government Accession No. 3 significant changes in traffic operation and safety. A review of the design standard documents shows Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

350

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-6655-CT-1 2. Government Accession No presents four documents created by the TxDOT Multi-Tier Pavement Management Workgroup. 17. Key Words System Operation, Preservation Optimization 18. Distribution Statement No restrictions. This document is available

Texas at Austin, University of

351

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-5517-1 2. Government Accession No. 3 for a series of tire bale case histories. The following document outlines all the work conducted as part Statement No restrictions. This document is available to the public through the National Technical

Texas at Austin, University of

352

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-05/0-1778-5 2. Government Accession No. 3 and funded by the Texas Department of Transportation (TxDOT). Project 0-1778 documents the efforts conducted-Button, Pavement Distress Index (PDI), z-score. 18. Distribution Statement No restrictions. This document

Texas at Austin, University of

353

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-06/0-4085-1 2. Government Accession No. 3-related problems. Research is currently underway to document the performance of concrete using these mitigation Formation (DEF) 18. Distribution Statement No restrictions. This document is available to the public through

Texas at Austin, University of

354

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-04/5-1873-01-1 2. Government Accession No to improve safety and facilitate traffic flow. Finally, they documented these design considerations. This document is available to the public through the National Technical Information Service, Springfield

Texas at Austin, University of

355

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA-IF-02-034 2. Government Accession No. 3. DiMaggio 16. Abstract This document presents state-of-the-practice information on the evaluation of soil and rock properties for geotechnical design applications. This document addresses the entire range

Mayne, Paul W.

356

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

Technical Report Documentation Page 1. Report No. FHWA/TX-10/0-6044-1 2. Government Accession No. 3 the researchers' understanding of the general T&R approach used by the industry, (c) documents the research No restrictions. This document is available to the public through the National Technical Information Service

Texas at Austin, University of

357

Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: A dosimetric analysis  

SciTech Connect (OSTI)

Stereotactic body radiation therapy (SBRT) achieves excellent local control for locally advanced pancreatic cancer (LAPC), but may increase late duodenal toxicity. Volumetric-modulated arc therapy (VMAT) delivers intensity-modulated radiation therapy (IMRT) with a rotating gantry rather than multiple fixed beams. This study dosimetrically evaluates the feasibility of implementing duodenal constraints for SBRT using VMAT vs IMRT. Non–duodenal sparing (NS) and duodenal-sparing (DS) VMAT and IMRT plans delivering 25 Gy in 1 fraction were generated for 15 patients with LAPC. DS plans were constrained to duodenal D{sub max} of<30 Gy at any point. VMAT used 1 360° coplanar arc with 4° spacing between control points, whereas IMRT used 9 coplanar beams with fixed gantry positions at 40° angles. Dosimetric parameters for target volumes and organs at risk were compared for DS planning vs NS planning and VMAT vs IMRT using paired-sample Wilcoxon signed rank tests. Both DS VMAT and DS IMRT achieved significantly reduced duodenal D{sub mean}, D{sub max}, D{sub 1cc}, D{sub 4%}, and V{sub 20} {sub Gy} compared with NS plans (all p?0.002). DS constraints compromised target coverage for IMRT as demonstrated by reduced V{sub 95%} (p = 0.01) and D{sub mean} (p = 0.02), but not for VMAT. DS constraints resulted in increased dose to right kidney, spinal cord, stomach, and liver for VMAT. Direct comparison of DS VMAT and DS IMRT revealed that VMAT was superior in sparing the left kidney (p<0.001) and the spinal cord (p<0.001), whereas IMRT was superior in sparing the stomach (p = 0.05) and the liver (p = 0.003). DS VMAT required 21% fewer monitor units (p<0.001) and delivered treatment 2.4 minutes faster (p<0.001) than DS IMRT. Implementing DS constraints during SBRT planning for LAPC can significantly reduce duodenal point or volumetric dose parameters for both VMAT and IMRT. The primary consequence of implementing DS constraints for VMAT is increased dose to other organs at risk, whereas for IMRT it is compromised target coverage. These findings suggest clinical situations where each technique may be most useful if DS constraints are to be employed.

Kumar, Rachit; Wild, Aaron T.; Ziegler, Mark A.; Hooker, Ted K.; Dah, Samson D.; Tran, Phuoc T.; Kang, Jun; Smith, Koren; Zeng, Jing [Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, 401N. Broadway, Weinberg Suite 1440, Baltimore, MD 21231 (United States); Pawlik, Timothy M. [Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD (United States); Tryggestad, Erik [Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, 401N. Broadway, Weinberg Suite 1440, Baltimore, MD 21231 (United States); Ford, Eric [Department of Radiation Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA (United States); Herman, Joseph M., E-mail: jherma15@jhmi.edu [Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, 401N. Broadway, Weinberg Suite 1440, Baltimore, MD 21231 (United States)

2013-10-01T23:59:59.000Z

358

INEL BNCT research program: Annual report, 1995  

SciTech Connect (OSTI)

This report is a summary of the progress and research produced for the Idaho National Engineering Laboratory (INEL) Boron Neutron Capture Therapy (BNCT) Research Program for calendar year 1995. Contributions from the principal investigators about their individual projects are included, specifically, physics (treatment planning software, real-time neutron beam measurement dosimetry), and radiation biology (large animal models efficacy studies). Design of a reactor based epithermal neutron extraction facility is discussed in detail. Final results of boron magnetic resonance imagining is included for both borocaptate sodium (BSH) and boronophenylalanine (BPA) in rats, and BSH in humans. Design of an epithermal neutron facility using electron linear accelerators is presented, including a treatise on energy removal from the beam target. Information on the multiple fraction injection of BSH in rats is presented.

Venhuizen, J.R. [ed.

1996-04-01T23:59:59.000Z

359

Hemophilia A Pseudoaneurysm in a Patient with High Responding Inhibitors Complicating Total Knee Arthroplasty: Embolization: A Cost-Reducing Alternative to Medical Therapy  

SciTech Connect (OSTI)

Joint hemorrhages are very common in patients with severe hemophilia. Inhibitors in patients with hemophilia are allo-antibodies that neutralize the activity of the clotting factor. After total knee replacement, rare intra-articular bleeding complications might occur that do not respond to clotting factor replacement. We report a 40-year-old male with severe hemophilia A and high responding inhibitors presenting with recurrent knee joint hemorrhage after bilateral knee prosthetic surgery despite adequate clotting factor treatment. There were two episodes of marked postoperative hemarthrosis requiring extensive use of subsititution therapy. Eleven days postoperatively, there was further hemorrhage into the right knee. Digital subtraction angiography diagnosed a complicating pseudoaneurysm of the inferior lateral geniculate artery and embolization was successfully performed. Because clotting factor replacement therapy has proved to be excessively expensive and prolonged, especially in patients with inhibitors, we recommend the use of cost-effective early angiographic embolization.

Kickuth, Ralph, E-mail: ralph.kickuth@insel.ch; Anderson, Suzanne [Inselspital, University of Berne, Institute of Diagnostic, Interventional and Pediatric Radiology (Switzerland); Peter-Salonen, Kristiina; Laemmle, Bernhard [Inselspital, University of Berne, Department of Hematology (Switzerland); Eggli, Stefan [Inselspital, University of Berne, Department of Orthopedic Surgery (Switzerland); Triller, Juergen [Inselspital, University of Berne, Institute of Diagnostic, Interventional and Pediatric Radiology (Switzerland)

2006-12-15T23:59:59.000Z

360

PRI Annual Report 2004  

E-Print Network [OSTI]

research found within the pages of this annual report. To bring you closer to some of our research projects, the 2004 Annual Report focuses on three projects. Two teams of researchers are using innovative methods to examine important international issues...

Maynard-Moody, Steven

2005-04-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


361

SUMMARY REPORT ANNUAL IABP MEETING  

E-Print Network [OSTI]

SUMMARY REPORT THE 7TH ANNUAL IABP MEETING St. Petersburg, Russia, 3 - 6 June 1997 #12;IABP-7 Summary Report 2 Table of Contents Summary Report-ordinator's Report.......................................................... 20 5. Report of the Data Buoy Co

Rigor, Ignatius G.

362

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

contain suspended solids, metals, oil and grease, fecal coliform, and oxygen demanding organics. Highway, Springfield, Virginia 22161; www.ntis.gov. 19. Security Classif. (of report) Unclassified 20. Security Classif

Texas at Austin, University of

363

Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy  

DOE Patents [OSTI]

The present invention covers halogenated derivatives of boronated phorphyrins containing multiple carborane cages having the formula ##STR1## which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron-capture therapy and photodynamic therapy. The present invention also covers methods for using these halogenated derivatives of boronated porphyrins in tumor imaging and cancer treatment.

Miura, Michiko; Slatkin, Daniel N.

2005-10-04T23:59:59.000Z

364

Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy  

DOE Patents [OSTI]

The present invention covers halogenated derivatives of boronated porphyrins containing multiple carborane cages having the formula ##STR1## which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron- capture therapy and photodynamic therapy. The present invention also covers methods for using these halogenated derivatives of boronated porphyrins in tumor imaging and cancer treatment.

Miura, Michiko; Slatkin, Daniel N.

2003-05-20T23:59:59.000Z

365

System and method for delivery of neutron beams for medical therapy  

DOE Patents [OSTI]

A neutron delivery system that provides improved capability for tumor control during medical therapy is disclosed. The system creates a unique neutron beam that has a bimodal or multi-modal energy spectrum. This unique neutron beam can be used for fast-neutron therapy, boron neutron capture therapy (BNCT), or both. The invention includes both an apparatus and a method for accomplishing the purposes of the invention. 5 figs.

Nigg, D.W.; Wemple, C.A.

1999-07-06T23:59:59.000Z

366

System and method for delivery of neutron beams for medical therapy  

DOE Patents [OSTI]

A neutron delivery system that provides improved capability for tumor control during medical therapy. The system creates a unique neutron beam that has a bimodal or multi-modal energy spectrum. This unique neutron beam can be used for fast-neutron therapy, boron neutron capture therapy (BNCT), or both. The invention includes both an apparatus and a method for accomplishing the purposes of the invention.

Nigg, David W. (Idaho Falls, ID); Wemple, Charles A. (Idaho Falls, ID)

1999-01-01T23:59:59.000Z

367

MMCR Calibration Report  

SciTech Connect (OSTI)

Calibration report for the Millimeter Wavelength Cloud Radar performed for the ARM Climate Research Facility by ProSensing Inc.

Mead, D

2010-03-23T23:59:59.000Z

368

Certification reporting forms  

SciTech Connect (OSTI)

The required information and formats for the certification report including the cover sheet, compliance statement, and body of the report are given in this document. The body of the reports is different for each product. There are no product-to-product differences in the forms of the other parts of the reports. The products covered in this document include: furnaces, water heaters, refrigerator-freezers, central air conditioners, room air conditioners, and freezers.

Not Available

1981-02-18T23:59:59.000Z

369

Assorted Situation Reports  

Broader source: Energy.gov [DOE]

The Office of Electricity Delivery and Energy Reliability issues public Situation Reports during large scale energy emergencies.

370

KYUSHU UNIVERSITY FINANCIAL REPORT  

E-Print Network [OSTI]

KYUSHU UNIVERSITY FINANCIAL REPORT 200992009 #12;1 Kyushu University FINANCIAL REPORT 2009 Kyushu University FINANCIAL REPORT 2009 2 1 3 4 2 5 6 7 9 11 13 14 15 16 3 17 18 19 20 21 22 4 23 24 25 26 5 27 28 6 29 30 FINANCIAL REPORT index2009 #12;1,300 1,200 1,100 1,000 900 800 700 600 500 400 300 200 100 0 1

Nakamura, Iku

371

Hazard Analysis Database report  

SciTech Connect (OSTI)

This document describes and defines the Hazard Analysis Database for the Tank Waste Remediation System Final Safety Analysis Report.

Niemi, B.J.

1997-08-12T23:59:59.000Z

372

Hazard analysis results report  

SciTech Connect (OSTI)

This document describes and defines the Hazard Analysis Results for the Tank Waste Remediation System Final Safety Analysis Report.

Niemi, B.J., Westinghouse Hanford

1996-09-30T23:59:59.000Z

373

1995 PVUSA progress report. Final report  

SciTech Connect (OSTI)

Photovoltaics for Utility Scale Applications (PVUSA) is a national public-private partnership that is assessing and demonstrating the viability of utility-scale (US) photovoltaic (PV) electric generation systems and recent developments in PV module technology. This report updates the project`s progress, reviews the status and performance of the various PV installations during 1995, summarizes key accomplishments and conclusions, and serves as the final report under Pacific Gas and Electric Company`s project management.

NONE

1996-03-01T23:59:59.000Z

374

Organic solvent topical report  

SciTech Connect (OSTI)

This report is the technical basis for the accident and consequence analyses used in the Hanford Tank Farms Basis for Interim Operation. The report also contains the scientific and engineering information and reference material needed to understand the organic solvent safety issue. This report includes comments received from the Chemical Reactions Subcommittee of the Tank Advisory Panel.

Cowley, W.L.

1998-04-30T23:59:59.000Z

375

2011 -2012 Annual Report  

E-Print Network [OSTI]

2011 2012 Annual Report #12;2011 - 2012 Annual Report 2 INTRODUCING CAR SHARING Since the car share,116 Carpools 420 430 430 Car Share Members -- -- 661 #12;2011 - 2012 Annual Report 4 GARAGE PARKING INVENTORY or day, and gives the com- munity yet another reason to leave their cars at home. In its launch

Yang, Zong-Liang

376

Annual Report and Accounts  

E-Print Network [OSTI]

Annual Report and Accounts 2013­2014 The Research Agency of the Forestry CommissionHC 2 #12;Forest Research Annual Report and Accounts 2013­2014 Presented to the House of Commons pursuant to Section 7 Annual Report and Accounts 2013­2014 Forest Research 1 #12;© Crown Copyright 2014 You may re

377

SCHOOL REPORT COMMONAPPLICATIONID#  

E-Print Network [OSTI]

SCHOOL REPORT COMMONAPPLICATIONID#: Transfer Applicant The Transfer Common Application and Stanford LABELS STANFORD MAILING LABELS 1 OF 2 #12;Note: Stanford requires two Academic Reports with evaluation letters. At least one of your Academic Reports must be from a college instructor. Visit admission

Prinz, Friedrich B.

378

E-Print Network 3.0 - assessing intramyocardial therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Law, Natural Sciences, Summary: of Creative Art Therapies Where Inspiration Meets Innovation Faculty of Social Welfare and Health Sciences... 's Self-Portrait at the...

379

E-Print Network 3.0 - advanced music therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

a safe outlet for individuals... of Creative Art Therapies Where Inspiration Meets Innovation Faculty of Social Welfare and Health Sciences... 's Self-Portrait at the...

380

E-Print Network 3.0 - aroma therapy etude Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Law, Natural Sciences, Summary: of Creative Art Therapies Where Inspiration Meets Innovation Faculty of Social Welfare and Health Sciences... 's Self-Portrait at the...

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


381

E-Print Network 3.0 - autologous cell therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

2009 447 The new england Summary: of nonmyeloablative chemo- therapy followed by an infusion of autologous hematopoietic stem cells that had been trans... autologous CD34+ bone...

382

E-Print Network 3.0 - arc therapy planning Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

What is radiation therapy ? 2. ... Source: Hamza-Lup, Felix G. - School of Computing, Armstrong Atlantic State University Collection: Computer Technologies and Information Sciences...

383

E-Print Network 3.0 - anti-platelet therapy aspirin Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Until recently, it was thought that menopausal hormone therapy could lower the risks of heart attack Source: Parsegian, V. Adrian - Laboratory of Physical and Structural Biology,...

384

E-Print Network 3.0 - antiplatelet therapy principles Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

the magnitude of the research. Summary: involved in blood clotting. Treatment for a Heart Attack may include: THROMBOLYTIC THERAPY Depending... the chest pain. This is...

385

E-Print Network 3.0 - antiretroviral arv therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Summary: Abstract: Antiretroviral therapy (ARV) is becoming available in South Africa. Demand will exceed supply... to Evaluate the Ethics of Allocating Antiretrovirals in Africa...

386

E-Print Network 3.0 - adefovir dipivoxil therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

in order to earn the Music Therapy Source: Arnold, Jonathan - Nanoscale Science and Engineering Center & Department of Genetics, University of Georgia Collection:...

387

E-Print Network 3.0 - adjunctive photodynamic therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

applications as diverse as organic solar photo- voltaic cells, photodynamic therapy, oxygen Source: Hnsch, Theodor W. - Fakultt fr Physik, Ludwig-Maximilians-Universitt...

388

E-Print Network 3.0 - ala-mediated photodynamic therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

applications as diverse as organic solar photo- voltaic cells, photodynamic therapy, oxygen Source: Hnsch, Theodor W. - Fakultt fr Physik, Ludwig-Maximilians-Universitt...

389

E-Print Network 3.0 - acid-mediated photodynamic therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

applications as diverse as organic solar photo- voltaic cells, photodynamic therapy, oxygen Source: Hnsch, Theodor W. - Fakultt fr Physik, Ludwig-Maximilians-Universitt...

390

E-Print Network 3.0 - acid-based photodynamic therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

(PDT) requires oxygen... . INTRODUCTION Photodynamic therapy (PDT) (1,2) is an evolving ... Source: Yodh, Arjun G. - Departments of Radiology & Physics and Astronomy,...

391

E-Print Network 3.0 - affords photodynamic therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

(PDT) requires oxygen... . INTRODUCTION Photodynamic therapy (PDT) (1,2) is an evolving ... Source: Yodh, Arjun G. - Departments of Radiology & Physics and Astronomy,...

392

E-Print Network 3.0 - a-mediated photodynamic therapy Sample...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

applications as diverse as organic solar photo- voltaic cells, photodynamic therapy, oxygen Source: Hnsch, Theodor W. - Fakultt fr Physik, Ludwig-Maximilians-Universitt...

393

E-Print Network 3.0 - aminolevulinate-based photodynamic therapy...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

applications as diverse as organic solar photo- voltaic cells, photodynamic therapy, oxygen Source: Hnsch, Theodor W. - Fakultt fr Physik, Ludwig-Maximilians-Universitt...

394

E-Print Network 3.0 - acid photodynamic therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

(PDT) requires oxygen... . INTRODUCTION Photodynamic therapy (PDT) (1,2) is an evolving ... Source: Yodh, Arjun G. - Departments of Radiology & Physics and Astronomy,...

395

active anti-retroviral therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

treatments. There are differences between the hospitals how the treatments with radiopharmaceuticals are performed and how the activity for the therapy is determined. Mostly, the...

396

E-Print Network 3.0 - aids gene therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Collection: Biology and Medicine 15 PRESS RELEA Oct. 28, 2009 Summary: Therapies for Sickle Cell Disease, HIVAIDS and Brain, Ovarian and Colorectal Cancers Three...

397

anticoagulant therapy re-ly: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

be Indicated in Patients on AnticoagulantAntiplatelet Therapy Following Mild Traumatic Brain Injury University of California eScholarship Repository Summary: head injury and an...

398

E-Print Network 3.0 - antimalarial therapy selection Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

in international research networks, such as the WorldWide antimalarial... - optimising the use of artemisinin-based therapies, understanding the biology and mechanisms of...

399

E-Print Network 3.0 - antiretroviral therapy-treated patients...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

of 2 US. For all non-antiretroviral... antiretroviral drug therapy programme in Uganda: ... Source: Ecole Polytechnique, Centre de mathmatiques Collection: Mathematics 24...

400

E-Print Network 3.0 - adding proton therapy Sample Search Results  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

results for: adding proton therapy Page: << < 1 2 3 4 5 > >> 1 Proton and Particle Beams in Cancer Management Sponsored by the Program in Radiation Biology Summary: on...

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


401

anti-hiv drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

402

anti-parkinsonian drug therapy: Topics by E-print Network  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

EVIDENCE BASED DRUG THERAPY RESOURCE CiteSeer Summary: Management of acute and chronic gout is challenging in the setting of chronic kidney disease (CKD). Common gout treatments...

403

E-Print Network 3.0 - advanced medical therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

for: advanced medical therapy Page: << < 1 2 3 4 5 > >> 1 Louisiana State University Health Care Services Division Medical Center of Louisiana at New Orleans Summary: are...

404

E-Print Network 3.0 - alternative medical therapies Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

for: alternative medical therapies Page: << < 1 2 3 4 5 > >> 1 Louisiana State University Health Care Services Division Medical Center of Louisiana at New Orleans Summary: are...

405

E-Print Network 3.0 - airway pressurencpap therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

or with therapy. Air- way hyperresponsiveness... on a history of recurrent wheeze, cough, or shortness of breath, reversible airway obstruction ... Source: Akabas, Myles -...

406

E-Print Network 3.0 - antiviral therapy current Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

therapy, which exposes the patient to the risk of developing antiviral drug... and to design new trials of combination ... Source: Paris-Sud XI, Universit de - Institut...

407

E-Print Network 3.0 - african antiretroviral therapy Sample Search...  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Time: 3:30 pm Summary: Abstract: Antiretroviral therapy (ARV) is becoming available in South Africa. Demand will exceed supply... to Evaluate the Ethics of Allocating...

408

On bolus for megavoltage photon and electron radiation therapy  

SciTech Connect (OSTI)

Frequently, in radiation therapy one must treat superficial lesions on cancer patients; these are at or adjacent to the skin. Megavoltage photon radiotherapy penetrates through the skin to irradiate deep-seated tumors, with skin-sparing property. Hence, to treat superficial lesions, one must use a layer of scattering material to feign as the skin surface. Although megavoltage electron beams are used for superficial treatments, one occasionally needs to enhance the dose near the surface. Such is the function of a “bolus,” a natural or synthetically developed material that acts as a layer of tissue to provide a more effective treatment to the superficial lesions. Other uses of boluses are to correct for varying surface contours and to add scattering material around the patient's surface. Materials used as bolus vary from simple water to metal and include various mixtures and compounds. Even with the modernization of the technology for external-beam therapy and the emergence of various commercial boluses, the preparation and utilization of a bolus in clinical radiotherapy remains an art. Considering the varying experiences and practices, this paper briefly summarizes available boluses that have been proposed and are employed in clinical radiotherapy. Although this review is not exhaustive, it provides some initial guidance and answers questions that may arise in clinical practice.

Vyas, Vedang [University of Waterloo, Waterloo, Ontario (Canada); Grand River Regional Cancer Centre, Kitchener, Ontario (Canada); Palmer, Lisa; Mudge, Ray [Grand River Regional Cancer Centre, Kitchener, Ontario (Canada); Jiang, Runqing [University of Waterloo, Waterloo, Ontario (Canada); Grand River Regional Cancer Centre, Kitchener, Ontario (Canada); Fleck, Andre [Grand River Regional Cancer Centre, Kitchener, Ontario (Canada); Schaly, Bryan [London Regional Cancer Program, London, Ontario (Canada); Osei, Ernest [University of Waterloo, Waterloo, Ontario (Canada); Grand River Regional Cancer Centre, Kitchener, Ontario (Canada); Charland, Paule, E-mail: paule.charland@grhosp.on.ca [Grand River Regional Cancer Centre, Kitchener, Ontario (Canada)

2013-10-01T23:59:59.000Z

409

Proton therapy construction projects in the United States  

SciTech Connect (OSTI)

Proton and heavy-ion radiation therapy has been taking place now for 40 years, at many accelerator laboratories around the world, essentially all of these centers built originally for physics research. The high degree of promise shown for using these particles for treating and curing cancer has stimulated the medical community to look seriously at building dedicated accelerator facilities in a hospital setting, where more rapid progress can be made in clinical research, and development of effective treatments with these beams. In the United States, the first such facility, at the Loma Linda University Medical Center, has been in operation now for two years, and is currently treating a total of 35 to 40 patients per day. Two new projects are being designed at present, one at the Massachusetts General Hospital in Boston, Massachusetts, the second a joint project of the Lawrence Berkeley Laboratory and the University of California at Davis Medical Center in Sacramento, California. This paper will discuss accelerator and beam characteristics relevant to the proton-therapy application, and will present performance and operations characteristics for the Loma Linda facility, as well as details of the plans, process and progress towards construction of the new facilities in Boston and Sacramento.

Alonso, J.R.

1992-11-01T23:59:59.000Z

410

Report number codes  

SciTech Connect (OSTI)

This publication lists all report number codes processed by the Office of Scientific and Technical Information. The report codes are substantially based on the American National Standards Institute, Standard Technical Report Number (STRN)-Format and Creation Z39.23-1983. The Standard Technical Report Number (STRN) provides one of the primary methods of identifying a specific technical report. The STRN consists of two parts: The report code and the sequential number. The report code identifies the issuing organization, a specific program, or a type of document. The sequential number, which is assigned in sequence by each report issuing entity, is not included in this publication. Part I of this compilation is alphabetized by report codes followed by issuing installations. Part II lists the issuing organization followed by the assigned report code(s). In both Parts I and II, the names of issuing organizations appear for the most part in the form used at the time the reports were issued. However, for some of the more prolific installations which have had name changes, all entries have been merged under the current name.

Nelson, R.N. (ed.)

1985-05-01T23:59:59.000Z

411

SIGNIFICANT ITEMS (SIs) FY 2011 Senate Appropriations Committee Report  

E-Print Network [OSTI]

of Research Results 115 Down Syndrome 153 Dystonia Consortium 154 E Early Detection and Intervention 103 Bullosa (EB) 98 Epilepsy 48 F Fibromyalgia 155 Fragile X Syndrome 75 Frontotemporal Dementia 49 Funding Disabilities Research Centers (IDDRCs) 76 Interstitial Cystitis (IC) 41 Irritable Bowel Syndrome (IBS) 42 L

Rau, Don C.

412

Evaluation of a Thermoplastic Immobilization System for Breast and Chest Wall Radiation Therapy  

SciTech Connect (OSTI)

We report on the impact of a thermoplastic immobilization system on intra- and interfraction motion for patients undergoing breast or chest wall radiation therapy. Patients for this study were treated using helical tomotherapy. All patients were immobilized using a thermoplastic shell extending from the shoulders to the ribcage. Intrafraction motion was assessed by measuring maximum displacement of the skin, heart, and chest wall on a pretreatment 4D computed tomography, while inter-fraction motion was inferred from patient shift data arising from daily image guidance procedures on tomotherapy. Using thermoplastic immobilization, the average maximum motion of the external contour was 1.3 {+-} 1.6 mm, whereas the chest wall was found to be 1.6 {+-} 1.9 mm. The day-to-day setup variation was found to be large, with random errors of 4.0, 12.0, and 4.5 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively, and the standard deviations of the systematic errors were found to be 2.7, 9.8, and 4.1 mm. These errors would be expected to dominate any respiratory motion but can be mitigated by daily online image guidance. Using thermoplastic immobilization can effectively reduce respiratory motion of the chest wall and external contour, but these gains can only be realized if daily image guidance is used.

Strydhorst, Jared H. [Ottawa Hospital Cancer Centre, Ottawa (Canada); Department of Physics, Carleton University, Ottawa (Canada); Caudrelier, Jean-Michel [Ottawa Hospital Cancer Centre, Ottawa (Canada); Department of Radiology, University of Ottawa, Ottawa (Canada); Clark, Brenda G. [Ottawa Hospital Cancer Centre, Ottawa (Canada); Department of Physics, Carleton University, Ottawa (Canada); Department of Radiology, University of Ottawa, Ottawa (Canada); Montgomery, Lynn A.; Fox, Greg [Ottawa Hospital Cancer Centre, Ottawa (Canada); MacPherson, Miller S., E-mail: mmacpherson@cvh.on.c [Ottawa Hospital Cancer Centre, Ottawa (Canada); Department of Radiology, University of Ottawa, Ottawa (Canada); Department of Radiation Oncology, University of Toronto, Toronto (Canada); Radiation Medicine Program, Princess Margaret Hospital, Toronto (Canada)

2011-04-01T23:59:59.000Z

413

INEEL Advanced Radiotherapy Research Program Annual Report 2001  

SciTech Connect (OSTI)

This report summarizes the major activities and accomplishments of the Idaho National Engineering and Environmental Laboratory (INEEL) Advanced Radiotherapy Research Program for calendar year 2001. Applications of supportive research and development, as well as technology deployment in the fields of chemistry, radiation physics and dosimetry, and neutron source design and demonstration are described. Contributions in the fields of physics and biophysics include development of advanced patient treatment planning software, feasibility studies of accelerator neutron source technology for Neutron Capture Therapy (NCT), and completion of major modifications to the research reactor at Washington State University to produce an epithermal-neutron beam for NCT research applications.

Venhuizen, James Robert

2002-04-01T23:59:59.000Z

414

INEEL Advanced Radiotherapy Research Program Annual Report 2001  

SciTech Connect (OSTI)

This report summarizes the major activities and accomplishments of the Idaho National Engineering and Environmental Laboratory (INEEL) Advanced Radiotherapy Research Program for calendar year 2001. Applications of supportive research and development, as well as technology deployment in the fields of chemistry, radiation physics and dosimetry, and neutron source design and demonstration are described. Contributions in the fields of physics and biophysics include development of advanced patient treatment planning software, feasibility studies of accelerator neutron source technology for Neutron Capture Therapy (NCT), and completion of major modifications to the research reactor at Washington State University to produce an epithermal-neutron beam for NCT research applications.

Venhuizen, James R.

2002-04-30T23:59:59.000Z

415

The pharmaco-economics of combination therapies : a study of the effects of component and market factors on combined therapy price  

E-Print Network [OSTI]

For a growing number of indications, combination therapies are becoming increasingly common due in part to their superior efficacy, as compared to monotherapies. In fact, in the case of infectious diseases such as AIDS and ...

Subramaniam, Sundar

2006-01-01T23:59:59.000Z

416

2009 Wind Technologies Market Report  

E-Print Network [OSTI]

Wind Technologies Market Report References Acker, T. 2007.Industry Annual Market Report: Year Ending 2009. Washington,AWEA Mid-Year 2010 Market Report. Washington, DC: American

Wiser, Ryan

2010-01-01T23:59:59.000Z

417

ANNUAL SECURITY FIRE SAFETY REPORT  

E-Print Network [OSTI]

ANNUAL SECURITY AND FIRE SAFETY REPORT OCTOBER 1, 2013 DARTMOUTH COLLEGE http................................................................................................................................................................... 7 ANNUAL SECURITY REPORT........................................................................................................................9 PREPARATION OF THE REPORT AND DISCLOSURE OF CRIME STATISTICS

418

2012 Wind Technologies Market Report  

E-Print Network [OSTI]

Colorado: Xcel Energy. 2012 Wind Technologies Market ReportOperator. 2012 Wind Technologies Market Report Chadbourne &Power Company. 2012 Wind Technologies Market Report EnerNex

Wiser, Ryan

2014-01-01T23:59:59.000Z

419

National Compact Stellarator Experiment Project Closeout Report PROJECT CLOSEOUT REPORT  

E-Print Network [OSTI]

National Compact Stellarator Experiment Project Closeout Report i PROJECT CLOSEOUT REPORT NATIONAL of Science Princeton Plasma Physics Laboratory Oak Ridge National Laboratory #12;National Compact Stellarator Experiment Project Closeout Report PROJECT CLOSEOUT REPORT NATIONAL COMPACT STELLARATOR EXPERIMENT (NCSX

Princeton Plasma Physics Laboratory

420

The 2010 OSU Clery Act Report Fire Safety Report  

E-Print Network [OSTI]

The 2010 OSU Clery Act Report And Fire Safety Report The Jeanne Clery Disclosure of Campus Security Policy and Campus Crime Statistics Act #12;#12;Page | i Table of Contents The Annual Clery Act Report..........................................................................................................................................1 Reportable Areas

Escher, Christine

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


421

Annual Report Curtin University of Technology Annual Report 2006  

E-Print Network [OSTI]

Annual Report 2006 #12;#12;Curtin University of Technology Annual Report 2006 Chancellor's Foreword ........................................................................................................................ 2 Vice-Chancellor's Report ................................................................................................... 25 Report on Operations 28 Governance of the University

422

Education, Awareness & Prevention 2012 Annual Security Report and Fire Report  

E-Print Network [OSTI]

1 Education, Awareness & Prevention 2012 Annual Security Report and Fire Report Issue for 2013 criminal activity is being reported, i.e., 2012 TABLE OF CONTENTS Item Page Message from the President Action .................................................................. 14 Crimes Reported to FSUPD

423

LANSCE Activity Report  

SciTech Connect (OSTI)

The Los Alamos Neutron Science Center Activity Report describes scientific and technological progress and achievements in LANSCE Division during the period of 1995 to 1998. This report includes a message from the Division Director, an overview of LANSCE, sponsor overviews, research highlights, advanced projects and facility upgrades achievements, experimental and user program accomplishments, news and events, and a list of publications. The research highlights cover the areas of condensed-matter science and engineering, accelerator science, nuclear science, and radiography. This report also contains a compact disk that includes an overview, the Activity Report itself, LANSCE operations progress reports for 1996 and 1997, experiment reports from LANSCE users, as well as a search capability.

Amy Robinson; Audrey Archuleta; Barbara Maes; Dan Strottman; Earl Hoffman; Garth Tietjen; Gene Farnum; Geoff Greene; Joyce Roberts; Ken Johnson; Paul Lewis; Roger Pynn; Stan Schriber; Steve Sterbenz; Steve Wender; Sue Harper

1999-02-01T23:59:59.000Z

424

2005 SITE ENVIRONMENTAL REPORT  

SciTech Connect (OSTI)

Each year, Brookhaven National Laboratory (BNL) prepares an annual Site Environmental Report (SER) in accordance with DOE Order 231.1A, Environment, Safety and Health Reporting of the U.S. Department of Energy (DOE). The report is written to inform the public, regulators, employees, and other stakeholders of BNL's environmental performance during the calendar year in review. The SER summarizes environmental data; environmental management performance; compliance with applicable DOE, federal, state, and local regulations; and compliance, restoration, and surveillance monitoring program performance. BNL has prepared annual SERs since 1971 and has documented nearly all of its environmental history since the Laboratory's inception in 1947. The report is available in print and as a downloadable file on the BNL web page at http://www.bnl.gov/ewms/ser/. A summary of the SER is also prepared each year to provide a general overview of the report, and is distributed with a CD of the full report.

BROOKHAVEN NATIONAL LABORATORY

2006-08-29T23:59:59.000Z

425

2006 SITE ENVIRONMENTAL REPORT  

SciTech Connect (OSTI)

Each year, Brookhaven National Laboratory (BNL) prepares an annual Site Environmental Report (SER) in accordance with DOE Order 231.1A, Environment, Safety and Health Reporting of the U.S. Department of Energy. The report is written to inform the public, regulators, employees, and other stakeholders of BNL's environmental performance during the calendar year in review. The SER summarizes environmental data; environmental management performance; compliance with applicable DOE, federal, state, and local regulations; and compliance, restoration, and surveillance monitoring program performance. BNL has prepared annual SERs since 1971 and has documented nearly all of its environmental history since the Laboratory's inception in 1947. The report is available in print and as a downloadable file on the BNL web page at http://www.bnl.gov/ewms/ser/. A summary of the SER is also prepared each year to provide a general overview of the report, and is distributed with a CD of the full report.

BROOKHAVEN NATIONAL LABORATORY; RATEL,K.

2007-10-01T23:59:59.000Z

426

2009 Site Environmental Report  

SciTech Connect (OSTI)

Each year, Brookhaven National Laboratory (BNL) prepares an annual Site Environmental Report (SER) in accordance with DOE Order 231.1A, Environment, Safety and Health Reporting of the U.S. Department of Energy. The report is written to inform the public, regulators, employees, and other stakeholders of BNL's environmental performance during the calendar year in review. The SER summarizes environmental data; environmental management performance; compliance with applicable DOE, federal, state, and local regulations; and compliance, restoration, and surveillance monitoring program performance. BNL has prepared annual SERs since 1971 and has documented nearly all of its environmental history since the Laboratory's inception in 1947. The report is available in print and as a downloadable file on the BNL web page at http://www.bnl.gov/ewms/ser/. A summary of the SER is also prepared each year to provide a general overview of the report, and is distributed with a CD of the full report.

Ratel, K.M.; Brookhaven National Laboratory

2010-09-30T23:59:59.000Z

427

Melanoma Therapy with Rhenium-Cyclized Alpha Melanocyte Stimulating Hormone Peptide Analogs  

SciTech Connect (OSTI)

Malignant melanoma is the 6th most commonly diagnosed cancer with increasing incidence in the United States. It is estimated that 54,200 cases of malignant melanoma will be newly diagnosed and 7,600 cases of death will occur in the United States in the year 2003 (1). At the present time, more than 1.3% of Americans will develop malignant melanoma during their lifetime (2). The average survival for patients with metastatic melanoma is about 6-9 months (3). Moreover, metastatic melanoma deposits are resistant to conventional chemotherapy and external beam radiation therapy (3). Systematic chemotherapy is the primary therapeutic approach to treat patients with metastatic melanoma. Dacarbazine is the only single chemotherapy agent approved by FDA for metastatic melanoma treatment (5). However, the response rate to Dacarbazine is only approximately 20% (6). Therefore, there is a great need to develop novel treatment approaches for metastatic melanoma. The global goal of this research program is the rational design, characterization and validation of melanoma imaging and therapeutic radiopharmaceuticals. Significant progress has been made in the design and characterization of metal-cyclized radiolabeled alpha-melanocyte stimulating hormone peptides. Therapy studies with {sup 188}Re-CCMSH demonstrated the therapeutic efficacy of the receptor-targeted treatment in murine and human melanoma bearing mice (previous progress report). Dosimetry calculations, based on biodistribution data, indicated that a significant dose was delivered to the tumor. However, {sup 188}Re is a very energetic beta-particle emitter. The longer-range beta-particles theoretically would be better for larger tumors. In the treatment of melanoma, the larger primary tumor is usually surgically removed leaving metastatic disease as the focus of targeted radiotherapy. Isotopes with lower beta-energies and/or shorter particle lengths should be better suited for targeting metastases. The {sup 177}Lu-DOTA-Re(Arg11)CCMSH and {sup 212}Pb-DOTA-Re(Arg11)CCMSH complexes were developed and synthesized to investigate its ability to target and deliver an effective dose to small melanoma tumors and metastatic deposits. Dosimetry calculations for {sup 188}Re-CCMSH and {sup 212}Pb/{sup 212}Bi[DOTA]-Re(Arg11)CCMSH were compared in the B16/F1 mouse melanoma flank tumor model to analyze the delivered dose to tumor and normal organs.

Thomas P Quinn

2005-11-22T23:59:59.000Z

428

Cyclotron Produced Radionuclides for Diagnosis and Therapy of Human Neoplasms  

SciTech Connect (OSTI)

This project funded since 1986 serves as a core project for cancer research throughout MSKCC, producing key radiotracers as well as basic knowledge about thel physics of radiation decay and imaging, for nuclear medicine applications to cancer diagnosis and therapy. In recent years this research application has broadened to include experiments intended to lead to an improved understanding of cancer biology and into the discovery and testing of new cancer drugs. Advances in immune based radiotargeting form the basis for this project. Both antibody and cellular based immune targeting methods have been explored. The multi-step targeting methodologies (MST) developed by NeoRex (Seattle,Washington), have been adapted for use with positron emitting isotopes and PET allowing the quantification and optimization of targeted delivery. In addition, novel methods for radiolabeling immune T-cells with PET tracers have advanced our ability to track these cells of prolonged period of time.

Steven Larson MD

2009-09-21T23:59:59.000Z

429

Architecture, Engineering and Construction Sustainability Report Biannual Sustainability Report  

E-Print Network [OSTI]

Architecture, Engineering and Construction Sustainability Report i Biannual Sustainability Report Projects $5 Million and Over August 2012 Active Projects

Kamat, Vineet R.

430

Measurements and simulations of focused beam for orthovoltage therapy  

SciTech Connect (OSTI)

Purpose: Megavoltage photon beams are typically used for therapy because of their skin-sparing effect. However, a focused low-energy x-ray beam would also be skin sparing, and would have a higher dose concentration at the focal spot. Such a beam can be produced with polycapillary optics. MCNP5 was used to model dose profiles for a scanned focused beam, using measured beam parameters. The potential of low energy focused x-ray beams for radiation therapy was assessed. Methods: A polycapillary optic was used to focus the x-ray beam from a tungsten source. The optic was characterized and measurements were performed at 50 kV. PMMA blocks of varying thicknesses were placed between optic and the focal spot to observe any variation in the focusing of the beam after passing through the tissue-equivalent material. The measured energy spectrum was used to model the focused beam in MCNP5. A source card (SDEF) in MCNP5 was used to simulate the converging x-ray beam. Dose calculations were performed inside a breast tissue phantom. Results: The measured focal spot size for the polycapillary optic was 0.2 mm with a depth of field of 5 mm. The measured focal spot remained unchanged through 40 mm of phantom thickness. The calculated depth dose curve inside the breast tissue showed a dose peak several centimeters below the skin with a sharp dose fall off around the focus. The percent dose falls below 10% within 5 mm of the focus. It was shown that rotating the optic during scanning would preserve the skin-sparing effect of the focused beam. Conclusions: Low energy focused x-ray beams could be used to irradiate tumors inside soft tissue within 5 cm of the surface.

Abbas, Hassan, E-mail: Hassan.Abbas@Yale.Edu [Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, New Haven, 344 Lane Street Hamden, Connecticut 06514 (United States)] [Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, New Haven, 344 Lane Street Hamden, Connecticut 06514 (United States); Mahato, Dip N., E-mail: dip.n.mahato@intel.com [Intel Corporation, Mail-Stop RA3-410, 2501 NW 229th Avenue, Hillsboro, Oregon 97124 (United States); Satti, Jahangir, E-mail: sattij@mail.amc.edu [Department of Radiation Oncology, Albany Medical Center, 43 New Scotland Avenue, Albany, New York 12208 (United States)] [Department of Radiation Oncology, Albany Medical Center, 43 New Scotland Avenue, Albany, New York 12208 (United States); MacDonald, C. A., E-mail: c.macdonald@albany.edu [Department of Physics, University at Albany, SUNY, 1400 Washington Avenue, Albany, New York 12222 (United States)

2014-04-15T23:59:59.000Z

431

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

SECTIONS, DATA COLLECTION, ANALYSES, AND DATA STORAGE SYSTEM 5. Report Date Published: June 2012 6 plans, and 3) field test sections. The MS Access Data Storage System, used for storing and accessing, MS Access, Data Storage System, Test Section, M-E Model 18. Distribution Statement No restrictions

432

Tecbnleal Report Doeumentatlon Pale 1. Report No.  

E-Print Network [OSTI]

. Recipient's Catalog No. 4. Title and Subtitle S. Report Date July 1995 Impact ofCompressed Natural Gas systems to use alternative fuels to power bus fleets. Among such fuels, compressed natural gas (CNG ofcompleted page authorized #12;IMPACT OF COMPRESSED NATURAL GAS FUELED BUSES ON STREET PAVEMENTS by Dingyi

433

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

to be opened to long-haul Mexican carriers under NAFTA. As a result of truck traffic surge, from. Recipient's Catalog No. 5. Report Date April 2007 4. Title and Subtitle Characterizing Truck Traffic in truck movements in the countries. In 2004, the Supreme Court ruled against the requirement to undertake

434

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

, like person delay, fuel consumption, and mobile source emissions, were used to compare alternative Transportation Center Texas Transportation Institute The Texas A&M University System College Station, Texas 77843 in this report used eight months of travel time data (April through November 1994) available through Houston

435

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

creep issues. Thermal stresses also play a role in bridge deck cracking. These stresses result from. Recipient's Catalog No. 5. Report Date October 2003 4. Title and Subtitle Evaluation of Alternative Materials to Control Drying- Shrinkage Cracking in Concrete Bridge Decks 6. Performing Organization Code 7

Texas at Austin, University of

436

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

problems associated with using a global positioning system (GPS) with real-time, satellite is available to the public through the National Technical Information Service, Springfield, Virginia 22161. 19. Security Classif. (of report) Unclassified 20. Security Classif. (of this page) Unclassified 21. No

Texas at Austin, University of

437

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

, topographical and satellite aerial maps to assist with the identification of the project extents. Once TRMs through the National Technical Information Service, Springfield, Virginia 22161; www.ntis.gov. 19. Security Classif. (of report) Unclassified 20. Security Classif. (of this page) Unclassified 21. No

Texas at Austin, University of

438

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

As the United States imports more than half of its oil and overall consumption continues to climb, the 1992 Information Service 5285 Port Royal Road Springfield, Virginia 22161 19. Security Classif.(of this report) Unclassified 20. Security Classif.(of this page) Unclassified 21. No. of Pages 54 22. Price Form DOT F 1700

439

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

and metropolitan areas. Economists have also predicted that oil prices will rise in real terms during the same: National Technical Information Service 5285 Port Royal Road Springfield, Virginia 22161 19. Security Classif. (of this report) Unclassified 20. Security Classif. (of this page) Unclassified 21. No. of Pages

440

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

been ongoing since the oil crises of the 1970s. While there are some commonalties in the regulatory 5285 Port Royal Road Springfield, Virginia 22161 19. Security Classif.(of this report) Unclassified 20. Security Classif.(of this page) Unclassified 21. No. of Pages 51 22. Price Form DOT F 1700.7 (8

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


441

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

that macro-economic conditions, such as prices of commodities (e.g. oil, cement and steel) affect the cost 5285 Port Royal Road Springfield, Virginia 22161 19. Security Classif.(of this report) Unclassified 20. Security Classif.(of this page) Unclassified 21. No. of Pages 174 22. Price Form DOT F 1700.7 (8

442

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

for Carbon Sequestration Using a Controlled Environment 5. Report Date May 2012 6. Performing Organization carbon sequestration techniques are rapidly becoming part of how environmental mitigation business is conducted, not only in Texas but globally. Terrestrial carbon sequestration is the general term used

443

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

in the laboratory for different pier sizes and for a range of subcritical flow conditions. Both water level changes. Recipient's Catalog No. 4. BACKWATER EFFECTS OF PIERS IN SUBCRITICAL FLOW 5. Report Date October 2001 6 or floodplain of natural waterways. These piers will obstruct the flow and may cause an increase in water levels

Texas at Austin, University of

444

Technical Report Documentation Page 1. Report No.  

E-Print Network [OSTI]

. Recipient's Catalog No. 4. Title and Subtitle FRONTAGE ROADS IN TEXAS: A Comprehensive Assessment. 5. Report corridors suggested that land near frontage roads is associated with lower household incomes, lower, in addition to efforts by other researchers, will assist in constructing a solid, formal policy for all states

Kockelman, Kara M.

445

International petroleum statistics report  

SciTech Connect (OSTI)

This report provides information on current international petroleum production, demand, imports, and stocks. World oil demand and OECD demand data are presented for the years 1970 thru 1995.

NONE

1996-08-01T23:59:59.000Z

446

1999 Site Environmental Report  

SciTech Connect (OSTI)

The Site Environmental Report for Brookhaven National Laboratory for the calendar year 1999, as required by DOE Order 231.1.

NONE

2000-09-01T23:59:59.000Z

447

WACR Calibration Report  

SciTech Connect (OSTI)

Calibration report for the W-Band (95 GHz) ARM Cloud Radar performed for the ARM Climate Research Facility by ProSensing Inc.

Mead, D

2010-03-23T23:59:59.000Z

448

2004 OMB Annual Report  

Broader source: Energy.gov (indexed) [DOE]

DOE contracts; and DOE safety basis documents (stated as a commitment or applied reference in DOE documented safety analyses, including safety analysis reports, standards...

449

Final Technical Report  

SciTech Connect (OSTI)

This report summarizes many of the projects, and lists all of the publications and persons trained with support from the grant.

Herrin, David L

2011-04-21T23:59:59.000Z

450

Visual Resource Report  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

Assessment Visual Resource Report in Support of the I-5 Corridor Reinforcement Project Environmental Impact Statement Prepared for: Bonneville Power Administration P.O. Box 3621...

451

BPA 2002 Annual Report  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

STATEMENTS 2002 Annual Report of the Bonneville Power Administration Cover photo BPA fish biologist Andy Thoms (upper right) works with students from H.B. Lee Middle School...

452

2007 Annual Report  

SciTech Connect (OSTI)

This annual report includes: a brief overview of Western; FY 2007 highlights; FY 2007 Integrated Resource Planning, or IRP, survey; and financial data.

none,

2007-01-01T23:59:59.000Z

453

EV Project Overview Report  

Broader source: Energy.gov (indexed) [DOE]

Report Project to date through March 2013 Charging Infrastructure Region Number of EV Project Charging Units Installed To Date Number of Charging Events Performed Electricity...

454

NTTAA 2010 OMB Report  

Broader source: Energy.gov (indexed) [DOE]

Technology Transfer and Advancement Act of 1995 2010 Annual Report for The Department of Energy Compressed Gas Association CGA Construction Safety Association of Ontario CSAO...

455

Web Survey Technical Report  

E-Print Network [OSTI]

Glisson,W.B. Welland,R.C. DCS Technical Report Series pp 27 Dept of Computing Science, University of Glasgow

Glisson, W.B.; Welland, R.C.

456

2007 Site Environmental Report  

SciTech Connect (OSTI)

Brookhaven National Laboratory (BNL) prepares an annual Site Environmental Report (SER) in accordance with DOE Order 231.1A, Environment, Safety and Health Reporting of the U.S. Department of Energy. The report is written to inform the public, regulators, employees, and other stakeholders of the Laboratory's environmental performance during the calendar year in review. Volume I of the SER summarizes environmental data; environmental management performance; compliance with applicable DOE, federal, state, and local regulations; and performance in restoration and surveillance monitoring programs. BNL has prepared annual SERs since 1971 and has documented nearly all of its environmental history since the Laboratory's inception in 1947. Volume II of the SER, the Groundwater Status Report, also is prepared annually to report on the status of and evaluate the performance of groundwater treatment systems at the Laboratory. Volume II includes detailed technical summaries of groundwater data and its interpretation, and is intended for internal BNL users, regulators, and other technically oriented stakeholders. A brief summary of the information contained in Volume II is included in this volume in Chapter 7, Groundwater Protection. Both reports are available in print and as downloadable files on the BNL web page at http://www.bnl.gov/ewms/ser/. An electronic version on compact disc is distributed with each printed report. In addition, a summary of Volume I is prepared each year to provide a general overview of the report, and is distributed with a compact disc containing the-length report.

Ratel,K.

2008-10-01T23:59:59.000Z

457

EMSL 2009 Annual Report  

SciTech Connect (OSTI)

The EMSL 2009 Annual Report describes the science conducted at EMSL during 2009 as well as outreach activities and awards and honors received by users and staff.

Showalter, Mary Ann; Kathmann, Loel E.; Manke, Kristin L.; Wiley, Julie G.; Reed, Jennifer R.

2010-02-26T23:59:59.000Z

458

2001 SITE ENVIRONMENTAL REPORT  

SciTech Connect (OSTI)

THE SITE ENVIRONMENTAL REPORT FOR BROOKHAVEN NATIONAL LABORATORY FOR THE CALENDAR YEAR 2001, AS REQUIRED BY DOE ORDER 231.1.

BROOKHAVEN NATIONAL LABORATORY

2002-09-01T23:59:59.000Z

459

DOE Final Report  

SciTech Connect (OSTI)

This final report contains a summary of work accomplished in the establishment of a Climate Data Center at the International Arctic Research Center, University of Alaska Fairbanks.

Hinzman, Larry D.; Long, James; Newby, Greg B.

2014-01-08T23:59:59.000Z

460

1982 analyses and reports: equipment availability report; component cause code report; and equipment availability report  

SciTech Connect (OSTI)

This equipment availability report (1973 to 1982, 1982) presents statistical information on the performance of the major types of generating units and their major component groups. (DLC)

Not Available

1982-01-01T23:59:59.000Z

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


461

Environmental Progress Report  

E-Print Network [OSTI]

Appendices A: Summary of past reports B: Comprehensive table of historical consumption of coal. Energy Consumption in Buildings ...................................................................... 6.............................................................................................................. 27 2. Energy Consumption in Buildings

Wang, Xiaorui "Ray"

462

REPORT OF POSSIBLE VIOLATION Campus Community Report 2008.doc  

E-Print Network [OSTI]

REPORT OF POSSIBLE VIOLATION Campus Community Report 2008.doc 1. Student Information Date of report: Student Last Name (if known): Student First Name: Student ID # 2. Reporting Party Information Your Last in which we may be able to respond to anonymous reports. 3. Type of Report: Honor: Lying Cheating Stealing

Swaddle, John

463

Environmental Report 2008  

SciTech Connect (OSTI)

The purposes of the Lawrence Livermore National Laboratory Environmental Report 2008 are to record Lawrence Livermore National Laboratory's (LLNL's) compliance with environmental standards and requirements, describe LLNL's environmental protection and remediation programs, and present the results of environmental monitoring at the two LLNL sites - the Livermore site and Site 300. The report is prepared for the U.S. Department of Energy (DOE) by LLNL's Environmental Protection Department. Submittal of the report satisfies requirements under DOE Order 231.1A, Environmental Safety and Health Reporting, and DOE Order 5400.5, Radiation Protection of the Public and Environment. The report is distributed electronically and is available at https://saer.lln.gov/, the website for the LLNL annual environmental report. Previous LLNL annual environmental reports beginning in 1994 are also on the website. Some references in the electronic report text are underlined, which indicates that they are clickable links. Clicking on one of these links will open the related document, data workbook, or website that it refers to. The report begins with an executive summary, which provides the purpose of the report and an overview of LLNL's compliance and monitoring results. The first three chapters provide background information: Chapter 1 is an overview of the location, meteorology, and hydrogeology of the two LLNL sites; Chapter 2 is a summary of LLNL's compliance with environmental regulations; and Chapter 3 is a description of LLNL's environmental programs with an emphasis on the Environmental Management System including pollution prevention. The majority of the report covers LLNL's environmental monitoring programs and monitoring data for 2008: effluent and ambient air (Chapter 4); waters, including wastewater, storm water runoff, surface water, rain, and groundwater (Chapter 5); and terrestrial, including soil, sediment, vegetation, foodstuff, ambient radiation, and special status wildlife and plants (Chapter 6). Complete monitoring data, which are summarized in the body of the report, are provided in Appendix A. The remaining three chapters discuss the radiological impact on the public from LLNL operations (Chapter 7), LLNL's groundwater remediation program (Chapter 8), and quality assurance for the environmental monitoring programs (Chapter 9). The report uses Systeme International units, consistent with the federal Metric Conversion Act of 1975 and Executive Order 12770, Metric Usage in Federal Government Programs (1991). For ease of comparison to environmental reports issued prior to 1991, dose values and many radiological measurements are given in both metric and U.S. customary units. A conversion table is provided in the glossary. The report is the responsibility of LLNL's Environmental Protection Department. Monitoring data were obtained through the combined efforts of the Environmental Protection Department; Environmental Restoration Department; Physical and Life Sciences Environmental Monitoring Radiation Laboratory; and the Hazards Control Department.

Gallegos, G; Bertoldo, N A; Campbell, C G; Cerruti, S; Dibley, V; Doman, J L; Grayson, A R; Jones, H E; Kumamoto, G; MacQueen, D H; Nelson, J C; Paterson, L; Revelli, M A; Wegrecki, A M; Wilson, K; Woollett, J

2009-09-16T23:59:59.000Z

464

Feasibility of a predictive model of Hsp70b-activated gene therapy protein expression during ultrasound hyperthermia  

E-Print Network [OSTI]

Gene therapy has been heralded as a possible approach to a variety of diseases and conditions, ranging from cancer and heart disease to blindness and neurodegenerative diseases. However, progress in gene therapy requires ...

Silcox, Christina Elise

2014-01-01T23:59:59.000Z

465

ANNUAL REPORT 2011 OFFICEOFSPONSOREDPROJECTS  

E-Print Network [OSTI]

Projects presents the Fiscal Year 2011 Annual Report on external funding at Northern Illinois University where the University experienced a significant increase in funding due to both the continued to comprehensively account for external funding for the university's core mission activities, this year's report also

Karonis, Nicholas T.

466

TRANSPORTATION Annual Report  

E-Print Network [OSTI]

2003 CENTER FOR TRANSPORTATION STUDIES Annual Report #12;Center for Transportation Studies University of Minnesota 200 Transportation and Safety Building 511 Washington Avenue S.E. Minneapolis, MN publication is a report of transportation research, education, and outreach activities for the period July

Minnesota, University of

467

Microhole Tubing Bending Report  

SciTech Connect (OSTI)

A downhole tubing bending study was made and is reported herein. IT contains a report and 2 excel spreadsheets to calculate tubing bending and to estimate contact points of the tubing to the drilled hole wall (creating a new support point).

Oglesby, Ken

2012-01-01T23:59:59.000Z

468

Technical Report Computer Laboratory  

E-Print Network [OSTI]

the opportunity to consider a physical attack, with very little to lose. We thus set out to analyse the deviceTechnical Report Number 592 Computer Laboratory UCAM-CL-TR-592 ISSN 1476-2986 Unwrapping J. Murdoch Technical reports published by the University of Cambridge Computer Laboratory are freely

Haddadi, Hamed

469

Technical Report Computer Laboratory  

E-Print Network [OSTI]

for criminal activity. One general attack route to breach the security is to carry out physical attack afterTechnical Report Number 829 Computer Laboratory UCAM-CL-TR-829 ISSN 1476-2986 Microelectronic report is based on a dissertation submitted January 2009 by the author for the degree of Doctor

Haddadi, Hamed

470

Kentucky Annual Economic Report  

E-Print Network [OSTI]

2014 Kentucky Annual Economic Report Center for Business and Economic Research Gatton College of Business and Economics University of Kentucky #12; #12;Kentucky Annual Economic Report 2014 Center for Business and Economic Research Department of Economics Gatton College of Business and Economics University

Hayes, Jane E.

471

UC Sustainability Office Report  

E-Print Network [OSTI]

1 UC Sustainability Office Report Introduction Welcome to the second annual UC Sustainability Office Report. 2012 saw the Sustainability Office focus its attentions on enhancing the student experience and building on UC's statement of strategic intent of `people prepared to make a difference'. We

Hickman, Mark

472

Microhole Tubing Bending Report  

DOE Data Explorer [Office of Scientific and Technical Information (OSTI)]

A downhole tubing bending study was made and is reported herein. IT contains a report and 2 excel spreadsheets to calculate tubing bending and to estimate contact points of the tubing to the drilled hole wall (creating a new support point).

Oglesby, Ken

473

Internet Polling Development Report  

E-Print Network [OSTI]

, and the development of a polling engine to launch the above procedures and pass the data on to the database server. This final report describes the automated polling procedures that have been developed for Synergistic, Highland and ABB loggers. This report also...

Klima, P.; Lockhart, D.; Haberl, J. S.

2001-01-01T23:59:59.000Z

474

2030 OCARTS Plan Report  

E-Print Network [OSTI]

......................................Director of Planning & Program Development Pearlie Tiggs................................................................... Community Planner 2030 OCARTS Plan Report Table of Contents PART 1 INTRODUCTION........................................................................ 1 Federal Legislation.......................................................................... 1 Purpose of the Plan Report and Relationship to other Plan Documents............. 3 Organization of the Transportation Planning Process...

Association of Central Oklahoma Governments

475

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Summer 2000 Vol. 15, No. 2 Department of Environmental Quality (DEQ) Implementing Nontidal Wetlands Protection Mandate Ellen Gilinsky wetland resources, but which occur outside of federal regulation. The General Assembly was motivated

476

The Virginia Wetlands Report  

E-Print Network [OSTI]

The Virginia Wetlands Report Summer 1997 Vol. 12, No. 2The Virginia Wetlands Report Wetlands mitigation banking is a relatively new tool for wetlands managers. It is finding increasing application in the struggle to achieve a "no net loss" goal for our remaining wetland resources. The concept of creating

477

The Virginia Wetlands Report  

E-Print Network [OSTI]

The Virginia Wetlands Report Fall 1997 Vol. 12, No. 3The Virginia Wetlands Report Almost everyone their actions. It is this com- mon sense notion which is motivating a new Wetlands Initiative under the auspices of the Chesapeake Bay Program Wetlands Workgroup. State and federal wet- lands program man- agers are working

478

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Fall 2001 Vol. 16, No. 3 A GIS Approach for Targeting Potential Wetlands Mitigation or Restoration Sites By Marcia Berman and Tamia vegeta- tion, islands, and wetlands. Most activi- ties enhance habitat for living resources, but also

479

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Spring 2002 Vol. 17, No. 1 Update On Virginia's New and Improved Nontidal Wetlands Program By Ellen Gilinsky, Ph.D. PWS Virginia wetlands program. Key changes included the provi- sion of additional jurisdic- tion over: excavation in all

480

The Virginia Wetlands Report  

E-Print Network [OSTI]

The Virginia Wetlands Report Continued on page 2 Spring 1996 Vol. 11, No. 2The Virginia Wetlands Report Completely Updated The Wetlands Program of the Vir- ginia Institute of Marine Science has completed its update of the Vir- ginia Wetlands Management Hand- book, and with the aid of the Marine

Note: This page contains sample records for the topic "reporting interstitial therapy" from the National Library of EnergyBeta (NLEBeta).
While these samples are representative of the content of NLEBeta,
they are not comprehensive nor are they the most current set.
We encourage you to perform a real-time search of NLEBeta
to obtain the most current and comprehensive results.


481

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Winter/Spring 2000 Vol. 15, No. 1 Virginia Debates Nontidal Wetlands Regulation Carl Hershner Wetland regulation is once again- trolling impacts on existing wetlands, as well as creating new wetlands. There is general agreement

482

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Fall 2005 Vol. 20, No. 2 VMRC Adopts Wetland Mitigation/ Compensation Policy Changes By Tom Barnard When the Virginia Wetlands Act went into effect on July 1, thirty- three years ago, no one had ever heard of compensatory mitigation, wetland

483

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Spring 2005 Vol. 20, No. 1 Annual Summary of Permitted Tidal Wetland Impacts - 2004 By Karen Duhring The Wetlands Program has main impact areas based on a site visit and information provided in the permit documents. The Wetlands Program

484

The Virginia Wetlands Report  

E-Print Network [OSTI]

VWR -- 1 The Virginia Wetlands Report The Virginia Wetlands Report Winter/Spring 2001 Vol. 16, No. 1 The VIMS Teaching Marsh: A Tidal Wetland Restoration and Education Project Karen Duhring Purpose wetlands education opportunities, including field lessons. Due to the vari- ety and geographic distribution

485

Routine Repeat Head CT may not be Indicated in Patients on Anticoagulant/Antiplatelet Therapy Following Mild Traumatic Brain Injury  

E-Print Network [OSTI]

therapy is frequently employed to treat or prevent vascularare separate units which both treat this patient population,

McCammack, Kevin C.; Sadler, Charlotte; Guo, Yueyang; Ramaswamy, Raja S; Farid, Nikdokht

2015-01-01T23:59:59.000Z

486

Environmental Report 2007  

SciTech Connect (OSTI)

The purposes of the 'Lawrence Livermore National Laboratory Environmental Report 2007' are to record Lawrence Livermore National Laboratory's (LLNL's) compliance with environmental standards and requirements, describe LLNL's environmental protection and remediation programs, and present the results of environmental monitoring at the two LLNL sites--the Livermore site and Site 300. The report is prepared for the U.S. Department of Energy (DOE) by LLNL's Environmental Protection Department. Submittal of the report satisfies requirements under DOE Order 231.1A, Environmental Safety and Health Reporting, and DOE Order 5400.5, Radiation Protection of the Public and Environment. The report is distributed electronically and is available at https://saer.lln.gov/, the website for the LLNL annual environmental report. Previous LLNL annual environmental reports beginning in 1994 are also on the website. Some references in the electronic report text are underlined, which indicates that they are clickable links. Clicking on one of these links will open the related document, data workbook, or website that it refers to. The report begins with an executive summary, which provides the purpose of the report and an overview of LLNL's compliance and monitoring results. The first three chapters provide background information: Chapter 1 is an overview of the location, meteorology, and hydrogeology of the two LLNL sites; Chapter 2 is a summary of LLNL's compliance with environmental regulations; and Chapter 3 is a description of LLNL's environmental programs with an emphasis on the Environmental Management System including pollution prevention. The majority of the report covers LLNL's environmental monitoring programs and monitoring data for 2007: effluent and ambient air (Chapter 4); waters, including wastewater, storm water runoff, surface water, rain, and groundwater (Chapter 5); and terrestrial, including soil, sediment, vegetation, foodstuff, ambient radiation, and special status wildlife and plants (Chapter 6). Complete monitoring data, which are summarized in the body of the report, are provided in Appendix A. The remaining three chapters discuss the radiological impact on the public from LLNL operations (Chapter 7), LLNL's groundwater remediation program (Chapter 8), and quality assurance for the environmental monitoring programs (Chapter 9). The report uses Systeme International units, consistent with the federal Metric Conversion Act of 1975 and Executive Order 12770, Metric Usage in Federal Government Programs (1991). For ease of comparison to environmental reports issued prior to 1991, dose values and many radiological measurements are given in both metric and U.S. customary units. A conversion table is provided in the glossary.

Mathews, S; Gallegos, G; Berg, L L; Bertoldo, N A; Campbell, C G; Cerruti, S; Doman, J L; Ferry, L S; Grayson, A R; Jones, H E; Kumamoto, G; Larson, J; MacQueen, D H; Paterson, L; Revelli, M A; Ridley, M; Rueppel, D; Wegrecki, A M; Wilson, K; Woollett, J

2008-09-24T23:59:59.000Z

487

International petroleum statistics report  

SciTech Connect (OSTI)

The International Petroleum Statistics Report is a monthly publication that provides current international oil data. This report presents data on international oil production, demand, imports, exports and stocks. The report has four sections. Section 1 contains time series data on world oil production, and on oil demand and stocks in the Organization for Economic Cooperation and Development (OECD). Section 2 presents an oil supply/demand balance for the world, in quarterly intervals for the most recent two years. Section 3 presents data on oil imports by OECD countries. Section 4 presents annual time series data on world oil production and oil stocks, demand, and trade in OECD countries.

NONE

1995-10-01T23:59:59.000Z

488

A report language  

E-Print Network [OSTI]

determine after using a printer spacing chart. The programmer is, however, given the option of explicitly specifying the print positions as might be required when a report is to be produced on a pre-printed form. 1. 2. The Need For The Lan ua e A survey... to the Lan ua e Section 2 contains a detailed description of the "EASYOUT" language snd Appendix A, two sample reports. The following example is included as a preliminary introduction to the language. Suppose the problem is to produce a report from cards...

McKinney, Melvin Howard

2012-06-07T23:59:59.000Z

489

ReportDisplay  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLas ConchasPassive Solar HomePromisingStories » Removing nuclear waste,ReportReportReport on

490

Report #: 2010-00292 Reported: 07/30/10 1523  

E-Print Network [OSTI]

July 2010 Report #: 2010-00292 Reported: 07/30/10 1523 Occurred: Same Incident: Medical Emergency Location: Lot F Disposition: Report--Closed Comments: Subject complaining of chest pains and shortness of breath; transported to hospital by ambulance. Report #: 2010-00291 Reported: 07/30/10 1313 Occurred: 08

Boyce, Richard L.

491

Report #: 2008-00484 Reported: 05/31/08 1229  

E-Print Network [OSTI]

MAY 2008 Report #: 2008-00484 Reported: 05/31/08 1229 Occurred: Same Incident: Medical Emergency Location: University Suites Disposition: Report--Closed Comments: Subject complaining of chest pains; life squad transported subject to hospital. Report #: 2008-00483 Reported: 05/31/08 1100 Occurred: Same

Boyce, Richard L.

492

Report #: 2008-00523 Reported: 06/20/08 0855  

E-Print Network [OSTI]

June 2008 Report #: 2008-00523 Reported: 06/20/08 0855 Occurred: Same Incident: Disorderly Person Location: Dorm ­ Norse Commons Disposition: Report--Closed Comments: Complaint of a disorderly juvenile that was attending a camp on campus. Report #: 2008-00522 Reported: 06/30/08 0034 Occurred: Same Incident: Found

Boyce, Richard L.

493

Academy Member Annual Update Report 1Academy Member Update Report  

E-Print Network [OSTI]

Academy Member Annual Update Report 1Academy Member Update Report The annual update report is an important activity associated with active membership in the Academy. These reports are due annually questions. A separate document includes the required report format and directions. Please email omerad

494

Report #: 2008-00404 Reported: 04/30/08 2119  

E-Print Network [OSTI]

April 2008 Report #: 2008-00404 Reported: 04/30/08 2119 Occurred: Same Incident: Traffic Stop. Report #: 2008-00403 Reported: 04/30/08 2059 Occurred: Same Incident: Traffic Stop Location: Nunn Drive Disposition: Citation--Closed Comments: Citation issued for speed and failure to produce insurance. Report

Boyce, Richard L.

495

Report #: 2008-00271 Reported: 03/31/08 2141  

E-Print Network [OSTI]

March 2008 Report #: 2008-00271 Reported: 03/31/08 2141 Occurred: Same Incident: Fire/Smoke Alarm Location: Dorms--University Suites Disposition: Report--Closed Comments: False alarm due to a cleaning product; Central Campbell Fire Department responded. Report #: 2008-00270 Reported: 03/30/08 2306 Occurred

Boyce, Richard L.

496

Leg 192 Preliminary Report72 Leg 192 Preliminary Report  

E-Print Network [OSTI]

Leg 192 Preliminary Report72 Figure 21 cm 70 75 80 65 60 #12;Leg 192 Preliminary Report Figure 22 73 Basalt C D E F A B #12;Leg 192 Preliminary Report74 Figure 23 #12;Leg192PreliminaryReport Figure207002120021300 21100 21000 20900 20800 Shotpoints #12;Leg192PreliminaryReport76 Figure 25 Nannofossils

497

Report #: 2008-00572 Reported: 07/31/08 2200  

E-Print Network [OSTI]

July 2008 Report #: 2008-00572 Reported: 07/31/08 2200 Occurred: Same Incident: Disorderly Conduct and trying to incite a crowd. Report #: 2008-00571 Reported: 07/31/08 1012 Occurred: 07/30/08 1230 to 07/31/08 1000 Incident: Burglary Location: Landrum Disposition: Report--Open Comments: Theft of property from

Boyce, Richard L.

498

Microsoft Word - Blue Report Cover Report  

Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE: Alternative Fuels Data Center Home Page on Google Bookmark EERE: Alternative Fuels Data Center Home Page on Delicious RankCombustion | Department ofT ib l L d F S i DOE Tribal Leader HOWARD8-04Audit ServicesTheReport on

499

2012 Hanford Climate Survey Report - ATL Report  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLasDelivered‰PNGExperience hands-onASTROPHYSICS H. I. Park, L.2 Wed,Energy 2ATL Report

500

2012 Hanford Climate Survey Report - MSA Report  

Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

AFDC Printable Version Share this resource Send a link to EERE: Alternative Fuels Data Center Home Page to someone by E-mail Share EERE: Alternative Fuels Data Center Home Page on Facebook Tweet about EERE: Alternative Fuels Data Center Home Page on Twitter Bookmark EERE:1 First Use of Energy for All Purposes (Fuel and Nonfuel),Feet) Year Jan Feb Mar Apr May JunDatastreamsmmcrcalgovInstrumentsrucLasDelivered‰PNGExperience hands-onASTROPHYSICS H. I. Park, L.2 Wed,EnergyMSA Report